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Robotic rehabilitation devices have been developed to assist therapists to rehabilitate 
stroke patients based on intensive, high repetitions of task specific exercises to train the 
impaired limbs of patients. In contrast, conventional therapy is labour intensive and 
places physical strain on therapists when sustaining intense exercises. Hence it is hoped 
that with robotic assistive devices, better rehabilitation progress can be achieved for 
patients, together with alleviation of time and physical demands on therapists.  
 
However, there are still uncertainties regarding the use of robotic devices. Studies on 
the clinical effectiveness of robotic devices have presented a mixed picture. Robotic 
devices are high capital cost items and its economic cost effectiveness is unclear. The 
adoption of robotic devices into clinical settings is also an area lacking clarity, as these 
devices do not work alone but are part of a wider spectrum of clinical care that involves 
clinicians, patients, hospital administrators and device manufacturers. Inadequate, or 
incomplete interconnection across these domains of clinical care could affect adoption 
into clinical settings. 
 
Given these uncertainties, the aim of this thesis was to examine and investigate the 
clinical effectiveness, economic cost, and clinical adoption of robotic rehabilitation. The 
specific research questions were: 
 Can robotic devices help adult stroke patients to regain motor movement of their 
upper and lower limbs?  
 Can robotic devices rehabilitate adult stroke patients cost economically?  
 What are the clinical views and experiences of utilizing robotic rehabilitation? 
What are the factors to consider when introducing robotic devices into the clinical 
care environment? 
 How can findings from the effectiveness, economic cost and adoption studies be 
aggregated to create a conceptual framework of providing robotic rehabilitation? 
 
To determine the effectiveness and cost effectiveness of robotic rehabilitation, two 
systematic reviews were conducted according to the JBI review methodology. To seek 
insights regarding its clinical adoption, qualitative descriptive interviews were conducted 




The findings of our research show that robotic rehabilitation is not only clinically effective 
but also economically cost effective, and especially for severely impaired lower limb 
patients robotic therapy provides better outcomes. The adoption study, which bridges 
the gap between the effectiveness and economic evidence from systematic reviews and 
translation into clinical practice, has uncovered a multitude of factors that need to be 
taken into consideration when introducing robotic rehabilitation into practice. These 
factors involve not just simply user training for these devices, but also aspects such as 
workflow processes, interfacing systems, communication strategies to influence 
adoption, perceived benefits, and attitudes and motivations of users. From the 
understandings gained from these various streams of research, a conceptual framework 
on implementing robotic rehabilitation was developed in order to facilitate translation of 
the research evidence into practice. 
 
This thesis contributes new evidence on effectiveness, cost-effectiveness and clinical 
integration to the global knowledge base about the use of robotic rehabilitation, and 
ultimately will lead to stroke patients benefiting from robotic rehabilitation and gaining 
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Chapter One: Introduction 
 
This chapter describes the nature of stroke in adults: its causes, impairment effects, and 
rehabilitation methods. From the concept of neuroplasticity and the use of intensive 
therapy to regain functional improvements, the application of robotic devices in 
rehabilitation is introduced. We then discuss uncertainties surrounding robotic 
rehabilitation which leads to the aim of this thesis, that is to determine the clinical and 
cost effectiveness, and adoption considerations of robotic rehabilitation in clinical 
settings. Lastly, we outline the composition of subsequent chapters contained in this 
thesis that answer the research questions posed. 
 
Incidence of stroke 
Stroke is a leading cause of long-term disability and is the third most common cause of 
mortality in developed countries with 15 million people suffering a stroke yearly.1 The 
annual incidence of stroke is around 2 per 1000 in developed countries and the incidence 
of stroke rises steeply with increasing age, with the average age of stroke patients at 75 
years old.2 In terms of gender, men are 25% to 30% more likely to suffer a stroke 
compared to women, and people in lower socio-economic strata are 60% more likely 
than those in higher strata to suffer a stroke.2 The mortality risk within three months after 
a stroke incident is around 30%, and even if they survive a stroke incident, stroke 
survivors are commonly left with long-term impairments (physical, speech and cognitive 
deficits).2 
 
In Australia, stroke is also a leading cause of disability, with 65% of stroke survivors 
unable to carry out daily living activities unassisted.3 In 2017 there were around 475,000 
people living with the effects of stroke and this is predicted to increase to one million by 
2050.3 In terms of the financial cost (health system cost, direct and indirect costs) of 
stroke in Australia, it is estimated to be around $5 billion each year.3 
 
Causes and effects of stroke 
Stroke is an acute neurologic deficit and is caused by cerebrovascular aetiology, when 
the flow of blood to the brain is interrupted. Oxygen is carried from the lungs to tissues 
in the body by the protein haemoglobin in red blood cells, and an interruption of oxygen 
supply for a few minutes to the brain will cause neuronal death (cerebral infarction).4 
This leads to a loss of neurological functions, which manifest as physical, speech and 
cognitive impairments. When an infarction occurs, there is a central area of dead brain 
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tissue, which is surrounded by brain tissue that is ischemic (i.e. with restricted blood 
supply) but not yet dead. Further from the central infarction area, the brain becomes less 
ischemic. Recovery of neurological functions within this ischemic penumbra, together 
with the ability of unaffected parts of the brain taking over the affected parts (i.e. 
neuroplasticity), are the likely mechanisms that contribute to the therapeutic 
rehabilitation of stroke patients.2 
 
There are two types of stroke: ischemic and haemorrhagic. Ischemic stroke is caused 
by blockage of blood vessels (vascular occlusion or stenosis) and haemorrhagic stroke 
by rupture of blood vessels (vascular rupture). Ischemic stroke is the main type of stroke 
and accounts for 80% of stroke cases.5  
 
Two types of ischemic strokes exist.5 They are: 
 Embolic 
o Stroke that is caused by a clot that is formed elsewhere in the body and is 
transported via the blood stream to the brain. In the brain, the clot reaches 
an artery which is too small for it to pass through and becomes embedded, 
thus limiting blood flow. 
 Thrombotic 
o Stroke that is caused by cholesterol deposits on the inner walls of blood 
vessels. Over time, the deposit grows in size and leads to a narrowing and 
eventual blockage of the artery. 
 
Haemorrhagic strokes can also be classified into two types:5 
 Intracerebral 
o Haemorrhage that is caused when an artery within the brain bursts and blood 
flows out of the blood vessel into the brain tissue. 
 Subarachnoid 
o Haemorrhage that is caused by blood flow into the meninges of the brain. 
 
Stroke-like symptoms can also occur in what is known as ‘Transient Ischemic Attack’ 
(TIA).5 TIA is mainly caused by clots that initially block the flow of blood but which 
dissolves and allows blood flow again. TIA can also be caused by a sudden drop in blood 
pressure that reduces blood flow to the brain. Symptoms of TIA are sudden onset of 
numbness, loss of movement or weakness in the face, arm or leg (usually on one side 
of the body), vision changes or inability to speak. These symptoms gradually reduce as 
blood flow is restored and last for less than 24 hours. TIA is a warning sign of a possible 
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future stroke incident (a very high risk of stroke in the first month after the TIA event and 
up to one year thereafter).6 
 
The number-one cause of stroke is high blood pressure.7 High blood pressure, in turn, 
is affected by factors such as smoking, excessive alcohol consumption, obesity, and 
high intake of fatty or salty food. When blood pressure is high, it causes more stress on 
the walls of blood vessels, thus weakening them. Eventually it could lead to a rupture 
causing a haemorrhagic stroke. High blood pressure can also cause blood clots or 
plaque (formed from cholesterol or fat-like substances) to be broken off from the inner 
walls of blood vessels. These clots can then travel to a brain artery where it blocks off 
the flow of blood, causing an ischemic stroke. Another cause of stroke is diabetes. 
Diabetes can cause blood vessels to harden and narrow, increasing the risk of stroke. A 
medical condition, Fibromuscular Dysplasia (FMD), is also a cause of stroke.8 FMD is a 
condition whereby fibrous tissue is formed in the walls of arteries, causing narrowing of 
the arteries. As a result, blood flow through the arteries decreases. FMD usually affects 
arteries to the kidney but it can also affect the carotid (neck) arteries that supply blood 
to the brain. Cardiovascular diseases, such as abnormal heart rhythms (e.g. atrial 
fibrillation) and heart valve problems can cause blood clots to form. When these clots 
block an artery in the brain, stroke can occur. 
 
Different parts of the brain control different bodily functions. If a person survives a stroke 
and depending on the location of brain damage, severity and duration of the stroke, it 
can have various effects. Broadly, the impairment effects of stroke can be physical or 
cognitive related. The most common physical effect of stroke is the loss of motor abilities 
of the limbs. The upper or lower limbs can experience weakness (paresis) or paralysis 
(plegia), and this physical impairment can affect one side of the body or just an arm or 
leg. The most common type of limb impairment is hemiparesis which affects eight out of 
ten stroke survivors7. The affected side is usually on the opposite side of where the brain 
damage is, due to the cross-over of the motor and sensory tracts of the nervous system 
from one side to the other. Hemiparesis patients will experience weakness to the arms, 
hands, legs and facial muscles. Consequently, patients have difficulties performing 
everyday activities such as walking, eating or dressing. Another physical effect of stroke 
is the loss of visual fields or vision perception. Under visual field loss, stroke patients 
usually experience blindness on one side of both eyes. If the left side of the brain is 
damaged (left hemisphere stroke), visual fields on the right side of both eyes will be 
affected (this symptom is called homonymous hemianopia). Another type of visual field 
loss is blindness in the outer half of the visual field, which results in the loss of peripheral 
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vision (i.e. tunnel vision). Stroke patients with loss of vision perception experience 
challenges gauging depth and distances, double vision of seeing two of a thing, or 
shifting of the centre line of sight to either left or right side. This visual midline shift can 
result in the loss of balance and tilting of the body more to the left or right.  Another type 
of visual perception is called visual neglect, where the patient does not register objects 
in a certain area. Under this condition, patients may only take food from only one half of 
the plate. Other physical impairments caused by stroke are difficulty swallowing 
(dysphagia), apraxia of speech, incontinence, joint pain or neuropathic pain (caused by 
inability of the brain to correctly interpret sensory signals in response to stimuli to the 
affected limbs).7 
 
Cognitive effects of stroke are aphasia, memory loss and vascular dementia.7 Stroke 
patients can lose the ability to understand speech or the capacity to read, think or reason. 
Normal mental tasks can present big challenges to stroke patients and can affect their 
quality of life. Patients may not be able to follow instructions, remember directions, dates 
or time; or demonstrate a lack of rationale when undertaking tasks that are not safe. 
 
The drastic changes in physical and cognitive abilities caused by stroke can lead to 
emotional effects for stroke patients. Stroke survivors can experience depression after 
stroke when they encounter problems in doing tasks that they could easily do pre-stroke. 
Along with depression, they can experience a lack of motivation and mental fatigue. 
Another emotional effect of stroke is the sudden and uncontrollable onset of laughing 
and crying, which can occur even though the patient does not have such emotions 
internally. This involuntary outburst is called Pseudobulbar Affect (PBA) and is caused 
by damage to parts of the brain that control emotion.7  
 
Rehabilitation of stroke survivors 
For post-stroke survivors, rehabilitation is the pathway to regaining or managing their 
impaired functions.9 There is no definite end to recovery but most rapid improvement is 
within the first 6-months post stroke.10 Before a patient undergoes rehabilitation, an 
assessment is first done to determine if a patient is medically stable and fit for a 
rehabilitation program.11,12 If the patient is assessed to be suitable, then depending on 
the level of rehabilitative supervision required, the patient could undergo rehabilitation in 





Rehabilitation is administered by a multi-disciplinary team of physiotherapist, 
occupational therapist, speech therapist and neuropsychologist, who work together to 
offer an integrated, holistic rehabilitation therapy.9,12,16 Depending on the type of 
impairment, rehabilitation specialists will assess the appropriate therapies needed and 
set realistic goals for patients to achieve. Generally, stroke patients are given a minimum 
of 45 minutes for each therapy over at least 5 days per week, so long as the patient can 
tolerate the rehabilitation regime6. 
 
One of the main goals in stroke rehabilitation is the restoration of physical motor skills 
and this involves the patient undergoing repetitive, high intensity, task-specific exercises 
that enables them to regain their motor and functional abilities.17 It is theorized that the 
brain is plastic in nature and that repetitive exercises over long periods can enable the 
brain to adapt and regain the motor functionality that has been repeatedly stimulated. 
This involves the formation of new neuronal interconnections that enable the re-
transmission of motor signals18. It has been shown in animal studies that test subjects 
regained motor abilities after intensive and repetitive task training.19 This was associated 
with a reorganization of the undamaged motor cortex to enable recovery of motor 
abilities of the affected limbs.20 Such ‘neuroplasticity’ is the underlying principle of motor 
learning involving repetitive, high intensity, task-specific exercises.21 
 
Robotic rehabilitation 
To facilitate ‘neuroplasticity’ motor learning, robotic devices have been developed to 
assist therapists to rehabilitate patients based on high repetitions of task specific 
exercises.22 These robotic devices provide intensive, consistent and repetitive cycles 
over long periods to train the impaired limbs of patients. There are two main types of 
robotic devices: exoskeletons or end-effectors. Exoskeletons are devices that wrap 
around limbs and are able to assist each limb joint to move. End-effectors are devices 
that assist only the extremities of a limb (either hands or feet).23 Regardless of design 
mechanism, one key feature of robotic devices is the ability to automatically assist 
patients to move their limbs when they are unable to do so by themselves. This 
automated assistive feature enables high repetitions to be achieved.  
 
In contrast, to achieve the high repetitions needed for ‘neuroplasticity’, conventional 
therapy can be labour intensive and places physical strain on therapists when sustaining 
intense exercises.23 Coupled with the requirements of stroke patients for medical care 
and intensive rehabilitation exercises (which frequently entails one-to-one manual 
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interaction with therapists), therapist time and organizational budget would face 
difficulties to provide an optimal rehabilitation program.23 Therefore, it is hoped that with 
robotic assistive devices, better rehabilitation progress can be achieved for patients 
together with alleviation of time and physical demands on therapists. With the assistance 
of robots, therapists could concentrate more on functional rehabilitation during individual 
training sessions or be able to supervise multiple patients simultaneously during robot 
assisted therapy sessions. This approach would maximize the expertise and time of 
therapists, thus improving the effectiveness of the rehabilitation program.23 
 
There have been clinical studies to determine the effectiveness of robotic assistive 
devices in the rehabilitation of stroke patients.24 However, these studies presented a 
mixed picture of the effectiveness of robotic devices. One study on lower limbs reported 
an improvement in a motor movement scale (Fugl-Meyer Assessment lower-extremity 
score) but not for another motor scale (leg score of Motricity Index) and also stated no 
improvement on a walking scale (Functional Ambulation Category).25 Others reported 
that there was no statistically significant difference between robotic assisted therapy and 
conventional therapy,26,27 while one study that investigated walking speeds and distance 
found that conventional therapy was more effective than robotic assisted therapy.28 The 
inconclusive findings and diverse outcomes in the existing evidence base, unfortunately, 
do not provide a clear determination of the effectiveness of robotic rehabilitation.  
 
Besides the clinical effectiveness, there is also a need to evaluate the economic cost of 
robotic rehabilitation. Robotic devices enable a high intensity training regime, but the 
devices incur a significant capital outlay for healthcare providers. Some of the robotic 
training equipment can cost up to several hundred thousand dollars per device.29 Despite 
its high cost, robotic devices may increase the work efficiency of therapists, meaning 
that more patients can be treated and this could lead to an overall reduction in cost of 
treatment per patient.30,31 Hence, the decision to introduce robotic devices into clinical 
settings and offer robotic stroke rehabilitation to patients is a major economic cost 
consideration for hospitals, and it is important to identify appropriate treatment methods 
that can not only reduce the disability experienced by stroke survivors but are also 
economically viable.  
 
Another consideration is the adoption of robotic rehabilitation devices into clinical 
settings. One of the end goals of rehabilitation is to improve the functional ability of 
patients. For physical disability this requires gradual training of minimal movements and 
progressing to more complex task specific actions.16 Therapy also focuses on improving 
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strength, endurance, precision and speed of movements. Coupled with the various types 
of robotic devices with different therapeutic modalities (active, passive, active-assist 
training modes), it is important to determine how therapists and robotics can work 
together to improve the physical functionality of patients. Robotic devices also do not 
work alone but are part of a wider spectrum of clinical care that involves clinicians, 
patients, hospital administrators and device manufacturers. This interconnection to other 
parties could affect its adoption into a clinical setting in diverse ways, raising questions 
such as the work scope of therapists when robotic devices are doing the rehabilitation, 
the responses of patients to robotic treatment that has less human contact, and the 
optimal treatment protocols that can best combine the benefits of conventional and 
robotic training. The presence of robotic devices could change the way clinicians work 
and how patients are handled in a rehabilitation unit. Therefore, the clinical, 
organisational and human behavioural dimensions could present challenges to the 
adoption of robotic devices. 
 
Objective of thesis 
It is the aim of this thesis to examine and investigate the abovementioned aspects of 
robotic rehabilitation in terms of its clinical effectiveness, economic cost, and adoption 
into clinical settings. The specific research questions to be addressed are:  
 Can robotic devices help adult stroke patients to regain motor movement of their 
upper and lower limbs?  
 Can robotic devices rehabilitate adult stroke patients cost economically?  
 What are the clinical views and experiences of utilizing robotic rehabilitation? 
What are the factors to consider when introducing robotic devices into the clinical 
care environment? 
 How can findings from the effectiveness, economic cost and adoption studies be 
aggregated to create a conceptual framework of providing robotic rehabilitation? 
 
This thesis is organized into seven chapters and has been undertaken through a series 
of publications. Chapter one introduces the topic and outlines the aims and the 
composition of the thesis. Chapter two is a systematic review that examined the clinical 
effectiveness of robotic rehabilitation, and chapter three supplements the systematic 
review by analysing the sources of heterogeneity that was encountered during the 
systematic review. Chapter four investigates the economic cost perspectives of robotic 
rehabilitation via an economic systematic review, and chapter five introduces a 
supplemental method to extend the hierarchical decision matrix used in the economic 
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systematic review. This supplemental method was applied in order to gain a more 
differentiating analysis of the economic systematic review. Both systematic reviews for 
effectiveness and economic cost have been conducted according to the review 
methodology of the Joanna Briggs Institute (JBI). Each review has been peer reviewed 
and subsequently published in the JBI Database of Systematic Reviews and 
Implementation Reports.  
 
The systematic review methodology has been applied in our research as it enables a 
comprehensive and objective assessment of evidence in order to answer the specific 
questions, namely the clinical and cost effectiveness of robotic rehabilitation for adult 
stroke patients. With the large volume of research literature available regarding a clinical 
question, robust methods for systematically finding and reviewing the available 
evidence, and to undertake meta-analyses of the results of such evidence is needed.32 
Here, for the two systematic reviews, the review methodology of JBI has been applied. 
The JBI methodology, through its defined PICO (Participant, Intervention, Comparator, 
Outcome) inclusion criteria, allows for a comprehensive and yet informed selection of 
studies that best address the research question. Without the PICO inclusion criteria of a 
systematic review, the large volume of information would not be manageable and be 
digestible for analysis.33 The structured and rigorous assessment of risks of bias (i.e. 
methodological quality) also contributes to the reliability and quality of the review 
findings.32,34 The detection of the levels of heterogeneity and use of sub-group analysis 
in a systematic review further ensures a robust interpretation of review findings.35 Lastly, 
through the use of meta-analysis, systematic reviews offer increased power and 
precision in estimates of effect sizes by statistically pooling all available data of included 
studies.32,33 In view of these benefits, systematic review is the most appropriate method 
to answer the specific clinical and cost effectiveness questions posed in this thesis. 
 
Chapter six details the qualitative findings from interviews with rehabilitation therapists 
on their perspectives and experiences adopting and working with robotic devices in 
clinical settings. Ethics approval has been obtained to conduct the interviews (HREC 
approval number: H-2017-151). In chapter six, the method applied for this study was 
based on qualitative description analysis.36 This method involves the identification of 
findings that are close to the data (i.e. straight and largely unadorned answers), and with 
minimal transformation (i.e. with little imputation of meaning by researchers).36 This 
descriptive analysis approach enabled us to identify and extract data that described 
specific adoption considerations, such as what worked/did not work as expressed by 
participants, i.e. manifest context is described with low interpretation of data.36 
15 
 
Qualitative descriptive analysis also facilitated our data collection method of semi-
structured interviews with individual clinicians. The semi-structured interview format not 
only allowed us to tap into the knowledge, past experiences and learning points of 
clinicians, but also enabled the collection of further information to uncover and probe 
deeper into specific points during the interviews. We used the qualitative descriptive 
analysis as it allowed us to understand the actual nature of the situations faced by those 
involved, thereby giving us a sharper resolution of the events that were being 
encountered on the ground, without any loss of details or contextual meaning.36 This 
then enabled us to identify specific adoption findings. 
 
In chapter seven, the findings from prior studies are amalgamated to generate a 
conceptual framework for implementing robotic rehabilitation for adult stroke patients, 
which takes into account the findings from the effectiveness and economic reviews, and 
the qualitative adoption study. Implications of the thesis findings are also discussed, and 
key clinical and economic cost domains that should be considered when introducing 
robotic training are identified. 
 
Ultimately, it is hoped that stroke patients can benefit from robotic rehabilitation and gain 






Chapter Two: Effectiveness Systematic Review (Paper 
One and Two – Published) 
  
Paper 1: Lo K, Stephenson M, Lockwood C. Effectiveness of robotic assisted 
rehabilitation for mobility and functional ability in adult stroke patients: a systematic 
review. JBI Database System Rev Implement Rep. 2017;15(12):3049-91. 
 
Paper 2: Lo K, Stephenson M, Lockwood C. Effectiveness of robotic assisted 
rehabilitation for mobility and functional ability in adult stroke patients: a systematic 




Statement of Contribution 
 
Kenneth Lo (Candidate)  
 
I was responsible for the overall creation of this paper. As the primary author I developed 
the protocol, conducted the literature searches, retrieved papers, and assessed each 
paper for their eligibility. I subsequently undertook critical appraisal, data extraction and 
data analysis. I was also responsible for responses to reviewers and revisions to the 
paper. The review was conducted using tools provided by the Joanna Briggs Institute. 
  
Statement of Authorship 
 
Title of Paper Effectiveness of robotic assisted rehabilitation for mobility and functional ability in adult stroke patients: a systematic review. 
Publication Status  Published   Accepted for Publication 
 
Unpublished and Unsubmitted work written in 
 Submitted for Publication manuscript  style 
 
Publication Details Journal: JBI Database of Systematic Reviews and Implementation Reports  
Citation: Lo K, Stephenson M, Lockwood C. Effectiveness of robotic assisted 
rehabilitation for mobility and functional ability in adult stroke patients: a systematic 
review. JBI Database System Rev Implement Rep. 2017;15(12):3049-91. 
Principal Author 
 
Name of Principal Author (Candidate)  Kenneth Lo 
Contribution to the Paper  I was responsible for the overall creation of this paper. As the primary author I  developed the protocol, conducted the literature searches, retrieved papers, and 
assessed each paper for their eligibility. I subsequently undertook critical appraisal, data 
extraction and data analysis. I was also responsible for responses to reviewers and 
revisions to the paper. The review was conducted using tools provided by the Joanna 
Briggs Institute.  
 
Overall percentage (%)  80% 
Certification: This paper reports on original research I conducted during the period of my Higher Degree by 
Research candidature and is not subject to any obligations or contractual agreements with a 





  October 2019 
 
Co-Author Contributions 
By signing the Statement of Authorship, each author certifies that: 
i. the candidate’s stated contribution to the publication is accurate (as detailed above); 
ii. permission is granted for the candidate in include the publication in the thesis; and 
iii. the sum of all co-author contributions is equal to 100% less the candidate’s stated contribution. 
 
 
Name of Co-Author  Dr. Matthew Stephenson 
Contribution to the Paper 
  
 Supervisor: provided conceptualization and methodological guidance to the 
manuscript. Contributed to the writing and revision of the paper, including responding to 










Name of Co-Author  Assoc. Prof. Craig Lockwood 
Contribution to the Paper    Supervisor: provided conceptualization and methodological guidance to the 
manuscript. Contributed to the writing and revision of the paper, including responding to 






Date    October 2019 
Please cut and paste additional co-author panels here as required. 
SYSTEMATIC REVIEWEffectiveness of robotic assisted rehabilitation for
mobility and functional ability in adult stroke patients:
a systematic review
Kenneth Lo  Matthew Stephenson  Craig Lockwood
The Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, AustraliaE X E C U T I V E S UMMA R Y
Background
Stroke is a leading cause of long-term disability, and rehabilitation, involving repetitive, high intensity, task-specific
exercises, is the pathway to restoring motor skills. Robotic assistive devices are increasingly being used and it is
hoped that with robotic devices, rehabilitation progress can be achieved for patients.
Objectives
To examine the effectiveness of robotic devices in the rehabilitation of stroke patients for upper limb mobility, lower
limb mobility, and activities of daily living. The sustainability of treatment effect was also examined.
Inclusion criteria
Types of participants
Adult stroke patients 18 years and over.
Types of intervention(s)
Rehabilitation of stroke patients using robotic devices with assistive automation, compared to conventional
physiotherapy.
Outcomes
Motor movements of upper limbs, walkingmovement of lower limbs and activities of daily living, including follow-up
measurements to examine the sustainability of treatment effect.
Types of studies
Randomized and controlled clinical trials.
Search strategy
Published and unpublished studies in English were searched.
Methodological quality
All studies meeting the review inclusion criteria were independently assessed for methodological quality by two
reviewers.
Data extraction
Quantitative data were extracted using the standardized data extraction tool from the Joanna Briggs Institute Meta-
Analysis of Statistics Assessment and Review Instrument.
Data synthesis
Quantitative data were pooled in statistical meta-analysis. Effect sizes expressed as standardized mean difference,
95% confidence intervals and levels of heterogeneity (I2) were calculated. Where statistical pooling was not possible,
the findings were presented in narrative form.
Results
Fifty-one studies with 1798 patients were included in this review. Thirty studies examined upper limb interventions
and 21 studies evaluated lower limb gait training. Non-significant results were found for upper limb (SMD 0.07, 95%
CI 0.11 to 0.26, I2¼ 41%, P¼ 0.45), lower limb (SMD 0.17, 95% CI 0.15 to 0.48, I2¼ 75%, P¼ 0.31) and activities ofCorrespondence: Kenneth Lo, kenneth.lo@adelaide.edu.au
There is no conflict of interest in this project.
DOI: 10.11124/JBISRIR-2017-003456
JBI Database of Systematic Reviews and Implementation Reports  2017 THE JOANNA BRIGGS INSTITUTE 3049
©2017 Joanna Briggs Institute. Unauthorized reproduction of this article is prohibited.
SYSTEMATIC REVIEW K. Lo et al.daily living (SMD 0.11, 95% CI 0.11 to 0.33, I2¼ 66%, P¼ 0.32). For patients with severely impaired lower limbs, a
significant difference was observed in favor of robotics (SMD 0.41, 95% CI 0.19 to 0.63, I2¼ 28%, P¼ 0.0003). P-value
analysis did not show significant results for the sustainability of treatment effect post intervention.
Conclusions
Robotic training is just as effective as conventional training for upper limb motor movement, lower limb walking
mobility and for activities of daily living. For lower limb patients with severe impairment, robotic training produces
better outcomes than conventional training. The sufficient quantity of studies included and the reasonable quality of
Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence support the findings.
For treatment sustainability of upper and lower limbs, robotic training is just as effective as conventional training.
However, the low quality of GRADE evidence and the lower number of studies included require caution for this
finding. For treatment sustainability of activities of daily living, the better quality of GRADE evidence and the larger
number of studies analyzed indicate that robotic training is just as effective as conventional training.
Keywords cerebrovascular accident; rehabilitation; robotics; robots; Stroke
JBI Database System Rev Implement Rep 2017; 15(12):3049–3091.GRADE Summary of FindingsRoboc assisted rehabilitaon for mobility and funconal ability in adult stroke paents compared to convenonal physiotherapy
Bibliography: Kenneth L, Stephenson M, Lockwood C. Effecveness of roboc assisted rehabilitaon for mobility
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(29 RCTs) HIGH 
- - SMD 0.07 
higher
(0.11 lower to 
0.26 higher) 
Upper Limb - therapy rao = 0 507
(16 RCTs) HIGH 
- - SMD 0.13 
higher
(0.13 lower to 
0.39 higher) 
Upper limb - follow-up (<=3 months) 293
(9 RCTs) LOW a,b
- - SMD 0.06 
higher
(0.22 lower to 
0.33 higher) 
Upper limb - follow-up (>3 months) 217
(7 RCTs) LOW a,b
- - SMD 0 
(0.45 lower to 
0.45 higher) 
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Lower limb - follow-Up (<=3 months) 259
(5 RCTs) LOW a,b
- - SMD 0.33 lower
(1.31 lower to 
0.65 higher) 
Lower limb - follow-up (>3 months) 408
(6 RCTs) HIGH 
- - SMD 0.3 higher
(0.05 lower to 
0.65 higher) 
Acvies of daily living (ADL) 1120
(31 RCTs) HIGH 
- - SMD 0.11 
higher
(0.11 lower to 
0.33 higher) 
ADL - therapy rao = 0 345
(12 RCTs) MODERATE a
- - SMD 0 
(0.54 lower to 
0.53 higher) 
ADL - follow-up (<=3 months) 428
(11 RCTs) MODERATE b
- - SMD 0.1 lower
(0.57 lower to 
0.38 higher) 
ADL - follow-up (>3 months) 481
(9 RCTs) HIGH 
- - SMD 0.14 
higher
(0.27 lower to 
0.56 higher) 
*The risk in the intervenon group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relave 
effect of the intervenon (and its 95% CI). 
CI: Confidence interval; SMD: Standardized mean difference
GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the esmate of the effect
Moderate quality: We are moderately confident in the effect esmate: The true effect is likely to be close to the esmate of the effect, but 
there is a possibility that it is substanally different
Low quality: Our confidence in the effect esmate is limited: The true effect may be substanally different from the esmate of the effect
Very low quality: We have very lile confidence in the effect esmate: The true effect is likely to be substanally different from the esm ate 
of effect
a. Imprecision: Sample sizes of experimental and control groups are less than 400 
b. Publication Bias: Funnel plot shows a possible bias
Lower limb - severe 510
(10 RCTs) HIGH 
- - SMD 0.41 
higher
(0.19 higher to 
0.63 higher) 
Lower limb - therapy rao = 0 207
(6 RCTs) LOW a,b
- - SMD 0.08 SD 
lower
(0.74 lower to 
0.58 higher) 
Lower limb 701
(15 RCTs) HIGH 
- - SMD 0.17 
higher
(0.15 lower to 
0.48 higher) 
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Stroke is a leading cause of long-term disability and
is the third most common cause of mortality in
developed countries, with 15 million people suffer-
ing a stroke yearly.1 Different parts of the brain
control different bodily functions. If a person sur-
vives a stroke and, depending on the location of
brain damage, severity and duration of the stroke,
various effects can follow. Broadly, the effects of
stroke can be physical, cognitive or emotional in
nature. In terms of the physical effects of stroke, the
loss of motor abilities of the limbs presents signifi-
cant challenges for patients, as their mobility and
activities of daily living are affected. The upper or
lower limbs can experience weakness (paresis) or
paralysis (plegia), with the most common type of
limb impairment being hemiparesis, which affects
eight out of ten stroke survivors.2 Other physical
effects of stroke are loss of visual fields, vision
perception, difficulty swallowing (dysphagia),
apraxia of speech, incontinence and joint pain or
neuropathic pain (caused by inability of the brain to
correctly interpret sensory signals in response to
stimuli to the affected limbs). Cognitive effects of
stroke are aphasia, memory loss and vascular
dementia. Stroke patients can lose the ability to
understand speech or the capacity to read, think
or reason, and normal mental tasks can present
big challenges to stroke patients, affecting their
quality of life. The drastic changes in physical and
cognitive abilities caused by stroke also lead to
emotional effects. Stroke survivors can experience
depression when they encounter problems in doing
tasks that they can easily do pre-stroke. Along with
depression, they can experience a lack of motivation
and mental fatigue.2
For stroke patients, rehabilitation is the pathway
to regaining or managing their impaired functions.
There is no definite end to recovery but most rapid
improvement is within the first six months post
stroke.3 Before a patient undergoes rehabilitation,
an assessment is first done to determine if a patient is
medically stable and fit for a rehabilitation pro-
gram.4 If the patient is assessed to be suitable, then,
depending on the level of rehabilitative supervision
required, the patient could undergo rehabilitation
in various settings: as an inpatient/outpatient (at
either a hospital or nursing facility) or at home.3,4
Rehabilitation should be administered by a multi-
disciplinary team of physiotherapists, occupationalJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizetherapist, speech therapist and neuropsychologists,
who work together to offer integrated, holistic reha-
bilitation therapy.4 Depending on the type of
impairment, rehabilitation specialists will assess
the appropriate therapies needed and set realistic
goals for patients to achieve. Generally, stroke
patients should be given a minimum of 45 minutes
for each therapy session per day over at least five
days per week, so long as the patient can tolerate the
rehabilitation regime.3
One of the main goals in stroke rehabilitation is
the restoration of motor skills and this involves
patients undergoing repetitive, high intensity, task-
specific exercises that enables them to regain their
motor and functional abilities.5,6 It is theorized that
the brain is plastic in nature and that repetitive
exercises over long periods can enable the brain to
adapt and regain the motor skills that are repeatedly
stimulated.7 This involves the formation of new
neuronal interconnections that enable re-transmis-
sion of motor signals.8
Over the years, a number of robotic assistive
devices have been used to rehabilitate patients based
on high repetitions of task specific exercises.9 These
robotic assistive devices provide intensive, consistent
and repetitive cycles over long periods and help
patients train their limbs to keep receiving and
sending signals from and back to the brain, and
thereby regain their motor abilities. Such devices
are complex in nature, involving interactive automa-
tion, sensors and dynamic control logic and are able
to function without much intervention from physi-
otherapists. Several devices have been used for reha-
bilitation of upper limb (e.g. ARMin [Sensory-
Motor Systems Lab, ETH Zurich, Switzerland],
InMotion ARMTM [Bionik Laboratories], NeReBot
[University of Padua, Italy], Armeo1Spring
[Hocoma]) and lower limb (e.g. Lokomat1
[Hocoma], Gait TrainerTM [Reha-Stim Medtec],
G-EO SystemTM [Reha Technology], Hybrid Assis-
tive Leg1 [Cyberdyne]).10,11 As an example, for
patients who are unable to walk, there are gait
training devices such as the Lokomat1 that help
patients to recover their walking ability. Initially
the physiotherapist will set up the patient into the
device and start a software program that cycles
through the various stages of walking.12 The
patient’s lower limbs will be moved by the device
and the physiotherapist is able to set the pace of
simulated walking and amount of guidance force to 2017 THE JOANNA BRIGGS INSTITUTE 3052
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weight support.12
In comparison, for conventional rehabilitation of
the lower limbs without assistive devices, it would
require at least two physiotherapists to train a
patient to walk, and the pace and pattern of walking
may not be consistent.13 It is also physically strenu-
ous for the physiotherapists to sustain the exercise
over long periods, thus affecting the rehabilitation
progress of the patient. The labor-intensive nature of
conventional physiotherapy places a great strain on
physiotherapists. Coupled with the requirements of
stroke patients for medical care and intensive reha-
bilitation exercises (which frequently entails one-to-
one manual interaction with therapists), providing
an optimal rehabilitation program would place a
huge strain on therapist time and organizational
budget.10 Therefore, it is hoped that with robotic
assistive devices, better rehabilitation progress can
be achieved for patients, together with the allevia-
tion of time and physical demands on physiothera-
pists. With the assistance of robots, physiotherapists
will be able to concentrate more on functional reha-
bilitation during individual training sessions and
supervision of multiple patients simultaneously dur-
ing robot assisted therapy sessions. This approach
would maximize the expertise and time of physio-
therapists, thus improving the effectiveness of reha-
bilitation programs.10
There have been clinical studies to determine the
effectiveness of robotic assistive devices in the reha-
bilitation of stroke patients.14 However, these stud-
ies presented a mixed picture of the effectiveness of
robotic devices. One study on lower limbs reported
improvement in a motor movement scale (Fugl-
Meyer Assessment lower-extremity score) but not
in another motor scale (leg score of Motricity Index),
and also stated no improvement in a walking scale
(Functional Ambulation Category).15 Others
reported that there was no statistically significant
difference between robotic assisted therapy and con-
ventional therapy,16,17 while one study that investi-
gated walking speeds and distance found that
conventional therapy was more effective than
robotic assisted therapy.12 There were also various
types of study designs. Some studies examined not
just robot-assisted rehabilitation but combinations
of robot-assisted rehabilitation and non-conven-
tional physiotherapies (e.g. functional electrical sim-
ulation [FES], constraint induced therapy [CIT],JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizetranscranial direct current stimulation or motor
imagery) versus conventional therapies in three-
arm studies.18-20 Other studies involved patients in
randomized controlled cross-over trials with or
without a wash-out period.21,22
A variety of outcomes were used to assess motor
movement, motor strength/duration, walking speed
or functional activities across the included studies in
this systematic review, complicating the analysis.23
In a trial with multiple outcome measures, this could
lead to increased risk of Type I error when multiple
simultaneous hypotheses are tested at set p-values.24
To mitigate this, Feise24 recommended that research-
ers facing multiple outcome measures select a pri-
mary outcome measure or use a global assessment
measure. As robotic devices are primarily designed
to enable movement of a particular limb,10 a suitable
outcome measure that reflects the design function of
the device is necessary in order to accurately deter-
mine the effectiveness of these devices. In view of
this, outcomes that measure motor movement of the
paretic limbs were considered, such as Fugl-Meyer
Scale Assessment (upper extremity) for the upper
limbs or Functional Ambulation Category for the
lower limbs. The current review also aimed to
address the question of sustainability of the treat-
ment effects, for example, is the improved motor
movement measured at the end of the intervention
period maintained post intervention?
The diverse range of outcomes and study designs
in the existing evidence base do not provide a clear
determination of the effectiveness of robotic assisted
rehabilitation and therefore it was the intent of this
review to give clarity to the discussion and offer
useful recommendations for clinical practice. In this
review, robotic assisted therapies for both upper and
lower limbs were studied to gain a detailed under-
standing of the effectiveness of robotic devices in
these two areas, where a large proportion of reha-
bilitation efforts are devoted. The methods of the
review have been described in a previously published
protocol.25
Objectives
The objective of this review was to synthesize the
best available evidence on the effectiveness of
robotic assistive devices in the rehabilitation of adult
stroke patients for recovery of impairments in the
upper and lower limbs. The specific review question
to be addressed was: Can robotic assistive devices 2017 THE JOANNA BRIGGS INSTITUTE 3053
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their upper and lower limbs?
The secondary objective of this systematic review
was to investigate the sustainability of the treatment
effect associated with use of robotic devices.
Inclusion criteria
Types of participants
This review considered studies that included adult
stroke patients (18 years and over) of all genders,
regardless of whether stroke was due to ischemic
or hemorrhagic causes. Patients with pre-existing
impairments that were not caused by stroke, such
as disabilities due to spinal cord injuries, Parkinson’s
disease, multiple sclerosis and traumatic brain inju-
ries (caused by accidents, falls, infections, tumors or
chemical toxins) were excluded. Study participants
were new stroke patients or repeat stroke patients at
acute, sub-acute or chronic stages of their stroke, as
long as they had been accepted into a formal reha-
bilitation program. Only trials where the rehabilita-
tion setting was either inpatient or outpatient
were included. Home rehabilitation patients were
excluded due to potential confounding of treatment
adherence. The rehabilitation program was con-
ducted at hospitals, nursing facilities or across
multi-centers and only physical impairments related
to upper and lower limbs were considered.
Types of intervention(s)
This review considered studies that evaluated reha-
bilitation of stroke patients using interactive, auto-
mated electro-mechanical equipment (i.e. assistive
robotics) and compared the outcomes to control
groups which had conventional physiotherapy.
The types of robotic assistive devices were varied
(e.g. either robotic exoskeletons or end-effectors for
gait training, and unilateral or bilateral arm robotics
for upper limb training). Interventions involving the
devices below were not considered as robotic reha-





Non-interactive devices that delivered passive
motion such as treadmills, static body-weight
assisted treadmills, bicycles, static walking aids,
static orthoses (such as ankle-foot orthoses
addressing foot drop) or pure mechanical trainers
(e.g. Reha-SlideTM [Reha-Stim Medtec], Reha-
Slide DuoTM [Reha-Stim Medtec]).Database of Systematic Reviews and Implementation Reports
2017 Joanna Briggs Institute. Unauthorize
d rStandalone video games that were controlled
solely by patient without automated assistive
feature, such as Wii UTM (Nintendo Co. Ltd.). Rehabilitation programs using non-conventional
therapies such as acupuncture, FES, transcranial
direct current stimulation, motor imagery,
biofeedback, CIT.
Intervention groups analyzed had a combination
of robotic and conventional physiotherapy training
in various therapy ratios (i.e. duration of conven-
tional training/duration of robotic training), and in
other studies, some intervention groups had purely
robotic training and did not include conventional
therapy components. The examined intervention
groups also did not contain other types of non-
conventional therapy (e.g. FES, transcranial direct
current stimulation, motor imagery or CIT). For
multiple-arm studies, only results of the interven-
tion arm with robotic-assisted rehabilitation was
compared to the control arm. The intervention
arm with a combination of robotic assistive devices
and non-conventional therapy was excluded from
analysis.
Outcomes
This review considered studies that included the
outcome measure of the amount of motor movement
demonstrated by the paretic limbs and only studies
that used scales that measure motor movement were
considered for the review.
 For the outcome measure of upper limbs, the
Fugl-Meyer Assessment26 (upper extremity
score) was the preferred scale. If a study did
not use this scale, then an alternative measure-
ment scale that quantified upper limb motor
movement (e.g. upper limb Motricity Index27)
was considered. For the outcome measure of lower limbs, the
Functional Ambulation Category28 was the pre-
ferred scale. If a study did not use this scale, then
an alternative measurement scale that quantified
walking was considered, e.g. Barthel Index29
(ambulation item) or Functional Independence
Measure30 (walking item).
The second outcome of interest that was exam-
ined was the level of activities of daily living (ADLs)
attained after the intervention. For outcome measure
of ADLs, Functional Independence Measure was the
preferred scale. If a study did not use this scale, then 2017 THE JOANNA BRIGGS INSTITUTE 3054
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the level of ADLs was considered, e.g. Barthel
Index. As ADLs involved usage of both upper and
lower limbs, a global ADLs measurement combining
both subgroups of upper and lower limbs was
considered.
In clinical trials, patient outcomes were measured
at different stages of rehabilitation. Usually mea-
sures were taken at pre-, mid- and post-intervention
stages but some studies continued to take follow-up
measurements in the months after the end of the
intervention therapy. For this review, measurements
taken at pre- and post- intervention therapy were
included for analysis. Follow-up measurements
taken after interventions had ended were also
included to examine the sustainability of the treat-
ment effect.Types of studies
The review was limited to randomized and con-
trolled clinical trials. For studies with cross-over
design, only the first study period (before cross-over)
was considered for inclusion.Search strategy
The search strategy aimed to find both published
and unpublished studies. A three-step search strat-
egy was utilized in this review. An initial limited
search of PubMed was undertaken followed by
analysis of the text words contained in the title
and abstract, and of the index terms used to describe
the article. A second search using all identified key-
words and index terms (modified for goodness of fit
with each specific database thesaurus) was then
undertaken across all included databases. Thirdly,
the reference list of all identified reports and articles
was searched for additional studies. Studies pub-
lished in English were considered for inclusion in
this review and a date limit starting from 2000 was
set, as automated robotic devices have increasingly
been used since 2000, together with an associated
increase in the number of studies undertaken. The
overall search date range was from January 2000 to
June 2016.
The databases searched included: PubMed,
Embase, CINAHL, Cochrane Central Register of
Controlled Trials (CENTRAL) and PEDro (Physio-
therapy Evidence Database).JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeThe search for unpublished studies included:
MedNar, ProQuest Dissertations and Theses,
ClinicalTrials.gov, Google Scholar.
Initial keywords used for PubMed were:
Robotics[mh] OR Robot[tw] OR Exoskeleton
Device[mh] OR Exoskeleton[tw] OR Gait Train-
er[tw] OR Lokomat[tw] AND Rehabilitation[mh]
OR Rehabilitation[tw] OR Habilitation[tw]
AND Stroke[mh] OR Stroke[tw] OR ‘‘Cerebrovas-
cular Accident’’ OR Cerebral[tw] OR ‘‘Cerebral
Stroke’’ OR ‘‘Cerebrovascular Stroke’’ OR ‘‘Acute
Stroke’’ OR ‘‘Sub-acute Stroke’’ OR ‘‘Subacute
Stroke’’.
The full search strategy is provided in Appendix I.Assessment of methodological quality
Articles selected for retrieval were assessed by two
independent reviewers for methodological validity
prior to inclusion in the review using the standard-
ized critical appraisal instrument from the Joanna
Briggs Institute System for the Unified Manage-
ment, Assessment and Review of Information
(JBI SUMARI).31 Any disagreements that arose
between the reviewers were resolved through dis-
cussion, or with a third reviewer. To establish the
quality of evidence, the Grading of Recommenda-
tions Assessment, Development and Evaluation
(GRADE)32 approach and Summary of Findings
were used.
The key appraisal criteria to include or exclude
studies were questions pertaining to true
randomization (Question 1) and whether the treat-
ment groups were treated identically (i.e. both
intervention and control groups) were dose
matched (Question 7). Studies that received a
‘‘No’’ to either of these two questions were
excluded.
Two appraisal questions (Questions 4 and 5) were
assessed as being not applicable given the rehabili-
tation context of the trials, where it was not practi-
cally feasible to blind participants or treatment
therapists.Data extraction
Data were extracted from papers included in the
review using the standardized data extraction tool
from JBI SUMARI.31 The data extracted included
specific details about the interventions, populations, 2017 THE JOANNA BRIGGS INSTITUTE 3055
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review question and specific objectives.
Data synthesis
Data were, where possible, pooled in statistical
meta-analysis using Review Manager 5 (Copenha-
gen: The Nordic Cochrane Centre, Cochrane).
Effect sizes expressed as standardized mean differ-
ence (SMD) for continuous data and their 95%
confidence intervals (95% CI) were calculated for
analysis. Heterogeneity was assessed statistically
using I2 and the standard Chi-square. Where statis-
tical pooling was not possible the findings have
been presented in narrative form including tables
and figures to aid in data presentation where
appropriate.




Upper limb and lower limb interventions
 Acute/sub-acute patients (less than six months
post stroke) and chronic patients (more than or
equal to six months post stroke) Severe impairment patients and moderate/mild
impairment patients Intervention groups whereby there is only robotic
training and no conventional training (i.e. Ther-
apy Ratio [TR]¼0, TR¼Duration of Conven-
tional Training/Duration of Robotic Training) Intervention groups with follow-up less than or
equal to three months and follow-up more than
three months.The different impairment levels for upper limb are
as follows:
 Severe impairment: 0<Fugl-Meyer (UL)<¼20
 For patients with severe motor impairment,
majority of the scale ratings are unable to
perform (rating¼0), with some ratings
between partial performance (rating¼1)
and near normal performance (rating¼2)33Data
20derate impairment: 20<Fugl-Meyer (UL)
40 Mo
<¼
 For patients with moderate motor
impairment, the bulk of the ratings are
between partial performance level (rating¼1)
1) and near normal performance level (rating
¼2)33
ld impairment: 40<Fugl-Meyer (UL)<¼66
For patients with mild motor impairment, the Mi

bulk of the ratings are at the near normal
performance level (rating¼2).33base of Systematic Reviews and Implementation Reports
17 Joanna Briggs Institute. Unauthorized reprdifferent impairment levels for lower limb areThe
as follows:
 Severe impairment: 0<Functional Ambulation
Categorie (FAC)<¼1.5
 0: Patient cannot walk or requires help from
two or more people34
 1: Patient requires firm, continuous support
from one person who helps with carrying
weight and with balance34derate impairment: 1.5<FAC<¼3.5
2: Patient needs continuous or intermittent Mo

support from one person to help with balance
or coordination34
 3: Patient requires verbal supervision or assis-
tance to stand with help from one person
without physical contact34ld impairment: 3.5<FAC<¼5
4: Patient can walk independently on level Mi

ground, but requires help on stairs, slopes or
uneven surfaces34 5: Patient can walk independently.34
studies had data as median values and three ofSix
these35-37 were converted to means and standard
deviations using the methods of Wan et al.38 The
median data of the other three studies39-41 were not
suitable for conversion, as they had only the inter-
quartile range but did not contain the required
quartile 1 and quartile 3 values.
Results
A total of 3048 citations were generated from the
final search strategy and 681 were identified
from other sources such as MedNar, ProQuest Dis-
sertations and Theses, ClinicalTrials.gov and
Google Scholar (Figure 1).42 After initial screening
of titles and abstracts, 158 studies went through
the process of verification of study eligibility (Appen-
dix II). Consequently, 51 studies were appraised
for quality.
Description of included studies
A total of 51 studies with 1,798 patients were
included in this review. There were 30 studies that
examined upper limb interventions and 21 studies
that evaluated lower limb gait training. Of the
included studies, 27 had acute/sub-acute patients
and 24 had chronic patients.
The studies came from diverse regions: Americas
(USA, Mexico), Europe (Italy, Finland, Germany, 2017 THE JOANNA BRIGGS INSTITUTE 3056
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Figure 1: PRISMA flow diagram of study selection and inclusion process42
SYSTEMATIC REVIEW K. Lo et al.the Netherlands, Portugal, Switzerland), Middle
East (Israel) and Asia (Hong Kong, Japan,
Singapore, South Korea, Taiwan). Trial participants
were all adults and were predominantly around
60 years old. Three trials with the largest sample
sizes (Pohl et al.,43 Chua et al.44 and Lo et al.17) had a
majority of male patients (around 80% on average
for the three studies). However, the average male
percentage over all included studies was 64%. In
terms of stroke types, more patients had ischemicJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizestroke (60% to 90%) than hemorrhagic stroke.
There were various training durations across studies,
with total training hours ranging from four hours to
300 hours. However, within each study, the therapy
dosage was the same for intervention and control
groups (i.e. groups were dose-matched).
There were 22 studies that compared purely
robotic training to purely conventional training
(i.e. experimental group had no conventional train-
ing component; TR¼0). Of these 22 studies, 16 2017 THE JOANNA BRIGGS INSTITUTE 3057
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limb studies. The remaining studies had varying
amounts of conventional training combined with
robotic training in the experimental groups (TR
ranges from 0.2 to 6). Further details of the studies
are presented in Appendix III.
Methodological quality
Various sources of bias such as selection, perfor-
mance, detection and attrition biases45,46 were
considered significant in the assessment of the
included studies. For this review, the important
strategies for assessing attempts to minimize the
risk of bias were whether studies were truly ran-
domized, and if experimental and control groups
were treated equally in terms of the duration
of training given. If studies were not properly ran-
domized, or if trials were not dose-matched,
these would be major risks of bias, as the patient
group receiving higher training durations would
be likely to have better outcomes. An imbalance
in this respect would make outcome comparisons
meaningless. In these two areas, all included studies
were required to score a ‘‘Yes’’ to appraisal ques-
tions 1 and 7, which significantly reduces the risk
of bias.
In terms of homogeneity of patient characteristics
between groups at baseline (question 3), the major-
ity of studies (92%) scored a ‘‘Yes’’. This indicated
that trial subjects were mostly comparable at the
start of the study. Due to the rehabilitation nature of
the trials, it was not practically feasible for patients
and therapists to be blinded and this could have
introduced bias into the outcomes.47 Patients who
were in the experimental group with novel robotic
training could have felt more motivated than
patients in the conventional training and so achieve
better outcome measures.48 Nevertheless, this risk
of bias is common for rehabilitation type of trials
and do not necessarily mean that the trials were of
low quality.49
Another potential source of bias is non-blinded
assessment.50 Assessors might have over-rated
patients with robotic training in order to show
positive results or they themselves might have been
pre-disposed towards robotic training. There were
11 out of the 51 studies that did not have blinded
assessment and they had a sample size of 354
patients, which is around 20% of the total sample
size. In terms of study designs, most trials involvedJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizetwo-arm and three-arm studies, and only two studies
had a cross-over design.
Overall, the included studies had good methodo-
logical quality with no major sources of bias.
For non-blinded assessment, this could be a poten-
tial source of bias and was addressed via a
sensitivity analysis46,51 which is described further
in the discussion section. Appendix IV outlines the
appraisal of methodological quality for the included
studies.Findings of the review
Here we present the findings of the review based on
the following three sub-groups: upper limb, lower
limb and activities of daily living. For each sub-
group, we looked at overall outcomes of the included
studies. Then we explored if the outcomes were any
different based on comparing robotic therapy alone
to conventional therapy alone (i.e. TR¼0) and
looking at sustainability of treatment effects. For
the three studies39-41 that were not suitable for
meta-analysis, we did a narrative review. As part
of the review, we also analyzed for heterogeneity and
non-blinded assessment.Upper limb movement
For the outcome of upper limb movement, 29
studies with a total patient population of 860
were analyzed. Overall, the forest plot showed
no significant difference between experimental
and control groups (Figure 2). The pooled SMD
(random-effects model) was 0.07, 95% CI 0.11
to 0.26, I2¼41%, P¼0.45. No evidence for publi-
cation bias was found from the funnel plot
(Figure 3).
Sub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients and
moderate/mild impairment patients were conducted
and these showed no significant differences between
experimental and control groups (Acute/Sub-Acute:
SMD 0.02, 95% CI 0.42 to 0.39, P¼0.93;
Chronic: SMD 0.11, 95% CI 0.06 to 0.28,
P¼0.22; Severe: SMD 0.17, 95% CI 0.18 to
0.51, P¼0.34; Moderate/Mild: SMD 0.03, 95%
CI 0.19 to 0.26, P¼0.78).
Upper limb movement (TRU 0)
For the comparison of robotic therapy alone to
conventional therapy alone (TR¼0), 16 studies with 2017 THE JOANNA BRIGGS INSTITUTE 3058
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Figure 2: Effect of robotic therapy in experimental group compared with conventional therapy control
group on upper limb movement (SD: standard deviation; CI: confidence interval)
SYSTEMATIC REVIEW K. Lo et al.a total patient population of 507 were analyzed and
the result showed no significant difference between
experimental and control groups (Figure 4). The
pooled SMD (random-effects model) was 0.13,
95% CI 0.13 to 0.39, I2¼48%, P¼0.33. No
evidence for publication bias was found from the
funnel plot (Figure 5).Figure 3: Funnel plot of upper limb studies (SE:
standard error; SMD: standard mean difference)
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeSub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients and
moderate/mild impairment patients were conducted
and these showed no significant differences between
experimental and control groups (Acute/Sub-Acute:
SMD 0.06, 95% CI 0.60 to 0.73, P¼0.85;
Chronic: SMD 0.14, 95% CI 0.07 to 0.36,
P¼0.19; Severe: SMD 0.25, 95% CI 0.10 to
0.61, P¼0.16; Moderate/Mild: SMD 0.02, 95%
CI 0.37 to 0.42, P¼0.90).Upper limb movement (sustainability)
To examine the sustainability effects, analyses
involving intervention groups with: (i) follow-up
in less than or equal to three months, and (ii) fol-
low-up in more than three months were conducted.Follow-up in less than or equal to three months
Nine studies with a total patient population of 293
were analyzed. The forest plot showed no significant
difference between experimental and control groups
(Figure 6). The pooled SMD (random-effects model)
was 0.06, 95% CI 0.22 to 0.33, I2¼24%, 2017 THE JOANNA BRIGGS INSTITUTE 3059
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Figure 5: Funnel plot of upper limb studies with
TR¼0 (SE: standard error; SMD: standard mean
difference)
Figure 4: Effect of robotic therapy in experimental group compared with conventional therapy control
group on upper limb movement (TR¼0) (SD: standard deviation; CI: confidence interval)
Figure 6: Effect of robotic therapy in experimental g
group on upper limbmovement (follow-up in less tha
confidence interval)
SYSTEMATIC REVIEW K. Lo et al.
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeP¼0.68. A potential for publication bias was found
from the funnel plot (Figure 7).Follow-up in more than three months
Seven studies with a total patient population of 217
were analyzed. The forest plot showed no significant
difference between experimental and control groups
(Figure 8). The pooled SMD (random-effects model)
was 0.00, 95% CI 0.45 to 0.45, I2¼59%,
P¼1.00. The funnel plot showed a possible publi-
cation bias (Figure 9).
Lower limb walking
Fifteen studies with a total patient population of 701
were analyzed. The forest plot showed no significant
difference between experimental and control groupsroup compared with conventional therapy control
n or equal to 3months) (SD: standard deviation; CI:
 2017 THE JOANNA BRIGGS INSTITUTE 3060
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Figure 7: Funnel plot of upper limb studies with
follow-up in less than or equal to 3 months (SD:
standard deviation; CI: confidence interval)
Figure 9: Funnel plot of upper limb studies with
follow-up in more than 3 months (SE: standard
error; SMD: standard mean difference)
SYSTEMATIC REVIEW K. Lo et al.(Figure 10). The pooled SMD (random-effects
model) was 0.17, 95% CI 0.15 to 0.48, I2¼
75%, P¼0.31. No evidence for publication bias
was found from the funnel plot (Figure 11).Figure 8: Effect of robotic therapy in experimental g
group on upper limb movement (follow-up in more
confidence interval)
Figure 10: Effect of robotic therapy in experimental g
group on lower limb walking (SD: standard deviatio
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeSub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients and
moderate/mild impairment patients were conducted.
For acute/sub-acute patients, chronic patients androup compared with conventional therapy control
than 3 months) (SD: standard deviation; CI:
roup compared with conventional therapy control
n; CI: confidence interval)
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Figure 11: Funnel plot of lower limb studies (SE:
standard error; SMD: standard mean difference)
Figure 13: Funnel plot of lower limb studies
(severe impairment) (SE: standard error; SMD:
standard mean difference)
SYSTEMATIC REVIEW K. Lo et al.moderate/mild impairment patients, there were no
significant differences between experimental and
control groups (Acute/Sub-Acute: SMD 0.24, 95%
CI 0.15 to 0.62, P¼0.23; Chronic: SMD 0.10,
95% CI 0.44 to 0.25, P¼0.59; Moderate/Mild:
SMD 0.34, 95% CI 0.97 to 0.29, P¼0.29).
However, for severe impairment patients, a statisti-
cally significant difference favoring the experimental
group was found (Figure 12). The pooled SMD
(random-effects model) was 0.41, 95% CI 0.19
to 0.63, I2¼28%, P¼0.0003. No evidence for
publication bias was found from the funnel plot
(Figure 13).
Lower limb walking (TRU 0)
For the comparison of robotic therapy alone to
conventional therapy alone (TR¼0), six studiesFigure 12: Effect of robotic therapy in experimental g
group on lower limb walking (severe impairment) (S
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizewith a total patient population of 207 were analyzed
and the result showed no significant difference
between experimental and control groups
(Figure 14). The pooled SMD (random-effects
model) was 0.08, 95% CI 0.74 to 0.58,
I2¼80%, P¼0.81. The funnel plot showed asym-
metry indicative of publication bias (Figure 15).
Sub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients and
moderate/mild impairment patients were conducted
and these showed no significant differences between
experimental and control groups (Acute/Sub-Acute:
SMD 0.23, 95% CI 1.43 to 0.96, P¼0.70;
Chronic: SMD 0.03, 95% CI 0.39 to 0.45,
P¼0.88; Severe: SMD 0.40, 95% CI 0.13 to
0.93, P¼0.14; Moderate/Mild: SMD 0.31, 95%
CI 1.13 to 0.51, P¼0.46).roup compared with conventional therapy control
D: standard deviation; CI: confidence interval)
 2017 THE JOANNA BRIGGS INSTITUTE 3062
d reproduction of this article is prohibited.
Figure 14: Effect of robotic therapy in experimental group compared with conventional therapy control
group on lower limb walking (TR¼0) (SD: standard deviation; CI: confidence interval)
Figure 15: Funnel plot of lower limb studies
(TR¼0) (SE: standard error; SMD: standard mean
difference)
Figure 17: Funnel plot of lower limb studies with
follow-up in less than or equal to 3 months (SE:
standard error; SMD: standard mean difference)
SYSTEMATIC REVIEW K. Lo et al.Lower limb walking (sustainability)
Follow-up in less than or equal to three months
Five studies with a total patient population of 259
were analyzed. The forest plot showed no significant
difference between experimental and control groups
(Figure 16). The pooled SMD (random-effects
model) was 0.33, 95% CI 1.31 to 0.65,
I2¼92%, P¼0.51. A potential for publication bias
was found from the funnel plot (Figure 17).Figure 16: Effect of robotic therapy in experimental g
group on lower limb walking (follow-up in less than
confidence interval)
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeFollow-up in more than three months
Six studies with a total patient population of 408
were analyzed. The forest plot showed no significant
difference between experimental and control groups
(Figure 18). The pooled SMD (random-effects
model) was 0.30, 95% CI 0.05 to 0.65,
I2¼63%, P¼0.10. No evidence of publication bias
was found from the funnel plot. (Figure 19).roup compared with conventional therapy control
or equal to 3 months) (SD: standard deviation; CI:
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Figure 18: Effectof robotic therapy inexperimental groupcomparedwith conventional therapycontrol group
on lower limb walking (follow-up in more than 3 months) (SD: standard deviation; CI: confidence interval)
Figure 19: Funnel plot of lower limb studies with
follow-up in more than 3 months (SE: standard
error; SMD: standard mean difference)
Figure 20: Effect of robotic therapy in experimental g
group on activities of daily living (SD: standard dev
SYSTEMATIC REVIEW K. Lo et al.
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeActivities of daily living
Thirty-one studies with a total patient population of
1120 were analyzed. The forest plot showed no
significant difference between experimental and con-
trol groups (Figure 20). The pooled SMD (random-
effects model) was 0.11, 95% CI 0.11 to 0.33,
I2¼66%, P¼0.32. No evidence of publication bias
was found from the funnel plot (Figure 21).
Sub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients and
moderate/mild impairment patients were conducted
and these showed no significant differences between
experimental and control groups (Acute/Sub-Acute:roup compared with conventional therapy control
iation; CI: confidence interval)
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Figure 21: Funnel plot of activities of daily living
studies (SE: standard error; SMD: standard mean
difference)
Figure 23: Funnel plot of activities of daily living
studies (TR¼0) (SE: standard error; SMD: standard
mean difference)
SYSTEMATIC REVIEW K. Lo et al.SMD 0.01, 95% CI 0.38 to 0.35, P¼0.95;
Chronic: SMD 0.22, 95% CI 0.03 to 0.47,
P¼0.08; Severe: SMD 0.20, 95% CI 0.10 to
0.49, P¼0.19; Moderate/Mild: SMD 0.06, 95%
CI 0.24 to 0.36, P¼0.68).
Activities of daily living (TRU 0)
For the comparison of robotic therapy alone to
conventional therapy alone (TR¼0), 12 studies with
a total patient population of 345 were analyzed and
the result showed no significant difference between
experimental and control groups (Figure 22). The
pooled SMD (random-effects model) was 0.00, 95%
CI 0.54 to 0.53, I2¼82%, P¼0.99. No evidence
of publication bias was found from the funnel plot
(Figure 23).
Sub-group analyses for acute/sub-acute patients,
chronic patients, severe impairment patients andFigure 22: Effect of robotic therapy in experimental g
group on activities of daily living (TR¼0) (SD: stand
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizemoderate/mild impairment patients were conducted
and these showed no significant differences between
experimental and control groups (Acute/Sub-Acute:
SMD 0.71, 95% CI 1.95 to 0.54, P¼0.26;
Chronic: SMD 0.33, 95% CI 0.05 to 0.70,
P¼0.09; Severe: SMD 0.07, 95% CI 1.42 to
1.28, P¼0.92; Moderate/Mild: SMD 0.01, 95%
CI 0.59 to 0.61, P¼0.98).
Activities of daily living (sustainability)
Follow-up in less than or equal to three months
Eleven studies with a total patient population of 428
were analyzed. The forest plot showed no significant
difference between experimental and control groups
(Figure 24). The pooled SMD (random-effects
model) was 0.10, 95% CI 0.57 to 0.38,
I2¼81%, P¼0.68. A potential for publication bias
was found from the funnel plot (Figure 25).roup compared with conventional therapy control
ard deviation; CI: confidence interval)
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Figure 24: Effect of robotic therapy in experimental group compared with conventional therapy control
group on activities of daily living (follow-up in less than or equal to 3 months) (SD: standard deviation;
CI: confidence interval)
Figure 25: Funnel plot of activities of daily living
studies with follow-up in less than or equal to 3
months (SE: standard error; SMD: standard mean
difference)
Figure 27: Funnel plot of activities of daily living
studies with follow-up in more than 3 months (SE:
standard error; SMD: standard mean difference)
SYSTEMATIC REVIEW K. Lo et al.Follow-up in more than three months
Nine studies with a total patient population of 481
were analyzed. The forest plot showed no significant
difference between experimental and control groupsFigure 26: Effect of robotic therapy in experimental g
group on activities of daily living (more than 3 month
JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorize(Figure 26). The pooled SMD (random-effects
model) was 0.14, 95% CI 0.27 to 0.56,
I2¼76%, P¼0.50. No evidence of publication bias
was found from the funnel plot. (Figure 27).roup compared with conventional therapy control
s) (SD: standard deviation; CI: confidence interval)
 2017 THE JOANNA BRIGGS INSTITUTE 3066
d reproduction of this article is prohibited.
Table 1: Results of narrative review of the three studies















0 (1) 0 (0) 1.5 (1) 1 (1) 1 (0) 1 (1)
Functional ambulation
category (post)
1 (3) 1 (3) 1.25 (0.58)y 1.29 (0.99)y 3 (1) 2 (2)
Functional ambulation
category (follow-up)
NA NA 2.60 (0.84)y 2.27 (1.42)y NA NA
Activities of daily living
(pre)
35 (41.25) 35 (18) 34 (39) 38 (22) 56 (20) 66.5 (18)
Activities of daily living
(post)
50 (25) 50 (10) 7 (21)y 12 (18)y 91 (17) 89.5 (26.5)
Activities of daily living
(follow-up)
NA NA NA NA NA NA
Values are median (Inter-Quartile Range); Unless otherwise indicated, comparison between groups was not statistically significant.
significant differences between groups.
yvalues are gains from baseline.
NA, Not Applicable.
SYSTEMATIC REVIEW K. Lo et al.Narrative review
Three studies only reported median data that were
not suitable for meta-analysis and the results of these
studies are shown in Table 1.
Husemann et al.40 found that there were no
significant differences between experimental and
control groups for outcome measures of Functional
Ambulation Category and ADLs. The authors con-
cluded that robotic training was comparable to
conventional training. Nunen et al.41 found no
significant differences for between group compar-
isons and concluded that robotic therapy was as
effective as conventional therapy. Tong et al.39
found that for Functional Ambulation Category,
the experimental group had significantly more
improvement than the control group but for ADLs,
no significant difference was found between the two
groups. Tong et al. concluded that intervention
patients had better mobility and improvement in
functional ambulation than patients who under-
went conventional gait training. In terms of sample
sizes, the three studies had comparable samples of
around 30 patients each and all involved acute/sub-
acute patients with severe impairments. Although
the three studies were dose-matched in terms of
training durations for experimental and controlJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizegroups, the significant improvement found by
Tong et al. could be due to the number of repeti-
tions received by patients: the robotic group had 10
times more repetitions compared to the conven-
tional group.39 No information on the quantity of
training repetitions were provided in the other
two studies.
Heterogeneity analysis
To identify causes of heterogeneity, sub-group anal-
yses were conducted and the results are shown in
Table 2. When sub-groups based on outcome scales
were examined, there was a change in heterogeneity
levels as compared to the main groups. For ADLs,
the change was more pronounced: one outcome scale
(Motor Activity Log - Quality of Movement) had an
I2 of 0%. We also divided the trial studies into two
sub-groups: those whose intervention groups had no
conventional therapy component (i.e. TR¼0) and
those which had a combination of robotic and con-
ventional therapies (i.e. TR>0). This analysis
revealed that there was a clear difference in I2 values.
For upper limb, lower limb and ADLs studies, the
same pattern of change was demonstrated: I2
increased for sub-group TR¼0, while I2 decreased
for sub-group TR>0. 2017 THE JOANNA BRIGGS INSTITUTE 3067
d reproduction of this article is prohibited.
Table 2: Sub-groups analyzed for heterogeneity
Analysis by outcome scales
Upper limb movement No. of studies I2 values P-values (chi-squared test)
Upper limb (all scales) 29 41% 0.01
Upper limb (only FM [UL]) 25 36% 0.04
Lower limb walking
Lower limb (all scales) 15 75% <0.00001
Lower limb (only FAC measure) 10 82% <0.00001
Activities of daily living (ADL)
ADL (all scales) 31 66% <0.00001
ADL (FIM [total]) 4 71% 0.01
ADL (BI) 3 72% 0.03
ADL (MAL-QOM) 4 0% 0.48
Analysis by therapy ratio
Upper limb movement No. of studies I2 values P-values (chi-squared test)
Upper limb (TR¼0) 16 48% 0.02
Upper limb (TR>0) 13 31% 0.13
Lower limb walking
Lower Limb (TR¼0) 6 80% 0.0001
Lower Limb (TR>0) 9 56% 0.02
Activities of daily living (ADL)
ADL (TR¼0) 12 82% <0.00001
ADL (TR>0) 19 25% 0.15
BI, Barthel Index; FAC, Functional Ambulation Category; FIM (total), Functional Independence Measure (total); FM (UL), Fugl-Myer (upper limb); MAL-QOM, Motor
Activity Log - Quality of Movement; TR, Therapy Ratio.
SYSTEMATIC REVIEW K. Lo et al.Sensitivity analysis for non-blinded assessment
Seven studies for meta-analysis of lower limb walk-
ing did not use blinded assessment. As there were 15
studies for this outcome, there could be a large effect
for this analysis. A sensitivity analysis excluding
studies with non-blinded assessment was done and
the result indicated no significant difference between
experimental and control groups (SMD 0.26, 95%
CI 0.07 to 0.6, I2¼63%, P¼0.13). For the severe
impairment sub-group, a sensitivity analysis was
also conducted and the result indicated that robotic
therapy was more effective than conventional ther-
apy (SMD 0.42, 95% CI 0.08 to 0.75, I2¼57%,
P¼0.02).JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeDiscussion
The review found no significant differences between
robotic therapy experimental and conventional ther-
apy control groups for the outcomes of upper limb
motor movement, lower limb walking and activities
of daily living. This indicated that robotic training
had equivalent treatment effect as conventional
training. However, for severely impaired lower limb
patients, a statistically significant difference favoring
the experimental group was found.
Compared to the findings of other systematic
reviews conducted, our findings were different. In
the systematic review of lower limb by Mehrholz
et al.,52 the authors found that robotic-assisted gait 2017 THE JOANNA BRIGGS INSTITUTE 3068
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SYSTEMATIC REVIEW K. Lo et al.training increased the odds of participants becoming
independent in walking. The difference in finding
could be due to the method of data analysis. The
authors pooled together data from robotic interven-
tion arms that included other therapies, such as
functional electrical stimulation applied to the legs
during gait training. In our review, the intervention
arm containing only robotic training (or combina-
tion of robotic and conventional training) was com-
pared to the conventional training control arm.
However, for the sub-group of severely impaired
patients, both our findings indicated that robotic
treatment was more effective.
For systematic reviews of upper limb by Mehrholz
et al.53 and Prange et al.,54 Mehrholz et al. found
that robot-assisted arm training improved arm
motor movement and activities of daily living scores,
while Prange et al. found that robot-assisted arm
training improved arm motor movement. For the
review by Prange et al., only two studies (sample size
of 70 patients) were included and this could have led
to an under-powering of the review. Compared to
the review by Mehrholz et al., our finding could be
different due, again, to the way data was pooled for
analysis. The authors pooled together data from
different intervention arms (containing robotic train-
ing and robotic training that is combined with other
interventions such as electroencephalography-based
brain computer interface or functional electrical
stimulation) and compared it with the conventional
training control arm.
Despite our findings being different to previous
systematic reviews, we are judiciously confident of
our findings, as a sufficient number of studies had
been included and these studies had reasonably good
quality of evidence.
Upper limb movement
Across the various sub-groups analyzed, we found
that the robotic experimental group was just as
effective as the conventional control group. It was
possible that the proportion of conventional training
of the experimental group could affect the outcome.
For example, if an experimental group had majority
conventional training, it could lead to outcomes
similar to that of the control groups. To remove this
potential confounding factor, an analysis was made
for studies whereby there was only robotic training
and no conventional training (i.e. TR¼0). Again,
the results showed that there was no significantJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizedifference. A GRADE assessment was done for these
two sub-groups and the included studies were rated
as high quality.
The reason that there were no significant differ-
ences between experimental and control groups
could be due to the number of training repetitions.
It was possible that in conventional arm training, the
amount of training repetitions that patients received
was of the same intensity as robotic group. Given
that upper limbs are physically lighter and easier to
access, therapists could maneuver the limbs more
and achieve the same intensity of training as
robotic devices.
In terms of the treatment sustainability, we
looked at follow-up measurements (<¼3 months
and >3 months) post intervention. From the forest
plots, no significant difference between the experi-
mental and control groups was found. This could
indicate that the treatment effects of robotic training
post intervention were the same as conventional
training. However, in view of the low-quality
GRADE evidence found for these two sub-groups,
this result should be interpreted with caution.
Lower limb walking
No significant difference was found between the
experimental and control groups. From the sub-
groups analyzed, we found that the robotic experi-
mental group was just as effective as the conven-
tional control group, except for the sub-group of
severe impairment patients. For this sub-group, we
found a significant difference showing that the
robotic training was more effective than conven-
tional training. In five out of the 10 included studies
for the severe sub-group, the experimental groups
had post intervention FAC outcomes that scored 3 or
higher, which indicated a reasonable degree of clini-
cal improvement. An FAC score of 3 indicates walk-
ing without physical assistance but requiring verbal
supervision, while an FAC score of less than 3
indicates dependency, whereby physical assistance
must be given in walking.34
We also analyzed studies where there was only
robotic training and no conventional training (i.e.
TR¼0). Again, the results showed that there was no
significant difference. A high-quality of GRADE
evidence rating was found for sub-groups ‘‘Lower
Limb’’ and ‘‘Lower Limb - Severe’’ but for ‘‘Lower
Limb - Therapy Ratio¼0’’, the evidence was of
low quality. 2017 THE JOANNA BRIGGS INSTITUTE 3069
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SYSTEMATIC REVIEW K. Lo et al.For patients with severe impairment, it could
be that the amount of repetitions that patients
performed during conventional training were of
lower intensity than robotic group. As these patients
had severe impairments, more effort was required
from therapists to exercise the lower limbs, which
are physically heavier and more difficult to
access. As a result, therapists might not be able
to maneuver the lower limbs as conveniently as
upper limbs and so not achieve the same intensity
of training as robotic devices. This could explain a
preference for robotic training in patients with
severe impairments, where higher repetitions could
be achieved with minimal physical effort from
therapists.
In terms of treatment sustainability, follow-up
measurements (<¼3 months and >3 months) post
intervention were examined and from the forest
plots, no significant differences between the experi-
mental and control groups were found. A low-
quality GRADE evidence was assessed for ‘‘Lower
limb - follow-up (<¼3 months)’’ but a high-quality
GRADE score was assessed for ‘‘Lower limb - fol-
low-up (>3 months)’’. This may indicate that the
longer-term treatment effects of robotic training post
intervention were the same as conventional training
but, in view of the conflicting GRADE evidence
found for these two sub-groups, the result should
be interpreted with caution.
Activities of daily living
The review found that there was no significant
difference between the experimental and control
groups. From the various sub-groups analyzed, we
found that the robotic experimental group was just
as effective as the conventional control group. Simi-
larly, an analysis was made for studies whereby there
was only robotic training and no conventional train-
ing (i.e. TR¼0). Again, the results showed that there
was no significant difference. A GRADE assessment
was done for these two sub-groups and a high-
quality of evidence was found for ‘‘Activities of daily
living (ADL)’’ and moderate-quality for ‘‘ADL -
Therapy Ratio¼0’’.
In terms of the treatment sustainability, we
looked at follow-up measurements (<¼3 months
and >3 months) post intervention. From the forest
plots, no significant differences between the experi-
mental and control groups were found. The sub-
group<¼3 months had a moderate-quality ofJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. UnauthorizeGRADE evidence, while the sub-group >3 months
had a high-quality of evidence.
In view of the reasonable quality of GRADE
evidence found for all the four ADL sub-groups,
the results could show that robotic training was as
effective as conventional training.
Limitations
Differences in outcome scales
For the meta-analysis, we encountered various scales
and included those scales which were more specific
to measuring the motor movement of the patients.
Scales that measured speeds of movements, walking
distances or muscle strengths were excluded.
In upper limb studies, the Fugl-Myer (Upper
Limb) was the most common scale but some of
the studies measured sub-components of the scale,
for example, the Fugl-Myer scale could be sub-
divided into proximal and distal components. If
the total Fugl-Myer (Upper Limb) score was not
provided, these sub-components would then be
added to obtain the total upper limb score. However,
one study55 had Fugl-Myer (Hand) data, as the study
only involved training for the hand. Overall, for
upper limb studies, scales used were: Fugl-Myer
(Upper Limb), Fugl-Myer (Hand), Motricity Index
(Upper Limb), Chedoke McMaster56 and Wolf
Motor Function Test.57
For lower limb studies, scales included were:
Functional Ambulation Category, Fugl-Myer
(Lower Limb), Motricity Index (Lower Limb), Func-
tional Independence Measure (Walking), Emory
Functional Ambulation Profile58 and modified
Emory Functional Ambulation Profile.59
For ADL studies, the scales involved were more
varied and the most common scale encountered was
Functional Independence Measure (FIM). For FIM,
some authors reported data for sub-components of
this scale, e.g. motor, self-care and transfer, and
mobility. Where authors reported the total FIM, this
data was used, otherwise the sub-components were
included. One study60 provided data only for com-
ponents of the FIM relating to upper limb, as the
study looked at upper limb therapy. Overall, scales
used were: FIM, FIM (Upper Limb), FIM (Self Care
and Transfer), FIM (Motor), FIM (Mobility), Stroke
Impact Scale (SIS),61 SIS – Activities of Daily Living/
Instrumental Activities of Daily Living,61 California
Functional Evaluation 40 (CAFÉ 40),62 Barthel
Index, Frenchay Activities Index,63 Motor Activity 2017 THE JOANNA BRIGGS INSTITUTE 3070
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SYSTEMATIC REVIEW K. Lo et al.Log – Quality of Movement,64 Korea Modified
Barthel Index,65 Arm Motor Ability Test - Func-
tion66 and Late Life Function and Disability Instru-
ment – Function.67
In the meta-analyses, related scales were pooled
together for sub-group analysis and the presence of
different scales in the pooled sub-group could add
bias to the findings. To minimize the risk of bias,
standardized mean difference was applied. Details of
the study outcomes included can be found under
characteristics of included studies (Appendix III).
Heterogeneity of studies
Another potential limitation of our analysis is the
heterogeneity of studies. For the three main sub-
groups of upper limb, activities of daily living and
lower limb, the level of heterogeneity (I2) ranged
from 41%, 66% to 75%, respectively, which was
moderate to substantial levels of heterogeneity.32
The heterogeneity could be due to the clinical and
methodological diversities of the studies,45 as the
studies exhibited differences in outcome scales, inter-
vention devices, intervention dosages, participant
characteristics and study designs (2-arm, 3-arm
and cross-over designs). For studies with follow-
up data, heterogeneity could also be due to the
outcomes being measured at various time points
post intervention, ranging from one month to ten
months after the intervention period.
When sub-group analysis based on outcome
scales were examined, the change in I2 heterogeneity
level was more pronounced for ADLs. For ADLs, the
wide range of measurement scales that had been used
in the studies was a likely cause of heterogeneity. The
included studies were further divided into two sub-
groups: TR¼0 and TR>0. This analysis revealed
that there was a clear difference in I2 values between
the two sub-groups. It is probable that for studies
with TR>0, the presence of conventional training, as
part of the robotic intervention, ‘‘masked’’ the
effects of robotic training and gave these studies less
clinical diversity. For those studies which had no
conventional training as part of the robotic interven-
tion, the different designs and types of robotic devi-
ces used could have caused a wider range of
treatment effects, leading to higher I2 values.
Despite using the random effects model, which
pulls estimates towards smaller studies,68 our results
were in concordance with the outcomes of the largest
trials included.69 For upper limb, our results showedJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizeno significant difference between experimental and
control groups, which was the same conclusion
reached by Lo et al.17 (sample size: 93 patients).
For lower limb and ADLs, our results were also in
agreement with Chua et al.44 (sample size: 106
patients). Taken altogether, we believe that hetero-
geneity, although present, should not distract us
from the treatment effect observed.
Non-blinded assessment
A potential source of bias is that some studies did not
use blinded assessment. Eleven out of the 51 studies
were of this nature and they had a sample size of 354
patients, which is around 20% of the total sample
size. Two studies were for upper limbs and nine were
for lower limbs. Out of the nine studies, one (Nunen
et al.41) was for narrative review and one (Peurala
et al.70) only had data for the ADL outcome. The
remaining seven were for meta-analysis of lower
limb walking. As there were 15 studies for this
outcome, there could be a large effect for this analy-
sis. Sensitivity analysis excluding studies with non-
blinded assessment indicated no significant differ-
ence between experimental and control groups. For
the severe impairment sub-group, the sensitivity
analysis also indicated that robotic therapy was
more effective than conventional therapy.
English language studies
For this review, only studies in English-language
were included and the inclusion of non-English-lan-
guage studies might have provided different outcome
results. This language bias could have led us to over-
estimate the effect sizes, as it was possible that papers
with positive results were more likely to be published
in English-language journals, while papers with neg-
ative results might have been more likely to be
published in non-English-language journals,71 which
catered more to local readers. However, in view that
a number of papers from non-English speaking
countries (e.g. Finland, Germany, Israel, Italy,
Japan, Mexico, the Netherlands, Portugal, South
Korea, Switzerland, Taiwan) had been included
for review, the risk of language bias is not considered
significant. There is also evidence to suggest that
excluding non-English-language studies may not
lead to bias. In a systematic review of risk of bias
due to limiting studies to English-language, the
authors found that that there were no major differ-
ences between treatment effects in English-language 2017 THE JOANNA BRIGGS INSTITUTE 3071
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inclusive meta-analyses.71
Conclusion
We found that robotic training was just as effective
as conventional training for upper limb motor move-
ment, lower limb walking mobility and ADL. For
patients with severe impairment of lower limbs, the
analysis showed that robotic training produces bet-
ter outcomes than conventional training. The suffi-
cient quantity of studies included and the reasonable
quality of GRADE evidence for the various interven-
tion analysis lends confidence to our findings.
In terms of treatment sustainability, we also
found that robotic training was just as effective as
conventional training. However, the low-quality of
GRADE evidence for upper and lower limb studies
with follow-up data, and the relatively lower number
of studies included require caution in interpreting
this finding. For treatment sustainability of ADL, the
better quality of GRADE evidence and the larger
number of studies analyzed give us stronger reasons
to believe that robotic training is just as effective as
conventional training.
Recommendations for practice
For patients with severely impaired lower limbs, after
their medical conditions stabilize, they may be treated
using robotic gait training devices. With the higher
repetitions that robotic devices can offer, patients can
practice more and this will stimulate neural plasticity
during the early stages of their recovery. When
patients are more able to walk, they can then transi-
tion to conventional over-ground walking to further
practice walking over different terrains, improve
balance and correct any abnormal gait patterns.
(Grade B: JBI Grades of Recommendation31)
That robotic assisted training is just as effective as
conventional physiotherapy may be utilized by phys-
iotherapists to use robotic devices as a multiplier tool
that enables them to provide training to more adult
stroke patients. Instead of one-to-one conventional
practice, therapists can simultaneously engage more
patients using robotic devices. This can free up
valuable therapist time either to give more severe
patients personalized training or to practice more
functional related tasks that require the integration
of different motor skills. By channeling their time to
these higher-value training activities and letting
robotic devices do the routine ‘‘heavy-lifting’’ tasks,JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizetherapists can offer appropriate levels of personal-
ized treatment for patients and increase their effi-
ciency. (Grade B: JBI Grades of Recommendation31)
Recommendations for research
The current review has observed that robotic and
conventional training are equally effective and, as
such, the considerations of introducing robotic devi-
ces into stroke rehabilitation units may need to turn
to other factors such as economic cost, treatment
efficiency and productivity. For example, by using
robotic devices, what is the resulting cost of treating
each patient and how many more patients can be
treated? Also, how many devices should a stroke unit
have and how can the workflow of robotic devices
and therapists be optimized in order to maximize
treatment efficiency? Research that addresses these
questions will provide insights and assist in identify-
ing optimal approaches into how robotic devices can
be deployed into stroke rehabilitation units and be
integrated into the work scope of therapists.
Acknowledgements
The authors would like to acknowledge the contri-
bution of Annika Theodoulou in co-reviewing the
critical appraisal questions and the funding support
from the Australian Government Research Training
Program.
References
1. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke:
Part 3 - The Burden: Global burden of stroke: World Health
Organization; 2004 [cited 2016 18 April]. Available from:
http://www.who.int/cardiovascular_diseases/resources/
atlas/en/.
2. National Stroke Association, USA. Hemiparesis; [Internet].
[cited 2016 February 16]. Available from: http://www.stroke.
org/we-can-help/survivors/stroke-recovery/post-stroke-
conditions/physical/hemiparesis.
3. Intercollegiate Stroke Working Party. National Clinical
Guideline for Stroke. 4th ed. London: Royal College of
Physicians; 2012.
4. GreshamGE, AlexanderD, BishopDS, Giuliani C, GoldbergG,
Holland A, et al. Rehabilitation. Stroke 1997;28(7):1522–6.
5. Van Peppen R, Kwakkel G, Wood-Dauphinee S, Hendriks
HJ, Van der Wees PJ, Dekker J. The impact of physical
therapy on functional outcomes after stroke: what’s the
evidence? Clin Rehabil 2004;18(8):833–62.
6. French B, Thomas LH, Leathley MJ, Sutton CJ, McAdam J,
Forster A, et al. Repetitive task training for improving
functional ability after stroke. Cochrane Database Syst
Rev (4)2007. 2017 THE JOANNA BRIGGS INSTITUTE 3072
d reproduction of this article is prohibited.
SYSTEMATIC REVIEW K. Lo et al.7. Whitall J. Stroke Rehabilitation Research: Time to Answer
More Specific Questions? Neurorehabil Neural Repair
2004;18(1):3–11.
8. Takeuchi N, Izumi S. Rehabilitation with poststroke motor
recovery: a review with a focus on neural plasticity. Stroke
Res Treat 2013;2013:13.
9. Yakub F, Md Khudzari AZ, Mori Y. Recent trends for
practical rehabilitation robotics, current challenges and
the future. Int J Rehabil Res 2014;37(1):9–21.
10. Masiero S, Poli P, Rosati G, Zanotto D, Iosa M, Paolucci S,
et al. The value of robotic systems in stroke rehabilitation.
Expert Rev Med Devices 2014;11(2):187–98.
11. Hesse S, Schmidt H, Werner C, Bardeleben A. Upper and
lower extremity robotic devices for rehabilitation and for
studying motor control. Curr Opin Neurol 2003;16(6):
705–10.
12. Hidler J, Nichols D, Pelliccio M, Brady K, Campbell DD, Kahn
JH, et al. Multicenter randomized clinical trial evaluating
the effectiveness of the Lokomat in subacute stroke.
Neurorehabil Neural Repair 2009;23(1):5–13.
13. Werner C, Von Frankenberg S, Treig T, Konrad M, Hesse S.
Treadmill training with partial body weight support and an
electromechanical gait trainer for restoration of gait in
subacute stroke patients: A randomized crossover study.
Stroke 2002;33(12):2895–901.
14. Fazekas G. Robotics in rehabilitation: successes and expec-
tations. Int J Rehabil Res 2013;36(2):95–6.
15. Chang WH, Kim MS, Huh JP, Lee PK, Kim YH. Effects of
robot-assisted gait training on cardiopulmonary fitness in
subacute stroke patients: a randomized controlled study.
Neurorehabil Neural Repair 2012;26(4):318–24.
16. McCabe J, Monkiewicz M, Holcomb J, Pundik S, Daly JJ.
Comparison of robotics, functional electrical stimulation,
and motor learning methods for treatment of persistent
upper extremity dysfunction after stroke: a randomized
controlled trial. Arch Phys Med Rehabil 2015;96(6):981–90.
17. Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg
GF, Federman DG, et al. Robot-assisted therapy for long-
term upper-limb impairment after stroke. N Engl J Med
2010;362(19):1772–83.
18. Ang KK, Guan C, Phua KS, Wang C, Zhou L, Tang KY, et al.
Brain-computer interface-based robotic end effector sys-
tem for wrist and hand rehabilitation: results of a three-
armed randomized controlled trial for chronic stroke. Front
Neuroeng 2014;7(30):30.
19. Geroin C, Picelli A, Munari D, Waldner A, Tomelleri C,
Smania N. Combined transcranial direct current stimula-
tion and robot-assisted gait training in patients with
chronic stroke: a preliminary comparison. Clin Rehabil
2011;25(6):537–48.
20. Hsieh YW, Lin KC, Horng YS, Wu CY, Wu TC, Ku FL.
Sequential combination of robot-assisted therapy and
constraint-induced therapy in stroke rehabilitation: a ran-
domized controlled trial. J Neurol 2014;261(5):1037–45.JBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorize21. Tanaka N, Saitou H, Takao T, Iizuka N, Okuno J, Yano H, et al.
Effects of gait rehabilitation with a footpad-type locomo-
tion interface in patients with chronic post-stroke hemi-
paresis: a pilot study. Clin Rehabil 2012;26(8):686–95.
22. Brokaw EB, Nichols D, Holley RJ, Lum PS. Robotic therapy
provides a stimulus for upper limbmotor recovery after stroke
that is complementary to and distinct from conventional
therapy. Neurorehabil Neural Repair 2014;28(4): 367–76.
23. Geroin C, Mazzoleni S, Smania N, Gandolfi M, Bonaiuti D,
Gasperini G, et al. Systematic review of outcome measures
of walking training using electromechanical and robotic
devices in patients with stroke. J Rehabil Med 2013;45(10):
987–96.
24. Feise RJ. Do multiple outcome measures require P-value
adjustment? BMC Med Res Methodol 2002;2(1):8.
25. Lo K, Stephensen M, Lockwood C. Effectiveness of Robotic
Assisted Rehabilitation for Mobility and Functional
Ability in Adult Stroke Patients: a systematic review proto-
col. JBI Database System Rev Implement Rep 2017;15(1):
39–48.
26. Canadian Partnership for Stroke Recovery. Fugl-Meyer
Assessment of Sensorimotor Recovery After Stroke
(FMA); [Internet]. [cited 2016 April 18]. Available from:
http://www.strokengine.ca/indepth/fma_indepth/.
27. Collin C, Wade D. Assessing motor impairment after stroke:
a pilot reliability study. J Neurol Neurosurg Psychiatry
1990;53(7):576–9.
28. Canadian Partnership for Stroke Recovery. Functional
Ambulation Categories (FAC); [Internet]. [cited 2016 April
18]. Available from: http://www.strokengine.ca/indepth/
fac_indepth/.
29. Canadian Partnership for Stroke Recovery. Barthel Index
(BI); [Internet]. [cited 2016 April 18]. Available from: http://
www.strokengine.ca/indepth/bi_indepth/.
30. Canadian Partnership for Stroke Recovery. Functional Inde-
pendence Measure (FIM); [Internet]. [cited 2016 April 18].
Available from: http://www.strokengine.ca/indepth/fim_
indepth/.
31. The Joanna Briggs Institute. The University of Adelaide.
Joanna Briggs Institute Reviewers’ Manual: 2014 edition.
Joanna Briggs Institute; 2014.
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in complex rehabilitation of post-stroke patients. European Journal of
Neurology, 2015. 22: 673.Not dose matched.Skvortsova VI, et al. Current approaches to restoring walking in patients
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SYSTEMATIC REVIEW PROTOCOLEffectiveness of robotic assisted rehabilitation for
mobility and functional ability in adult stroke patients:
a systematic review protocol
Kenneth Lo  Matthew Stephenson  Craig Lockwood





Review question/objective: The objective of this review is to synthesize the best available evidence on the
effectiveness of robotic assistive devices in the rehabilitation of adult stroke patients for recovery of impairments in
the upper and lower limbs. The secondary objective is to investigate the sustainability of treatment effects associated
with use of robotic devices.
The specific review question to be addressed is: can robotic assistive devices help adult stroke patients regain motor
movement of their upper and lower limbs?
Keywords Rehabilitation; robot; robotic; robotic assisted rehabilitation; stroke
JBI Database System Rev Implement Rep 2017; 15(1):39–48.Background
S troke is a leading cause of long-term disabilityand is the third most common cause of mortality
in developed countries with 15 million people suffer-
ing a stroke yearly.1 Different parts of the brain
control different bodily functions. If a person survives
a stroke, the effects can vary, depending on the
location of brain damage, severity and duration of
the stroke. Broadly, the effects of stroke can be
physical, cognitive or emotional in nature. In terms
of the physical effects of stroke, the loss of motor
abilities of the limbs presents significant challenges for
patients, as their mobility and activities of daily living
(ADLs) are affected. The upper or lower limbs can
experience weakness (paresis) or paralysis (plegia),
with the most common type of limb impairment being
hemiparesis, which affects eight out of 10 stroke
survivors.2 Other physical effects of stroke are loss
of visual fields, vision perception, difficulty swallow-
ing (dysphagia), apraxia of speech, incontinence, joint
pain or neuropathic pain (caused by inability of the
brain to correctly interpret sensory signals in response
to stimuli on the affected limbs). Cognitive effects of
stroke are aphasia, memory loss and vascular demen-
tia. Stroke patients can lose the ability to understandespondence: Kenneth Lo, kenneth.lo@adelaide.edu.au
re is no conflict of interest in this project.
: 10.11124/JBISRIR-2016-002957
Database of Systematic Reviews and Implementation Reports
2017 Joanna Briggs Institute. Unauthorizespeech or the capacity to read, think or reason, and
normal mental tasks can present big challenges,
affecting their quality of life. The drastic changes in
physical and cognitive abilities caused by stroke also
lead to emotional effects for stroke patients. Stroke
survivors can experience depression when they
encounter problems in doing tasks that they can easily
do pre-stroke. Along with depression, they canexperi-
ence a lack of motivation and mental fatigue.
For stroke patients, rehabilitation is the pathway to
regaining or managing their impaired functions.
There is no definite end to recovery but the most
rapid improvement is within the first six months post
stroke.3 Before a patient undergoes rehabilitation, an
assessment is first done to determine if a patient is
medically stable and fit for a rehabilitation program.
If the patient is assessed to be suitable, then depending
on the level of rehabilitative supervision required, the
patient could undergo rehabilitation in various set-
tings – as an in-patient/outpatient (at either a hospital
or nursing facility) or at home.3,4 Rehabilitation
should be administered by a multi-disciplinary team
of physiotherapists, occupational therapist, speech
therapist and neuropsychologists, who work together
to offer an integrated, holistic rehabilitation therapy.4
Depending on the type of impairment, rehabilitation
specialists will assess the appropriate therapies needed
and set realistic goals for patients to achieve. Gener-
ally, stroke patients should be given a minimum of 45
min for each therapy session over at least five days per 2017 THE JOANNA BRIGGS INSTITUTE 39
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itation regimen.3
One of the main goals in stroke rehabilitation is
the restoration of motor skills, and this involves
patients undergoing repetitive, high-intensity, task-
specific exercises that enable them to regain their
motor and functional abilities.5,6 It is theorized that
the brain is plastic in nature and that repetitive
exercises over long periods can enable the brain to
adapt and regain the motor functionality that has
been repeatedly stimulated.7 This involves the for-
mation of new neuronal interconnections that enable
the re-transmission of motor signals.8
Over the years, a number of robotic assistive
devices have been used to rehabilitate patients based
on high repetitions of task-specific exercises.9 These
robotic assistive devices provide consistent and
repetitive cycles over long periods and help train
the limbs of patients to keep receiving and sending
signals from and back to the brain and thereby regain
their motor abilities. Such devices are also complex
in nature involving interactive automation, sensors
and dynamic control logic and are able to function
without much intervention from physiotherapists.
Several devices have been used for rehabilitation of
both upper limb (e.g. ARMin, MIT-MANUS, NeR-
eBot and T-Wrex) and lower limb (e.g. Lokomat,
Gait Trainer, G-EO System and Hybrid Assistive
Leg).10,11 As an example, for patients who are
unable to walk, there are gait-training devices such
as the Lokomat that help patients to recover their
walking ability. Initially, the physiotherapist will set
the patient up with the device and start a software
program that cycles through the various stages of
walking. The patient’s lower limbs will be moved by
the device and the physiotherapist is able to set the
pace of the simulated walking and the amount of
guidance force to assist movement of the legs and
extent of body weight support.
In comparison, for conventional rehabilitation of
the lower limbs without assistive devices, it would
require at least two physiotherapists to train a
patient to walk, and the pace and pattern of walking
may not be consistent. It is also physically strenuous
for the physiotherapists to sustain the exercise over
long periods, thus affecting the rehabilitation prog-
ress of the patient. The labor-intensive nature of
conventional physiotherapy places great strain on
physiotherapists. Coupled with the requirements of
stroke patients for medical care and intensiveJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizerehabilitation exercises (which frequently entail
one-to-one manual interaction with therapists),
therapist time and organizational budgets, it is not
always possible to provide an optimal rehabilitation
program for patients.10 Therefore, it is hoped that
with robotic assistive devices, better rehabilitation
progress can be achieved for patients together with
alleviation of time and physical demands on phys-
iotherapists. With the assistance of robots, physio-
therapists will be able to concentrate more on
functional rehabilitation during individual training
sessions and supervision of multiple patients simul-
taneously during robot-assisted therapy sessions.
This approach would maximize the expertise and
time of physiotherapists, thus improving the effec-
tiveness of the rehabilitation program.10
There have been clinical studies to determine the
effectiveness of robotic assistive devices in the reha-
bilitation of stroke patients.12 However, these stud-
ies presented a mixed picture of the effectiveness of
robotic devices. One study on lower limbs reported
an improvement in a motor movement scale (Fugl-
Meyer Assessment lower extremity score) but not for
another motor scale (leg score of Motricity Index)
and also stated no improvement on a walking scale
(Functional Ambulation Category).13 Others
reported that there was no statistically significant
difference between robotic assisted therapy and con-
ventional therapy,14,15 while one study that inves-
tigated walking speeds and distance found that
conventional therapy was more effective than
robotic assisted therapy.16 There were also various
types of study designs. Some studies examined not
just robot-assisted rehabilitation but combinations
of robot-assisted rehabilitation and non-convention-
al physiotherapies (e.g. functional electrical simu-
lation [FES], constraint induced therapy [CIT],
transcranial direct current stimulation or motor
imagery) versus conventional therapies in three-
arm studies.17-19 Other studies involved patients in
a randomized controlled crossover trial with or
without a washout period.20,21
Typically, in studies, authors used different scales
for their primary and secondary outcomes. These
scales were used to measure motor movement, motor
strength/duration, walking speed or functional
activities. With various outcome scales used, it will
be a challenge to compare the results of clinical
trials,22 and the suitability of certain scales will also
depend on the modality of the robotic therapy given. 2017 THE JOANNA BRIGGS INSTITUTE 40
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will be better if patients have less assistive guidance
force provided (or conversely, more resistive guid-
ance force provided) and minimal gravity support
during therapy sessions.23 Also, in a trial with
multiple outcome measures, testing multiple simul-
taneous hypotheses at set P values could lead to
increased risk of Type I errors.24 To mitigate this,
Feise24 recommended that researchers facing
multiple outcome measures select a primary out-
come measure or use a global assessment measure.
As robotic devices are primarily designed to enable
movement of a particular limb,10 a suitable measure-
ment scale that reflects the design function of the
device is necessary to accurately determine the effec-
tiveness of these devices. In view of this, scales that
measure movement abilities of the paretic limbs
should be used, such as Fugl-Meyer Scale Assessment
(upper extremity) for the upper limbs or Functional
Ambulation Category for the lower limbs.
A preliminary search of PubMed, Embase, JBI
Database of Systematic Reviews and Implementa-
tion Reports and Cochrane Library identified three
systematic reviews that have been conducted in this
topic area.25-27
These reviews included a variety of outcome
measures for motor function, muscle strength, walk-
ing capacity and walking velocity. Mehrholz
et al.25,26 found that robot-assisted arm training
improved ADLs, arm function and muscle strength
of the paretic arm, and for the lower limbs walking
was improved but not for walking velocity or walk-
ing capacity. Prange et al.27 found that arm control
improved but not functional ability. The proposed
systematic review being undertaken has different
aspects to the previous reviews. First is the selection
of the outcome measure to examine primarily the
motor movement of the paretic limbs in order to
have a meaningful comparison across studies.22 Sec-
ond is the analysis approach toward multiple-arm
studies. In the first two reviews,25,26 the results of the
arms of robotic intervention groups, some with
additional forms of non-conventional treatment,
were pooled together for comparison against the
control group. In this review, only the arm of robotic
intervention group (without other forms of non-
conventional treatment, e.g. FES) will be compared
to the control group to clarify the effects of the
intervention. The current review also seeks to
address the question of sustainability of theJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizetreatment effects; for example, is the improved
motor movement ability measured at the end of
intervention period maintained post intervention?
If the outcome measure is maintained (or improved)
during follow-up measurements after intervention,
then the effect of rehabilitation can be considered as
being sustainable. From analyzing the intervention
sustainability, it is hoped that the optimal duration
and frequency of rehabilitation that generate the best
sustainability outcome can be identified. This could
assist rehabilitation specialists to formulate a suit-
able proportion of robotic assisted therapy in their
treatment protocols. Lastly, there have been new
studies28-33 published since these existing systematic
reviews were conducted, and this review seeks to
incorporate the most recent trial findings.
The diverse range of outcomes and study designs
does not provide a clear determination of the effec-
tiveness of robotic assisted rehabilitation, and it is
the intent of this review to provide clarity to the
discussion and offer useful recommendations for
clinical practice. In this review, robotic assisted
therapies for both upper and lower limbs will be
evaluated to gain a detailed understanding of the
effectiveness of robotic devices in these two areas to




The current review will consider studies that include
adult stroke patients (18 years and older) of all
genders, regardless if stroke is due to ischemic or
hemorrhagic causes. Patients with pre-existing
impairments that are not caused by stroke, such as
disabilities due to spinal cord injuries, Parkinson’s
disease, multiple sclerosis and traumatic brain inju-
ries (caused by accidents, falls, infections, tumors or
chemical toxins), will be excluded. Study partici-
pants may be new stroke patients or repeat stroke
patients at acute, sub-acute or chronic stages of their
stroke, so long as they have been accepted into a
formal rehabilitation program. Only trials where the
rehabilitation setting is either in-patient or outpa-
tient will be included. Home rehabilitation patients
will be excluded due to potential confounding of
treatment adherence. The rehabilitation program
can be conducted at hospitals, nursing facilities or
across multi-centers, and only physical impairments
related to upper and lower limbs will be considered. 2017 THE JOANNA BRIGGS INSTITUTE 41
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The current review will consider studies that evaluate
rehabilitation of stroke patients using interactive,
automated electromechanical equipment (i.e. assis-
tive robotics). The types of robotic assistive devices
can be varied (e.g. either robotic exoskeletons or end-
effectors for gait training), as long as interventions
involve electromechanical assistive devices with auto-
mation, sensors and dynamic control logic that help
patients regain their motor abilities. Interventions
involving the devices below are not considered as
robotic rehabilitation devices as they do not exhibit




Non-interactive devices that deliver passive
motion such as treadmills, static body-weight-
assisted treadmills, bicycles, static walking aids,
static orthoses (such as ankle-foot orthoses
addressing foot drop) or pure mechanical trainers
(e.g. Reha-Slide, Reha-Slide duo). Standalone video games controlled solely by
patient without automated assistive feature, such
as Nintendo Wii. Rehabilitation programs using non-conventional
therapies such as acupuncture, FES, transcranial
direct current stimulation, motor imagery, bio-
feedback and CIT.
The intervention group can have or not have anadded conventional physiotherapy component. If the
intervention group has an added conventional phys-
iotherapy component, this can involve non-interac-
tive static devices.
The intervention should not contain other types of
non-conventional therapy (e.g. FES, transcranial
direct current stimulation, motor imagery or CIT).
For multiple-arm studies, only results of the inter-
vention arm with robotic assisted rehabilitation will
be compared to the control arm. The intervention
arm with a combination of robotic assistive devices
and non-conventional therapy will be excluded
from analysis.
Comparator
As control groups, patients do not receive robotic
assisted rehabilitation but receive only conventional
physiotherapy or no physiotherapy treatment at all.
The conventional physiotherapy treatment, how-
ever, may include non-interactive static devices
(e.g. bicycles, treadmills and acupuncture).
The amount of therapy treatment in both inter-
vention and control groups should be the same inDatabase of Systematic Reviews and Implementation Reports
2017 Joanna Briggs Institute. Unauthorizeterms of frequency and duration, that is, dose-
matched. For example, if patients in the intervention
group undergo 60 min of therapy using a robotic
assistive device on top of a conventional physiother-
apy component, then in the control group the
patients should also undergo additional 60 min of
conventional physiotherapy. Therefore, the total
amount of therapy planned for patients (in terms
of frequency per week, duration of a therapy session
and overall rehabilitation period) should be the
same for both groups. This does not apply if, in
the control group, patients do not receive conven-
tional physiotherapy.
For robotic assisted rehabilitation, the duration of
therapy will consist of time for the patient to be set
up with and be taken out of the robotic device, thus
limiting the time for exercising the paretic limb (e.g.
for Lokomat, a robotic exoskeleton device, actual
exercise time can range from 35 to 40 min in a 60-
min therapy session).34 Although the actual exercise
duration can be less than the allocated duration of
therapy, it can still be considered as being equivalent
to the duration of a conventional physiotherapy
session, as during a conventional therapy session
not the full duration will be used for exercising.
There will also be time for patients to prepare or
rest in between exercises. In addition, some trials do
not provide a breakdown of actual exercise duration
but only the duration of a therapy session.
Outcomes
The current review will consider studies that include
the outcome measure of the amount of motor move-
ment demonstrated by the paretic limbs. To have an
accurate point of reference across studies, only stud-
ies that have used scales that measure motor move-
ment will be considered for the review.
For outcome measure of upper limbs, the Fugl-
Meyer Assessment35 (upper extremity score) is the
preferred scale. If a study does not use this scale, then
an alternative measurement scale that quantifies
upper limb motor movement (e.g. upper limb
Motricity Index36) will be considered.
For outcome measure of lower limbs, the Func-
tional Ambulation Category37 is the preferred scale.
If a study does not use this scale, then an alternative
measurement scale that quantifies walking will be
considered, for example Barthel Index38 (ambu-
lation item) or Functional Independence Measure39
(walking item). 2017 THE JOANNA BRIGGS INSTITUTE 42
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of ADLs attained after the intervention. For outcome
measure of ADLs, Functional Independence
Measure is the preferred scale. If a study does not
use this scale, then an alternative measurement scale
that quantifies the level of ADLs will be considered,
for example, the Barthel Index. As ADLs involve
usage of both upper and lower limbs, a global ADL
measurement combining both subgroups of upper
and lower limbs will be considered.
In clinical trials, patient outcomes at different
stages of the rehabilitation process are measured.
Usually measures are taken at pre-, mid- and post-
intervention stages but some studies will continue to
take follow-up measurements in the months after the
end of the intervention therapy. For this review,
measurements taken at pre- and post-intervention
therapy will be included for analysis. Follow-up
measurements taken after the intervention has ended
will also be compared to measurements taken at the
end of the intervention to examine the sustainability
of the treatment effect.
Types of studies
The current review will consider experimental study
designs of randomized controlled trials. For studies
with crossover design, only the first study period will
be considered for inclusion, as it is not clear if carry-
over effects will have diminished sufficiently during
the washout period. Also, given the context of reha-
bilitation where it is likely and desired for patients to
retain the effects of rehabilitative training, the two
different phases will have a dependence on each
other.16 Thus, it will be confounding if both the first
and second study periods of crossover trials are used
to assess the effectiveness of robotic assistive devices.
Search strategy
The search strategy aims to find published and
unpublished studies. A three-step search strategy will
be utilized in this review. An initial limited search of
PubMed will be undertaken followed by analysis of
the text words contained in the title and abstract,
and of the index terms used to describe the article. A
second search using all identified keywords and
index terms will then be undertaken across all
included databases. Third, the reference list of all
identified reports and articles will be searched for
additional studies. Studies published in English will
be considered for inclusion in this review and a dateJBI Database of Systematic Reviews and Implementation Reports
©2017 Joanna Briggs Institute. Unauthorizelimit starting from 2000 will be set, as automated
robotic devices have been increasingly used since
2000, together with an associated increase in the
number of studies undertaken.
The databases to be searched include:
PubMed, Embase, CINAHL, Cochrane Central
Register of Controlled Trials (CENTRAL) and
PEDro (Physiotherapy Evidence Database).
The search for unpublished studies will include:
Mednar, ProQuest Dissertations & Theses, Clinical-
Trials.gov, Google Scholar
Initial search terms to be used will be:
Robotics[mh] OR Robot[tw] OR Exoskeleton
Device[mh] OR Exoskeleton[tw] OR Gait Train-
er[tw] OR Lokomat[tw] AND Rehabilitation[mh]
OR Rehabilitation[tw] OR Habilitation[tw] AND
Stroke[mh] OR Stroke[tw] OR ‘‘Cerebrovascular
Accident’’ OR Cerebral[tw] OR ‘‘Cerebral Stroke’’
OR ‘‘Cerebrovascular Stroke’’ OR ‘‘Acute Stroke’’
OR ‘‘Sub-acute Stroke’’ OR ‘‘Subacute Stroke’’
Assessment of methodological quality
Papers selected for retrieval will be assessed by two
independent reviewers for methodological validity
prior to inclusion in the review using standardized
critical appraisal instruments from the Joanna Briggs
Institute Meta Analysis of Statistics Assessment and
Review Instrument (JBI-MAStARI) (Appendix I).
Any disagreements that arise between the reviewers
will be resolved through discussion or with a
third reviewer.
Data extraction
Data will be extracted from papers included in the
review using the standardized data extraction tool
from JBI-MAStARI (Appendix II). The data
extracted will include specific details about the
interventions, populations, study methods and out-
comes of significance to the review question and
specific objectives. In the event of specific data of
interest being absent from published articles, corre-
sponding authors will be contacted to request access
to the relevant data.
Data synthesis
Quantitative data will, where possible, be pooled in
statistical meta-analysis using JBI-MAStARI. All
results will be subject to double data entry. Effect
sizes expressed as odds ratio (for categorical data) 2017 THE JOANNA BRIGGS INSTITUTE 43
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continuous data) and their 95% confidence intervals
will be calculated for analysis. Heterogeneity will be
assessed statistically using I2 and the standard chi-
square. Where statistical pooling is not possible, the
findings will be presented in narrative form including
tables and figures to aid in data presentation where
appropriate. Sub-groups that may be considered for
analysis include upper limb interventions, lower
limb interventions, acute patients (i.e. less than three
months post stroke), sub-acute/chronic patients,
duration and frequency of intervention.
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©2019 UnAnalysis of heterogeneity in a systematic review using
meta-regression technique
Kenneth Lo MEng, Matthew Stephenson PhD and Craig Lockwood PhD
The Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, AustraliaAB S T R AC T
Aim: Heterogeneity is an important consideration in systematic reviews, as high heterogeneity may imply that it is
not suitable to perform meta-analysis. The degree of variation could be caused by clinical or methodological
differences among the studies, or it could be due to the randomness of chance. Methods of assessing heterogeneity
are calculating a statistical test for heterogeneity (the I2 value), visual evaluations of forest plots, conducting subgroup
analysis or meta-regression. We conducted meta-regression on data of our previous systematic review on the
effectiveness of robotic rehabilitation, and in this article, we present the findings and discuss its implications.
Method: In our meta-regression plots, plotted on the x-axis was the trial covariate (duration of intervention group
therapy), and plotted on the y-axis was the effect size measure (standardized mean differences), with positive effect
sizes favouring robotic intervention. Analysis using random effects was applied, and each study symbol was sized in
proportion to its precision (inverse-variance weighting).
Results: Differences were observed in the meta-regression plots between the subgroups of therapy ratio¼ 0 and
therapy ratio more than 0 for upper limb movement, lower limb walking and activities of daily living. For upper limb
movement, positive linear relationships were found for both subgroups. However, in terms of the strength of the
relationship, a stronger relationship was found for therapy ratio¼ 0. For lower limb walking, opposing linear
relationships were found in both subgroups: therapy ratio¼ 0 had a negative linear relationship, whereas therapy
ratio more than 0 had a positive linear relationship. For activities of daily living, positive linear relationships were
found for both subgroups, but a stronger linear relationship was found for therapy ratio¼ 0.
Conclusion: From themeta-regression analysis, we found that differing levels of linear relationships and the varying
spread of effect sizes across positive and negative ranges were the likely sources of heterogeneity. This was especially
so in the meta-regression of lower limb walking, which showed opposing directions of linear relationships. The wider
spread of effect sizes for therapy ratio¼ 0 could indicate that some robotic devices weremore effective than others. In
addition, for therapy ratio more than 0, the effect sizes were mainly found in the positive region, which implied that
adding conventional training to robotic training was generally positive for robotic devices.
Key words: Meta-analysis, meta-regression, robotic rehabilitation, stroke, systematic review
Int J Evid Based Healthc 2019; 17:000–000.What is known about the topic?
 Meta-analysis is used in quantitative systematic reviews to statistically
pool the results of outcome measures from across various studies to
obtain an overall effect size.
 Heterogeneity is an important consideration as it affects the
appropriateness of reporting a meta-analysis, and one method of
assessing and exploring potential causes of heterogeneity is meta-
regression.
 Meta-regression is a statistical technique for exploring the linear
associations between trial covariates and the treatment effect.
However, associations found in meta-regression cannot be regarded
as being definitive proof of causality.
What does this article add?
 From the meta-regression analysis, we found that differing levels of
linear relationships and the varying spread of effect sizes across
positive and negative ranges were the likely sources of heterogeneity.
 The wider spread of effect sizes for therapy ratio¼ 0 could indicate
that some robotic devices were more effective than others. This might
highlight the need for research to identify what types of robotic
devices were more effective.
 For therapy ratiomore than 0, the effect sizes weremainly found in the
positive region, which implied that adding conventional training to
robotic training was generally positive for robotic devices, and it
would be interesting to identify the optimal ratio of robotic
training to conventional training, in terms of duration in a single
therapy session.
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©2019 UnBackground
S ystematic reviews are used frequently in evidence-based healthcare to evaluate the effectiveness of
interventions, and meta-analysis is used in quantitative
systematic reviews to statistically pool the results of
outcome measures from across various studies to obtain
an overall effect size. During meta-analysis, the amount
of variation in the characteristics between included
studies is termed heterogeneity.1 The amount of varia-
tion could be due to clinical or methodological differ-
ences among the studies, or it could be due to the
randomness of chance.2 Causes of clinical heterogeneity
include differences in patient populations, intervention
dosages, follow-up periods or outcome measures
between the included studies.2 Methodological hetero-
geneity is caused by including different types of study
designs and quality issues in the included studies (such
as presence of selection, performance, detection and
attrition biases).1,2
Heterogeneity is an important consideration as it
affects the appropriateness of reporting a meta-analysis.
If included studies for review are clinically and method-
ologically heterogeneous, it may not be suitable to
report a meta-analysis, or to limit reporting to the
identification and exploration of the heterogeneity.1,3
To estimate the level of heterogeneity in meta-analysis, a
commonly applied statistical test for heterogeneity is I2,
whereby low, moderate and high levels of heterogeneity
could be tentatively associated with calculated I2 values
of 25, 50 and 75%, respectively.4 Other methods of
assessing and exploring potential causes of heterogene-
ity include visual evaluations of forest plots and con-
ducting subgroup analysis or meta-regression.2,5
Meta-regression is a statistical technique for exploring
whether there is a linear association between trial cova-
riates and the treatment effect, and also the direction of
the association.2 Associations found in meta-regression
are useful for generating hypotheses of causes of het-
erogeneity but cannot be regarded as being definitive
proof of causality.2,6 In a meta-regression, one or more
trial covariates are plotted against an outcome measure
in a scatter plot to find the line of ‘best fit’ and show the
direction of the association. In such a scatter plot, a
circular symbol representing each study is plotted, in
which the size of the circular symbol is proportional to
the precision of the study, and a larger symbol is
plotted for a study that has more precision (i.e. has less
variance).2,6
In meta-regression, aggregate level data and
not patient level data are used. Although both meta-
regression and linear regression aim to explore
linear associations between an independent variable2 International Journal of Evidence-Based
iversity of Adelaide, Joanna Briggs Institute. Uand a dependant variable, in a meta-regression each
study is a data point in the regression analysis, whereas
in a typical clinical linear regression, each individual
patient is a data point in the regression analysis.2 When
selecting the trial covariates, reviewers should also
take note not to use too many covariates, as it may
lead to a false positive conclusion when there are no
true associations between covariates and the outcome
measure.2,6,7
In our systematic review (the effectiveness of robotic
rehabilitation on mobility and functional ability of adult
stroke patients,8 a random effects meta-analysis with 51
studies) moderate to high levels of heterogeneity were
encountered. Consequently, we used meta-regression to
explore the sources of heterogeneity. In this article, we
present the results of our meta-regression analysis and
discuss its implications to inform and contextualize the
findings of our systematic review.
Meta-regression method
In our meta-regression plots, the duration (hours) of
intervention group therapy was the trial covariate, which
was plotted on the x-axis. This trial covariate was chosen
because different therapy durations were applied in the
studies, and this variability of durations facilitated the
plotting of a meta-regression line. Another positive
consideration was that the trials were dose-matched
due to the inclusion criteria of the original systematic
review (i.e. therapy duration was the same for both
intervention and control groups), and this minimized
the within-trial variation. The outcome measure used
was standardized mean differences and these effect
sizes were plotted on the y-axis, with positive effect
sizes favouring the robotic intervention. The meta-
regression line was plotted using a software package
for meta-analysis (Comprehensive Meta Analysis Version
3 from Biostat, Inc., Frederick, Maryland, USA). Analysis
using random effects was applied, and each study sym-
bol was sized in proportion to its precision (inverse-
variance weighting). The line started from the coordinate
point (0,0), as there would be no effect sizes when
duration of therapy was nil.
Results
During our systematic review conducted on the effec-
tiveness of robotic rehabilitation,8 we found moderate-
to-high levels of heterogeneity for the outcomes of
upper limb movement (I2¼ 41%), lower limb walking
(I2¼ 75%) and activities of daily living (ADL) (I2¼ 66%).
As a first step, we undertook subgroup analysis to
identify the sources of heterogeneity. One cause of
heterogeneity was due to the range of outcomeHealthcare  2019 University of Adelaide, Joanna Briggs Institute
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Table 1. Subgroups analysed for heterogeneity
Analysis by outcome scales
Upper limb movement No. of studies I2 values (%) P values (Chi-squared test)
Upper limb (all scales) 29 41 0.01
Upper limb [only FM (UL)] 25 36 0.04
Lower limb walking
Lower limb (all scales) 15 75 <0.00001
Lower limb (only FAC measure) 10 82 <0.00001
ADL
ADL (all scales) 31 66 <0.00001
ADL [FIM (total)] 4 71 0.01
ADL (BI) 3 72 0.03
ADL (MAL-QOM) 4 0 0.48
Analysis by therapy ratio
Upper limb movement No. of studies I2 values (%) P values (Chi-squared test)
Upper limb (TR¼ 0) 16 48 0.02
Upper limb (TR> 0) 13 31 0.13
Lower limb walking
Lower limb (TR¼ 0) 6 80 0.0001
Lower limb (TR> 0) 9 56 0.02
ADL
ADL (TR¼ 0) 12 82 <0.00001
ADL (TR> 0) 19 25 0.15
ADL, activities of daily living; BI, Barthel index; FAC, functional ambulation category; FIM (total), functional independence measure (total); FM (UL), Fugl-Meyer (upper
limb); MAL-QOM, motor activity log-quality of movement; TR, therapy ratio [TR¼Duration of conventional training/Duration of robotic training. Intervention groups
that had no conventional therapy component (i.e. TR¼ 0) and intervention groups that had a combination of both robotic and conventional therapies (i.e. TR> 0)].
ORIGINAL RESEARCH
©2019 Unscales used in the included studies to measure motor
movement and ADL. Another cause was that, in the
intervention group of some trials, the intervention
therapy could be purely robotic training with no con-
ventional component or mixed (i.e. a mix of robotic and
conventional training). The results of the subgroup anal-
ysis performed in our previous systematic review are
presented in Table 1.
We observed that for all the three outcomes exam-
ined (upper limb movement, lower limb walking and
ADL), there was the same pattern of change in I2, that is I2
increased for subgroup therapy ratio¼ 0, whereas I2
decreased for subgroup therapy ratio more than 0. In
that review, we had hypothesized that for studies
whereby therapy ratio was more than 0, the presence
of conventional training, as part of the robotic interven-
tion, ‘masked’ the effects of robotic training and gave
these studies less clinical diversity. For those studies that
had no conventional training as part of the robotic
intervention, the different designs and types of robotic
devices used could have caused a wider range of treat-
ment effects, leading to higher I2 values. Looking to
further understand the sources of heterogeneity, weInternational Journal of Evidence-Based Healthcare  2019 University
iversity of Adelaide, Joanna Briggs Institute. Unconducted meta-regression analysis. Presented here
are the results of our meta-regression.
Upper limb movement (therapy ratioU0)
Based on the line of ‘best fit’ (Fig. 1), the meta-regression
analysis showed a positive linear relationship between
duration of therapy and effect size, that is, as therapy
duration increased, the effect sizes trend towards more
positive values. Looking at the scatter plot, there was a
spread of effects sizes with about equal numbers of
studies that had negative and positive effect sizes.
Upper limb movement (therapy ratio >0)
Based on the line of ‘best fit’ (Fig. 2), the meta-regression
analysis showed a positive linear relationship between
duration of therapy and effect size. As therapy duration
increased, the effect sizes trend towards more positive
values. Looking at the scatter plot, the spread of effect
sizes was more in the positive range, with more studies
that had positive effect sizes.
One study (McCabe et al.9) was excluded as its inter-
vention therapy duration was 300 h, which was an outlier
and would have skewed the plot.of Adelaide, Joanna Briggs Institute 3
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Upper limb TR = 0
Therapy duration
































Y = 0.0000 + 0.0093 * Therapy duration
Figure 1. Meta-regression plot of upper limb (therapy ratio¼ 0).
Upper limb TR > 0 (exclude outlier McCabe et al.)
Therapy duration


























Y = 0.0000 + 0.0033 * Therapy duration
Figure 2. Meta-regression plot of upper limb (therapy ratio >0).
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Lower limb TR = 0
Therapy duration




























Y = 0.0000 – 0.0267 * Therapy duration
Figure 3. Meta-regression plot of lower limb (therapy ratio¼ 0).
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©2019 UnLower limb walking (therapy ratioU0)
Based on the line of ‘best fit’ (Fig. 3), the meta-regression
analysis showed a negative linear relationship between
duration of therapy and effect size. As therapy duration
increased, the effect sizes trend towards more negative
values. Looking at the scatter plot, there was a spread of
effects sizes with equal numbers of studies that had
negative and positive effect sizes.
Lower limb walking (therapy ratio >0)
Based on the line of ‘best fit’ (Fig. 4), the meta-regression
analysis showed a positive linear relationship between
duration of therapy and effect size. As therapy duration
increased, the effect sizes trend towards more positive
values. Looking at the scatter plot, the spread of effect
sizes was more in the positive range, with more studies
that had positive effect sizes.
Activities of daily living (therapy ratioU0)
Based on the line of ‘best fit’ (Fig. 5), the meta-regression
analysis showed a positive linear relationship between
duration of therapy and effect size. As therapy duration
increased, the effect sizes trend towards more positiveInternational Journal of Evidence-Based Healthcare  2019 University
iversity of Adelaide, Joanna Briggs Institute. Unvalues. Looking at the scatter plot, there was a spread of
effects sizes with about equal numbers of studies that
had negative and positive effect sizes.
Activities of daily living (therapy ratio >0)
Based on the line of ‘best fit’ (Fig. 6), the meta-regression
analysis showed a positive linear relationship between
duration of therapy and effect size. As therapy duration
increased, the effect sizes trend towards more positive
values. Looking at the scatter plot, the spread of effect
sizes was more in the positive range, with more studies
that had positive effect sizes.
One study was excluded as its intervention therapy
duration was 300 h, which was an outlier and would have
skewed the plot.9
Sensitivity analysis
A sensitivity analysis was conducted for meta-regression
plots by including the outlier study of McCabe et al.9 For
upper limb, a slight negative relationship was shown
(Fig. 7), while for ADL, no relationship was shown (Fig. 8).
We also conducted a sensitivity analysis for meta-
regression plots with an intercept. The meta-regressionof Adelaide, Joanna Briggs Institute 5
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Therapy duration


























Y = 0.0000 + 0.0112 * Therapy duration
Figure 4. Meta-regression plot of lower limb (therapy ratio >0).
ADL TR = 0
Therapy duration




























Y = 0.0000 + 0.0079 * Therapy duration
Figure 5. Meta-regression plot of activities of daily living (therapy ratio¼ 0).
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ADL TR > 0 (exclude outlier McCabe et al.)
Therapy duration


























Y = 0.0000 + 0.0031 * Therapy duration
Figure 6. Meta-regression plot of activities of daily living (therapy ratio >0).
Upper limb TR > 0 (include outlier McCabe et al.)
Therapy duration


























Y = 0.0000 - 0.0004 * Therapy duration
Figure 7. Plot of upper limb (therapy ratio >0) including outlier McCabe et al.9
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ADL TR > 0 (include outlier McCabe et al.)
Therapy duration


























Y = 0.0000 - 0.0000 * Therapy duration
Figure 8. Plot of activities of daily living (therapy ratio >0) including outlier McCabe et al.9
K Lo et al.
©2019 Unscatter plots presented in Figures 1–8 did not include an
intercept, as we had considered that when there was no
therapy (i.e. when therapy duration was nil), there should
not be any effect sizes.
Under the sensitivity analysis, for upper limb move-
ment, a positive linear relationship was still observed for
both therapy ratio¼ 0 and therapy ratio more than 0,
whereby a stronger relationship was found for therapy
ratio¼ 0. This was similar to the trends observed in the
main analysis. For lower limb walking, a negative rela-
tionship was still observed for therapy ratio¼ 0, but for
therapy ratio more than 0, a slight negative relationship
was found. This was in contrast to the positive relation-
ship found for therapy ratio more than 0 in the main
analysis. For ADL, therapy ratio¼ 0 had a positive rela-
tionship but therapy ratio more than 0 had a negative
relationship. This finding was different from the main
analysis, which showed positive relationships for
both subgroups.
When the outlier study, McCabe et al., was included
for upper limb therapy ratio more than 0, a slight
negative relationship was observed, which was similar
to the main analysis. For ADL, the inclusion of McCabe8 International Journal of Evidence-Based
iversity of Adelaide, Joanna Briggs Institute. Uet al. showed a negative relationship, instead of no
relationship that was observed under the main analysis.
Table 2 shows the line equations of the meta-regression
analysis with an intercept.
Discussion
We conducted meta-regression to investigate sources of
heterogeneity and, from the analysis, we could see
differences in the meta-regression plots between the
subgroups of therapy ratio¼ 0 and therapy ratio more
than 0 for upper limb movement, lower limb walking
and ADL.
Upper limb movement
In terms of the linear relationship seen in subgroups of
therapy ratio¼ 0 and therapy ratio more than 0, we
found positive relationships for both subgroups. How-
ever, in terms of the strength of the relationship, a
stronger relationship was found for therapy ratio¼ 0,
as seen by the line equations. Looking at therapy dura-
tion of 50 h, the effect size was 0.465 for therapy
ratio¼ 0, but for therapy ratio more than 0 the corre-
sponding effect size was less at 0.165. Viewing the scatterHealthcare  2019 University of Adelaide, Joanna Briggs Institute
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Table 2. Line equations of meta-regression with an intercept
TR¼0 TR>0
Upper limb movement Y¼0.4516þ 0.0281 therapy duration Y¼0.8287þ 0.0274 therapy duration
Lower limb walking Y¼ 0.8432 0.0894 therapy duration Y¼ 0.4130 0.0039 therapy duration
Activities of daily living Y¼0.8504þ 0.0563 therapy duration Y¼ 0.8186 0.0204 therapy duration
Lower limb walking (including
McCabe et al.9)
Not applicable Y¼ 0.0389 0.0007 therapy duration
Activities of daily living (including
McCabe et al.9)
Not applicable Y¼ 0.3033 0.0026 therapy duration
TR, therapy ratio.
ORIGINAL RESEARCH
©2019 Unplots of both subgroups, there was a wider spread of
effect sizes in therapy ratio¼ 0, as compared with ther-
apy ratio more than 0, which had mainly positive effect
sizes. The moderately high heterogeneity of upper limb
movement (I2¼ 41%) was likely due to these differences
found between the meta-regression plots of therapy
ratio¼ 0 and therapy ratio more than 0.
It is also to note that in subgroup therapy ratio¼ 0,
the stronger linear relationship could mean more pro-
nounced shifts in effect sizes across studies and, coupled
with a wider spread of effect sizes across both positive
and negative ranges, implied that some trials (and its
associated robotic devices) were more effective than
others. Future research could potentially examine the
effectiveness of robotic rehabilitation based on different
types of robotic devices, for example the effectiveness
of end-effector robotics compared with exoskeleton
devices.
Lower limb walking
In terms of the linear relationship seen in subgroups of
therapy ratio¼ 0 and therapy ratio more than 0, we
found opposing relationships in both subgroups: ther-
apy ratio¼ 0 had a negative linear relationship, whereas
therapy ratio more than 0 had a positive linear relation-
ship. Viewing the scatter plots of both subgroups, again
there was a wider spread of effect sizes in therapy
ratio¼ 0, whereas in therapy ratio more than 0, the
effect sizes were mainly in the positive range. The
opposite directions of linear relationships and the wider
spread of effect sizes for therapy ratio¼ 0 very likely
explained the high heterogeneity seen in lower limb
walking, which had an I2 value of 75%.
The contrasting relationships found between therapy
ratio¼ 0 and therapy ratio more than 0 was unexpected,
especially a negative relationship for therapy ratio¼ 0.
One possibility was that there might not be a linear
relationship but a quadratic relationship between ther-
apy duration and effect sizes for therapy ratio¼ 0 (Fig. 9).
It might be that, up to a certain therapy duration, robotic
training was more effective than conventional training,International Journal of Evidence-Based Healthcare  2019 University
iversity of Adelaide, Joanna Briggs Institute. Unand beyond this point, robotic training progressively
became less effective than conventional training. It could
be hypothesized that at the beginning, robotic devices
could provide more training repetitions and improve the
motor movement ability of a patient. However, as a
patient gradually regained his motor movement skills
over time, his walking speed might exceed that of the
robotic device, which would then limit the training
effectiveness. This limit on training progress was also
discussed in a trial on lower limb robotic training,10 in
which the authors found that conventional training had
better outcomes than robotic training, and one of the
reasons discussed was due to the speed of robotic
training. In the trial, the lower limb robotic device
allowed a maximum walking speed up to 3 km/h and
the authors postulated that this limited the training
potential when patients were able to walk faster than
3 km/h. As conventional training allowed for overground
walking without speed restriction, patients could train to
walk up to higher self-selected walking speeds.
It might be insightful to conduct trials to examine the
dose–response relationship for patients using lower
limb robotic devices to determine the true relationship
between intervention therapy duration and effect size.
To avoid confounding due to impairment levels of
patients, it might be suitable to measure the progress
for severely impaired patients, who would have a lower
base to start with. This would help to answer if there was
a transition point beyond which stroke patients ought to
progress from robotic to conventional training.
Activities of daily living
In terms of the linear relationship seen in subgroups of
therapy ratio¼ 0 and therapy ratio more than 0, we
found positive relationships for both subgroups. How-
ever, in terms of the strength of the relationship, a
stronger relationship was found for therapy ratio¼ 0,
as seen by the line equations. Looking at therapy dura-
tion of 25 h, the effect size was 0.1975 for therapy
ratio¼ 0, but for therapy ratio more than 0 the corre-
sponding effect size was less at 0.0775. Viewing theof Adelaide, Joanna Briggs Institute 9
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Figure 9. Hypothetical quadratic plot of lower limb (therapy ratio¼ 0).
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©2019 Unscatter plots of both subgroups, there was a wider spread
of effect sizes in therapy ratio¼ 0, as compared with
therapy ratio more than 0, which had mainly positive
effect sizes. These differences likely explained the
moderately high heterogeneity for ADL, which had
an I2 of 66%.
In subgroup therapy ratio¼ 0, the stronger linear
relationship could mean more pronounced shifts in
effect sizes across studies and, coupled with a wider
spread of effect sizes across both positive and negative
ranges, similarly implied that some trials (and its associ-
ated robotic devices) were more effective than others.
Again, future research could potentially examine the
effectiveness of robotic rehabilitation based on different
types of robotic devices.
Spread of effect sizes
In therapy ratio more than 0, the effect sizes were mainly
found in the positive region, which favoured the inter-
vention for robotic devices. This was in contrast to
therapy ratio¼ 0, which showed a wider spread of effect
sizes across positive and negative values. This probably
implied that adding conventional training to robotic
training was generally positive for robotic devices and
it would be interesting to identify the optimum ratio of
robotic training to conventional training in terms of
duration in a single therapy session.10 International Journal of Evidence-Based
iversity of Adelaide, Joanna Briggs Institute. ULimitations
One limitation was that aggregate level data were used.
In our meta-regression, therapy duration was the trial
covariate and this might not reflect the actual therapy
duration of each patient, and could lead to aggregation
bias.6 It was likely that the duration of therapy varied
according to patients, depending on their individual
capacity to tolerate training and the amount of rest
breaks needed. That the data for our meta-regression
analysis came from aggregated data of themeta-analysis
also limited the test of homoscedasticity assumptions,
due to lack of individual patient data. In a linear regres-
sion with nonaggregated data, homo/heteroscedasticity
could be explored. If the spread of values of the depen-
dent variable is consistent across all values of an inde-
pendent variable in a scatter plot of residuals, then a
linear regression plot line would be representative of the
data.11 However, in meta-regression, aggregated data is
used. Nevertheless, Higgins and Thompson7 investi-
gated the error rates of meta-regression in various sit-
uations in which the authors had considered sample
sizes, number of covariates, and the extent of collinearity
among the covariates; and found that ‘all random effects
meta-regression methods performed well on single
covariates when the number of studies is large’ (page
1679). In our meta-regression, we had a large number of
studies (51 studies) and only one covariate (therapyHealthcare  2019 University of Adelaide, Joanna Briggs Institute
nauthorized reproduction of this article is prohibited.
CE: Swati; IJEBH-D-18-00041; Total nos of Pages: 12;
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©2019 Unduration) was investigated. Hence, we would consider
the use of random-effects meta-regression in our analy-
sis to be appropriate.
Another limitation was that the use of the interven-
tion therapy duration as trial covariate was not prespe-
cified in our systematic review protocol.6 Preferably, it
should have been prespecified but at the time of drafting
the protocol, we had only considered using subgroups
for analysis of heterogeneity. Despite this, we believed
the trial covariate chosen for our meta-regression analy-
sis was appropriate, as a range of therapy durations were
used across different studies. This allowed us to have
variability of therapy durations across studies, which
made it easier to interpret our results.6
Although the use of therapy duration as a trial covari-
ate facilitated discussions of the dose–response rela-
tionship in the analysis of lower limb walking, we would
hesitate to draw any firm understanding, as the plot was
based on aggregated data and could be confounded by
other within-trial or patient characteristics. Furthermore,
none of the lower limb trials in the systematic review had
examined the relationship between therapy dose and
treatment effect, which would otherwise have offered
some direct evidence.
Sensitivity analysis
Inclusion of outlier study
We had excluded the trial by McCabe et al.,9 as its
intervention therapy duration was 300 h, which, if
included, would have ‘bunched up’ the other plots
(Fig. 7) and render plotting the meta-regression line
not so meaningful. Nevertheless, if McCabe et al.9 were
to be included for upper limb therapy ratio more than 0,
its inclusion would have led to showing that there was a
negative relationship between therapy duration and
effect size. This would have been a starker contrast to
the positive relationship seen for therapy ratio¼ 0 and
would have reinforced our analysis of heterogeneity
instead. This was also the case for the analysis of ADL
therapy ratio more than 0 (Fig. 8). The inclusion of
McCabe et al.9 led to showing that there was no rela-
tionship between therapy duration and effect size, which
was, again, a starker contrast to the positive relationship
seen for therapy ratio¼ 0.
Meta-regression analysis with an intercept
The meta-regression scatter plots presented in the main
analysis did not include an intercept, and to understand
the differences, we conducted a parallel analysis assum-
ing that there was an intercept. Under this parallel
analysis, we found differences in the trends of relation-
ships for the outcomes of lower limb walking and ADL.International Journal of Evidence-Based Healthcare  2019 University
iversity of Adelaide, Joanna Briggs Institute. UnFor lower limb walking, therapy ratio¼ 0 showed a
negative relationship, but for therapy ratio more than 0 a
slight negative relationship was found. This was in
contrast to the positive relationship found for therapy
ratio more than 0 in the main analysis. Nevertheless, the
difference in slope coefficients between therapy
ratio¼ 0 and therapy ratio more than 0 of the parallel
analysis still accounted for the heterogeneity. For ADL,
therapy ratio¼ 0 had a positive relationship but therapy
ratio more than 0 had a negative relationship. This
finding was different from the main analysis,
which showed positive relationships for both subgroups.
However, that therapy ratio¼ 0 and therapy ratio
more than 0 had opposite relationships still explained
the heterogeneity.
When the outlier study, McCabe et al.,9 was included
under the parallel analysis, a slight negative relationship
was observed for upper limb therapy ratio more than 0,
which still contrasted to the more negative relationship
of therapy ratio¼ 0. Similarly for ADL, the inclusion of
McCabe et al.9 showed a negative relationship, which still
contrasted to the positive relationship for therapy
ratio¼ 0.
Overall, the differences observed in the relationships
between therapy ratio¼ 0 and therapy ratio more than 0
(within the meta-regression plots with an intercept) still
served to explain the heterogeneity, although the trends
of the relationships were somewhat different from the
meta-regression plots without an intercept.
Conclusion
We used the technique of meta-regression to under-
stand the moderate to high heterogeneity levels seen in
outcomes of upper limb movement, lower limb walking
and ADL. From the meta-regression analysis, we found
that differing levels of linear relationships and the vary-
ing spread of effect sizes across positive and negative
ranges were the likely sources of heterogeneity. This
was especially so in the meta-regression of lower
limb walking, which showed opposing directions of
linear relationships.
The wider spread of effect sizes for therapy ratio¼ 0
could indicate that some robotic devices were more
effective than others. This might highlight the need
for research to identify what types of robotic devices
were more effective. In addition, for therapy ratio more
than 0, the effect sizes were mainly found in the positive
region, which implied that adding conventional training
to robotic training was generally positive for robotic
devices and it would be interesting to identify the
optimal ratio of robotic training to conventional training,
in terms of duration in a single therapy session.of Adelaide, Joanna Briggs Institute 11
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SYSTEMATIC REVIEWThe economic cost of robotic rehabilitation for adult
stroke patients: a systematic review
Kenneth Lo1,2,3  Matthew Stephenson1  Craig Lockwood1
1Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 2College of Medicine and Public
Health, Flinders University, Adelaide, Australia, and 3Australian Institute of Health Innovation, Faculty of Medicine and Health Sciences, Macquarie
University, Sydney, AustraliaA B S T R AC T
Objective: The objective of this review was to examine the economic cost of robotic therapy compared to
conventional therapy for adult stroke patients, from the perspective of hospitals.
Introduction: It is important to identify appropriate treatment methods that not only reduce the disability
experienced by stroke survivors but also do so cost effectively. While robotic devices enable a high-intensity
training regime for patients, robotic training equipment involves a significant capital outlay for healthcare providers.
Hence, the decision to introduce robotic devices into clinical settings and offer robotic stroke rehabilitation to
patients has an important cost consideration for hospitals.
Inclusion criteria: This review included rehabilitation trials of adult stroke patients (18 years and older) involving
robotic devices and comparing the economic outcomes to control groups that used conventional physiotherapy.
Methods: Wesearchedmajordatabases suchasPubMed, EmbaseandCINAHL for trial studies conducted fromyear 2000
and published in English. Included studies were critically appraised, and data were extracted and synthesized using the
Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI).
Results: Five studies with 213 patients were included in this review. Four studies examined upper limb inter-
ventions, and one study evaluated both upper limb and lower limb interventions. Of the five studies, two included
acute/sub-acute patients and three included chronic patients. The overall methodological quality of the studies was
of a moderate level. The included studies compared the cost of providing robotic intervention against the cost of
providing conventional therapy in dose-matched therapy sessions and computed the cost measures in terms of cost
per patient session or cost per patient. We performed a cost comparison of the various studies and reviewed the data
based on two approaches: the dominance ranking framework and the dominance ranking score. By comparing the
cost outcome of each study, four of the five studies showed better cost benefits for the robotic intervention group.
Under the dominance ranking framework and the dominance ranking score, the overall dominance levels for most
sub-groups favored robotic intervention.
Conclusions: Our review indicated that robotic therapy had a better economic outcome than conventional therapy.
For patients with severe disability from significant stroke, a moderate dominance favoring robotic therapy for health
benefit was found, and a strong dominance for robotic therapy for cost benefit was found. However, the limited
number of studies in the review required us to view the results with caution. Key sensitivity factors affecting robotic
therapy were the number of patients who could be treated per robotic session and the time therapists spent with
patients during a robotic session. Robotic therapy could be prescribed primarily for patients with severe impairment
after stroke. To maximize the cost economics, hospital providers may wish to organize their robotic therapy
programs based on cost-sensitivity factors. For further research, we suggest better collaboration in methods within
this field to enable a more comparable cost computation across studies.
Keywords Cost; economic; robotic rehabilitation; stroke; systematic review
JBI Database System Rev Implement Rep 2019; 17(4):520–547.Correspondence: Kenneth Lo, kenneth.lo@flinders.edu.au
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S troke is a leading cause of disability. Each year,15 million people suffer a stroke.1 It is impor-
tant to identify appropriate treatment methods that
not only reduce the disability of stroke survivors but
also do so cost effectively. Systematic reviews con-
ducted on robotic training devices for stroke reha-
bilitation have shown varying degrees of clinical
effectiveness. One systematic review assessing lower
limb outcomes found that robotic-assisted gait train-
ing increased the odds of participants walking inde-
pendently.2 For the sub-group of patients with severe
impairment, the findings indicated that robotic treat-
ment was more effective.2 In terms of upper limb
outcomes, two systematic reviews found that robot-
assisted arm training improved arm motor move-
ment3,4 and activities of daily living scores.3 A recent
systematic review found that robotic training was as
effective as conventional physiotherapy for upper
limb motor movement, lower limb walking and
activities of daily living, but for patients with severe
lower limb impairment, robotic training was found
to be more effective than conventional training.5
Overall, these reviews showed that robotic devices,
at a minimum, offered equivalent treatment out-
comes as conventional physiotherapy.
Traditionally, stroke patients undergo rehabilita-
tion post stroke. For physical impairments, patients
usually receive conventional physiotherapy, which
involves repetitive, high-intensity, task-specific exer-
cises that enable them to regain their motor and
functional abilities.6,7 Neuroplasticity is the under-
lying principle of motor learning and is associated
with a reorganization of the undamaged motor cor-
tex to enable recovery of motor abilities of the
affected limbs8 via repetitive, high-intensity, task-
specific exercises to the limbs.9 To facilitate the high
number of repetitions required, robotic devices have
been used to assist therapists.10 These devices pro-
vide intensive, consistent and repetitive cycles over
long periods to train the impaired limbs of patients.
There are two main types of robotic devices: exo-
skeletons and end-effectors. Exoskeletons are devi-
ces that wrap around limbs and are able to assist
each limb joint to move. End-effectors are devices
that assist only the extremities of a limb (either hands
or feet).11 Regardless of design mechanism, one key
feature of robotic devices is the ability to automati-
cally assist patients to move their limbs when theyJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedare unable to do so by themselves. This automated
assistive feature enables a high number of repetitions
to be achieved.
While robotic devices enable a high-intensity train-
ing regime that can be as effective as conventional
therapy, the robotic training equipment can cost up to
several hundred thousand dollars per device,12 which
is a significant capital outlay for healthcare providers.
Hence, the decision to introduce robotic devices into
clinical settings and offer robotic stroke rehabilitation
to patients has an important cost consideration for
hospitals. Despite the cost, robotic devices may
increase the work efficiency of therapists, meaning
that more patients can be treated, leading to an overall
reduction in cost of treatment per patient.13,14 There
have been clinical studies to determine the economic
cost of robotic devices in the rehabilitation of stroke
patients.15 However, these studies presented a mixed
picture of the cost impact of robotic devices. One
study that compared the cost-effectiveness of robotic
rehabilitation with conventional rehabilitation had
an uncertain finding,16 while another study found
that robotic devices were economically sustainable.17
A third study compared the treatment costs and found
that robotic training was less expensive than conven-
tional training.18 A preliminary search of PubMed,
Embase, JBI Database of Systematic Reviews and
Implementation Reports, Cochrane Library and
PROSPERO was also carried out to identify system-
atic reviews that had been conducted on this topic,
and no reviews were found.
The current literature does not provide a clear
determination of the cost impact of using robotic
devices for stroke rehabilitation, and it is the aim of
this review to examine the economic cost of robotic
therapy compared to conventional therapy for adult
stroke patients. The methods of the review have been
described in a previously published protocol.19
Review objective
The objective of this review was to identify the best
available evidence on the economic cost of robotic
rehabilitation for adult stroke patients to improve
their motor movement abilities. More specifically,
the objective was to identify the evidence on the
economic cost of robotic training compared to con-
ventional physiotherapy for adult stroke patients,
from the perspective of healthcare organizations
(such as hospitals). 2019 THE JOANNA BRIGGS INSTITUTE 521
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SYSTEMATIC REVIEW K. Lo et al.Inclusion criteria
Participants
This review considered studies that included adult
stroke patients (18 years and older) of all sexes,
regardless if stroke was due to ischemic or hemor-
rhagic causes. Patients with pre-existing impair-
ments that were not caused by stroke, such as
disabilities due to spinal cord injuries, Parkinson’s
disease, multiple sclerosis and traumatic brain inju-
ries, were excluded. Study participants were of dif-
ferent impairment levels and at various stages of
recovery: acute, sub-acute or chronic.Intervention
This review considered studies that evaluated the
rehabilitation of stroke patients using robotic devi-
ces. The types of robotic devices varied (e.g. either
robotic exoskeletons or end-effectors), but all devi-
ces had automated assistive feature that helped
patients to move their limbs if they were unable to
do so by themselves.Comparator
This review considered studies that compared the
intervention to control groups using conventional
physiotherapy. In the control groups, patients did
not receive robotic rehabilitation, only conventional
physiotherapy. The amount of therapy treatment in
both intervention and control groups were the same
in terms of duration, i.e. dose-matched.Context
The settings of selected studies included both inpa-
tient and outpatient rehabilitation. Trials with home
rehabilitation patients were excluded due to poten-
tial confounding of treatment adherence. The reha-
bilitation program was conducted either at a single
hospital or across multi-centers, and only physical
impairments related to upper and lower limbs were
considered.Outcomes
This review considered studies that had the follow-
ing outcomes:
Cost minimization
Studies that aimed to compare the cost of providing
robotic rehabilitation against the cost of providing
conventional physiotherapy.JBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. UnauthorizedCost effectiveness
Studies that aimed to compare the cost of providing
robotic rehabilitation against the cost of providing
conventional physiotherapy, whereby the outcome
was to be presented as relative costs to achieve a unit
of effect. The unit of effect was to reflect the motor
movement ability of patients and involve the follow-
ing measurement scales:

 reFor measurement scale of upper limbs, the Fugl-
Meyer Assessment20 (upper extremity score) was
the preferred scale. If a study did not use this
scale, then an alternative measurement scale that
quantified upper limb motor movement (e.g. upper
limb Motricity Index21) would be considered. For measurement scale of lower limbs, the Func-
tional Ambulation Category22 was the preferred
scale. If a study did not use this scale, then an
alternative measurement scale that quantified
walking would be considered, e.g. Barthel
Index23 (ambulation item) or Functional Inde-
pendence Measure24 (walking item).Cost utility
Studies that aimed to compare the cost of providing
robotic rehabilitation against the cost of providing
conventional physiotherapy, whereby the outcome
was to be presented as relative costs to achieve a unit
of utility, which was measured in quality-adjusted
life-years (QALY).
Cost benefit
Studies that aimed to compare the cost of providing
robotic rehabilitation against the cost of providing
conventional physiotherapy, whereby the outcome
was to be presented as relative costs to achieve a unit
of benefit, which was measured in monetary units.
The cost perspective adopted in this review was
from the viewpoint of healthcare organizations, as
hospitals are usually the main decision makers for
introducing robotic rehabilitation to stroke patients
in a clinical setting. As such, only direct medical costs
(e.g. therapist time, medical devices) were consid-
ered. Indirect costs, such as the cost of patients’
caregivers or patients’ travel expenses, were
excluded. Direct non-medical costs (e.g. hospital
administrative cost) were also excluded as this type
of cost was common to all patients, regardless of
robotic or conventional training. Cost components
during the follow-up period were excluded, as it was
the intent of the review to examine the costs 2019 THE JOANNA BRIGGS INSTITUTE 522
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SYSTEMATIC REVIEW K. Lo et al.associated with providing the intervention during
the treatment period.
Types of studies
Any study containing economic data was considered
for inclusion. The economic component of the
review only had cost minimization studies, which
compared robotic rehabilitation to conventional
physiotherapy in dose-matched therapy sessions.
Studies published in English were considered for
inclusion in this review and a date limit starting from
2000 was set, as automated robotic devices had
increasingly been used since 2000, together with




The search strategy aimed to find both published and
unpublished studies. An initial limited search of
PubMed was undertaken followed by analysis of
the text words contained in the title and abstract,
and of the index terms used to describe articles. This
then informed the development of a search strategy,
which was tailored for each information source. Full
search strategies for the various databases are
detailed in Appendix I. The reference lists of studies
selected for critical appraisal were also screened for
additional studies. The overall search date range was
from January 2000 to September 2017.
The databases that were searched included
PubMed, Embase, CINAHL, Cochrane (CENTRAL),
PEDro (Physiotherapy Evidence Database), NHS
Economic Evaluation Database (NHS EED), Cost-
Effectiveness Analysis (CEA) registry and Health
Technology Assessment (HTA) database.
The search for unpublished studies included
MedNar, ProQuest Dissertations and Theses and
ClinicalTrials.gov.
Study selection
Following the search, all identified citations were
collated and uploaded into the bibliographic software
EndNote X7.8 (Clarivate Analytics, PA, USA), and
duplicates were removed. Titles and abstracts were
screened against the inclusion criteria for the review.
Studies that potentially met the inclusion criteria were
retrieved in full and assessed in detail against the
inclusion criteria. Full-text studies that did not meet
the inclusion criteria were excluded, and the reasonsJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedfor exclusion were provided. Included studies then
underwent a process of critical appraisal.
Assessment of methodological quality
Selected studies were critically appraised by two
independent reviewers at the study level for meth-
odological quality using the standardized critical
appraisal instrument from the Joanna Briggs Insti-
tute for Economic Evaluation.25 Disagreements that
arose between the reviewers were resolved through
discussion. As economic analysis of robotic devices
was an emerging research area with limited numbers
of studies available, all studies regardless of meth-
odological quality underwent data extraction and
synthesis to maximize data collection.
Data extraction
Data were extracted by two independent reviewers
from papers included in the review using the stan-
dardized data extraction tool from JBI SUMARI.
The data extracted included descriptive data about
the interventions and comparators examined, study
participants and context, study methods, results for
the resource use and cost measures and authors’
conclusions on the cost comparisons.
Data synthesis
Economic findings were synthesized and presented
via a tabular summary and the dominance ranking
framework.26,27 The findings were also tabulated as
a dominance ranking score to further facilitate data
synthesis. The methodology of the dominance rank-
ing score is explained as follows:
Methodology of dominance ranking score
The dominance ranking framework shows the dis-
tribution of studies in the three different bands,
where a predominance of the number of studies in
a certain band will indicate the likely implication of
the intervention. However, if there are equal num-
bers of studies across two or three bands, no clear
conclusion can be drawn.
Also, as the basis of the distribution is on the
number of studies, this approach does not take into
account sample sizes of the studies. To illustrate, if
there are three studies and one is under the band that
favors the intervention while the other two are under
the band that rejects the intervention, under the
current ranking framework, it will imply that the
intervention is to be rejected. However, the two 2019 THE JOANNA BRIGGS INSTITUTE 523
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Figure 1: Dominance ranking score scale
SYSTEMATIC REVIEW K. Lo et al.studies that reject the intervention could be smaller
while the study that favors the intervention may have
a larger sample size. Rejecting the intervention in
such a scenario may lead to an inaccurate conclu-
sion. If we can extend the current framework to
incorporate sample size data, it can help to provide
more information for the analysis of dominance.
The sample size of a trial improves the precision
of the trial and the larger the sample size, the smaller
the confidence interval.28 We also know that under
the fixed effects model for meta-analysis, studies are
weighted by their variance, with larger studies hav-
ing more weight.29 To give a similar weighting to
larger studies, which should have more precision in
their effects, we can modify the existing dominance
ranking framework by adding a weighting to the cost
and health benefits that is based on their sample
sizes. The calculation schema are as follows:
Weighted Benefit ¼ n
N
 Benefit Value
Where: n¼ sample size of a study; N¼ total sample size of studies in a sub-
group analysis; Benefit Value¼1, 0 or þ1










Where: k ¼ number of studies included in a sub-group analysis
By adding a weighting based on sample size to the
cost benefit, the cumulative dominance ranking
score can range from1 toþ1. Similarly, by weight-
ing the health benefit, the cumulative ranking score
can range from 1 to þ1. Assuming that both cost
and health benefits play an equal role in determiningJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedthe overall ranking result, the weighed cost and
health benefits can be averaged to obtain the overall
dominance ranking score. Based on this approach,
the dominance ranking scores are color-coded in
Figure 1 to visually represent the level of dominance
of the intervention.
If the overall score is in the green zone (1 score
< 0), then the result favors the intervention, with a
score in the lighter green zone (0.5  score < 0)
showing a moderate dominance of the intervention,
while a score in the darker green zone (1  score
< 0.5) showing a strong dominance of the
intervention.
If the overall score is in the red zone (0 < score
1), then the result favors the control, with a score in
the lighter red zone (0 < score  0.5) showing a
moderate dominance of the control, while a score
in the darker red zone (0.5 < score 1) showing a
strong dominance of the control.
In the case that the overall score is equal to 0, then
it would mean that the intervention is equivalent to
the control.
Note that for weighting the health benefit, to align
the direction of the scoring to the cost benefit, a
better health benefit for the intervention of interest
would need to be given a negative sign. The legend
key of the benefit values for the dominance ranking
score is shown in Table 1.
The weightings are associated with a benefit value
(1, 0, þ1) which is, itself, a categorical expression
of the direction of dominance; therefore the starting
point (i.e. the benefit value) is not a precise measure
of dominance level. For example, in the scenario that
all studies in a review have lower intervention cost
outcome than control, this will mean that the cost
benefit values assigned would all be 1. In such a
case, regardless of the weightings, the calculated cost
dominance level would always be 1. Hence, the 2019 THE JOANNA BRIGGS INSTITUTE 524
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Table 1: Benefit values for dominance ranking
score




SYSTEMATIC REVIEW K. Lo et al.dominant ranking score is useful when studies have
heterogeneous benefit values and can help to better
differentiate the dominance level. The dominant
ranking score is also useful when the dominant
ranking framework shows an unclear interpretation
(such as an equal number of studies in each band).
We do not claim that the methodology of deter-
mining the dominant ranking score developed for
this review is comparable to the rigor of a quantita-
tive meta-analysis. We have merely extended the
dominant ranking framework to incorporate more
differentiating information, thereby enabling a more
informed analysis of dominance levels to be per-
formed. In fact, we suggest that reviewers conduct
a review tabulation using the dominant ranking
framework and then supplement their analysis with
the dominant ranking score, as has been performed
in this paper.
Sub-group analyses were also conducted based on
impairment levels (moderate/mild versus severe) and
stages of stroke recovery (acute/sub-acute versus
chronic). The authors had envisaged conducting a
sub-group analysis to shed light on whether there
were differences in robotic intervention costs due to
upper limb training or lower limb training. How-
ever, as there was only one study which examined
lower limb training (and this study had a mix of
upper limb training),30 a meaningful sub-group anal-
ysis based on limb extremity was not possible.
Results
Study inclusion
A total of 303 citations were generated from the
database searches, and 81 were identified from other
sources such as MedNar, ProQuest Dissertations
and Theses and ClinicalTrials.gov (Figure 2).31 After
initial screening of titles and abstracts, the full texts
of seven studies were retrieved and screened for
eligibility. After full-text review, two studies wereJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedexcluded, and the reference details of these excluded
studies with reasons for their exclusion are listed
in Appendix II. Consequently, five studies were
appraised for quality, and no further studies were
excluded at this stage. For the final review, these five
studies were included (Figures 3–7).
Methodological quality
Overall, the methodological quality of the included
studies was of moderate level. The included studies
had relatively positive scores in aspects of providing
sufficient details on intervention and control groups,
as well as a reasonably accurate and credible break-
down of relevant costs and outcomes reported. All of
the studies also measured the clinical effectiveness of
their interventions using Fugl-Meyer Assessment or
Motricity Index. Hence, these studies scored mainly
‘‘yes’’ for questions one through six on the JBI
critical appraisal checklist for economic evaluations
(Appendix III).
Of the five studies, only one (Wagner et al.16)
attempted to further analyze economic effects beyond
the cost minimization outcome. Wagner et al. ana-
lyzed both the incremental and sensitivity effects of
different levels of resource use, such as number of
patients using the robotics and the amount of thera-
pist time involved in conducting robotic therapy
sessions.16 Although the authors did further analysis,
they adopted a societal perspective in their computa-
tions. This rendered these additional analyses inap-
plicable for our review, as we were looking at costs
from the perspective of healthcare organizations.
Due to the lack of in-depth economic analysis, the
remaining four studies scored ‘‘no’’ for questions
seven, eight and nine as these questions addressed
aspects of incremental analysis, sensitivity analysis
and discount rate used. Similarly, because of the
insufficient exploration of the economic aspects,
these four studies also scored a ‘‘no’’ for question
10, as the results were not comprehensive enough
and did not address concerns relating to varying
levels of key variables and robustness of the findings.
Two of the five studies (Bustamante Valles et al.30
and Hesse et al.18) had a trial design using robotic
circuit training. This circuit training included non-
robotic devices and because of this, their cost com-
putations were not reflective of purely robotic devi-
ces. The trial by Bustamante Valles et al. was also
conducted in Mexico, where labor costs were not
comparable to the other trials, which were 2019 THE JOANNA BRIGGS INSTITUTE 525
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Figure 2: PRISMA flow diagram of search and study selection process31
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SYSTEMATIC REVIEW K. Lo et al.conducted in developed countries such as Germany,
Italy and the United States.30 As a result, these two
studies scored ‘‘no’’ for question 11, as their results
were not generalizable to a purely robotic clinical
setting that was typically found in developed coun-
tries. Appendix III outlines the appraisal of method-
ological quality for the included studies.
Characteristics of included studies
A total of five studies with 213 patients were
included in this review. Four studies16,18,32,33 exam-
ined upper limb interventions, and one study30
evaluated both upper limb and lower limb interven-
tions. Of the included studies, two18,33 had acute/
sub-acute patients and three16,30,32 had chronic
patients.
The studies came from various countries:
Germany,18 Italy,33 Mexico30 and the United
States.16,32 Trial participants were all adults and
were predominantly older than 60 years old,
although the robotic intervention group of Busta-
mante Valles et al.30 had an average age of 44 years.
In this trial, there was a significant difference
between the mean ages of the robotic intervention
group and the conventional control group, which
had been acknowledged by the authors in their study
report. Despite this age difference, in terms of their
pre-intervention Fugl-Meyer scores, the authors
stated no significant differences between the two
groups.
The included studies had mainly cost minimiza-
tion outcomes. These studies compared the costs of
robotic therapy versus the cost of conventional ther-
apy. Even though all these studies had measured
clinical outcomes such as Fugl-Meyer Assessment
or Motricity Index, there was no presentation of a
cost effectiveness comparison, except for the study
by Wagner et al.16 This study did compute an Incre-
mental Cost-Effectiveness Ratio,34-36 but this was
done by comparing the robotic arm versus the arm
that had no formal rehabilitation therapy program,
which was not the conventional therapy arm that we
were examining. Furthermore, the cost perspective
adopted by the study was from a societal perspective.
None of the studies provided outcomes in terms of
cost utility or cost benefit.
The trial with the largest sample size (Wagner
et al.16) had a majority of male patients (around
96%). because it recruited veterans from four Vet-
erans’ Affairs medical centers. However, the averageJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedpercentage of males across all included studies
was 72%.
In terms of stroke types, more patients (81%) had
ischemic stroke than hemorrhagic stroke. However,
two studies (Bustamante Valles et al.30 and McCabe
et al.32) did not record the types of stroke for
their participants.
The studies had various amounts of training
durations, with total training hours ranging from
20 hours to 300 hours. However, within each study,
the therapy dosage was the same for both the inter-
vention and control groups (i.e. both groups were
dose-matched).
Three studies (Bustamante Valles et al.,30 Vano-
glio et al.,33 Wagner et al.16) compared purely
robotic training to purely conventional training
(i.e. the intervention group had no conventional
training component), while two other studies (Hesse
et al.,18 and McCabe et al.32) had a mix of conven-
tional and robotic training in the intervention group.
Two studies16,32 had multiple-arm comparisons,
but only results of the intervention arm with robotic
rehabilitation were compared to the conventional
therapy control arm. In one study,32 the intervention
arm with a combination of robotic devices and
non-conventional therapy (functional electrical
stimulation [FES]) was excluded from analysis. In
the second study,16 one of the three arms had no
formal rehabilitation therapy program; therapy was
administered as needed. The result of this arm was
excluded from analysis.
In terms of trial design, two studies (Bustamante
Valles et al.30 and Hesse et al.18) adopted a robotic
circuit training concept, whereby patients were
cycled through various training stations during the
therapy session. In the trial by Bustamante Valles
et al.,30 patients underwent training using a mix of
upper limb/lower limb robotic devices, FES and
cognitive devices. Patients in this robotic interven-
tion group switched stations every half hour, work-
ing on four stations per day throughout the trial. For
the trial by Hesse et al.,18 the robotic circuit training
consisted only of upper limb devices. However, the
devices were a mix of robotic and non-assistive
mechanical devices. Each patient practiced for 15
minutes on one device and worked with two devices
during a therapy session. Although these trials had
mixed training equipment in the intervention
groups, they still compared the intervention groups
to control groups, which had conventional therapy. 2019 THE JOANNA BRIGGS INSTITUTE 527
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SYSTEMATIC REVIEW K. Lo et al.Because the therapy durations were also dose-
matched, these trials were included for the review.
Additional characteristics of the studies are pre-
sented in Appendix IV.
Review findings
Cost minimization
The included studies compared the cost of providing
robotic intervention against the cost of providing con-
ventional therapy in dose-matched therapy sessions.
The studies computed the cost measures in terms of
cost per patient session or cost per patient. Under cost
per patient session, authors calculated the cost to treat
one patient for one therapy session. Under cost per
patient, authors calculated the cost to treat one patient
for the entire intervention period. As part of their cost
considerations, the studies included cost components
such as robotic device cost, device depreciation period,
device maintenance cost and cost of therapist.
For the trials by Hesse et al.,18 Bustamante Valles
et al.30 and Wagner et al.,16 the authors compared
the intervention and control groups using cost per
patient session. In the trial by Hesse et al.,18 the
intervention group had 30 minutes of robotic ther-
apy and 30 minutes of conventional therapy, while





















Euro s9,600 s2,400 4
McCabe
et al.32
USD $17,800 $8,000 5
Vanoglio
et al.33
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Wagner
et al.16
USD $46,150 $15,000 5
MXN ¼ Mexican peso; USD ¼ United States dollar.
–The two years was the commercial payment period, which was used by the autho
device was not reported.
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©2019 Joanna Briggs Institute. Unauthorizedconventional therapy. However, in calculating the
cost per patient session, the authors compared only
the cost of 30 minutes of robotic therapy against the
cost of 30 minutes of conventional therapy. This was
still a reasonably acceptable comparison, as both
groups had the same therapy duration and the addi-
tional 30 minutes of conventional therapy in both
groups would have negated each other. Although the
magnitude of the comparison was affected, the direc-
tion of the comparison remained the same.
In the trial by Bustamante Valles et al.,30 the cost
per patient session was based on one therapy session
of two hours. In the study by Wagner et al.,16 the
authors adopted a societal perspective for their cost
computations, but in our review, we adopted a
healthcare organization perspective. Nevertheless,
Wagner et al.16 listed directly in their report the
intervention cost per patient for a therapy session
of one hour (i.e. cost per patient session). We
extracted this cost data to perform the relevant cost
comparison based on our review perspective.
Four of the five studies showed a lower robotic
therapy cost as compared to conventional therapy.
Only one study (McCabe et al.32) had a higher
robotic therapy cost. The cost comparisons of the















































r for depreciation cost calculations. The actual depreciation period of the robotic
 2019 THE JOANNA BRIGGS INSTITUTE 528
 reproduction of this article is prohibited.
SYSTEMATIC REVIEW K. Lo et al.Cost effectiveness
Although all studies measured the clinical effective-
ness of the interventions, none of the studies com-
pared the cost data against the effectiveness measure.
Four studies16,18,30,32 used the Fugl-Meyer Assess-
ment scale while one study33 utilized the Motricity
Index (upper limb).
Cost utility
None of the included studies examined the cost
utility outcome.
Cost benefit
None of the included studies examined the cost
benefit outcome.
Dominance ranking framework
We graded the studies using the dominance ranking
framework, which ranks studies based on their costTable 3: Dominance ranking framework (all studies)
Cost Health 
benefit 
Implication for decision m
+ – Reject intervention  
0 – Reject intervention  
+ 0 Reject intervention  
– – Unclear: judgment required 
is preferable considering inc
effectiveness measures and
pay  
0 0 Unclear: judgment required 
is preferable considering inc
effectiveness measures and
pay  
+ + Unclear: judgment required 
is preferable considering inc
effectiveness measures and
pay  
– 0 Favor intervention  
0 + Favor intervention  
– + Favor intervention  
(þ) ¼ higher cost/better health outcome; 0 ¼ equal cost/equal health outcome; (–)
JBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedand health benefit into three implications for deci-
sion making: reject intervention, unclear or favor
intervention.26 The studies were graded according to
different health and cost outcomes, and we also
presented sub-group analyses based on impairment
levels and stages of stroke recovery.
All included studies
Four studies were ranked under the band that favors
the intervention, while one study was ranked under
‘‘reject intervention’’ (Table 3). With most of the
studies showing that robotic intervention was more
favorable, it seemed to indicate that robotic therapy
was preferable to conventional therapy.
Studies with acute/sub-acute patients
There were two studies that had acute and sub-acute
patients, and when ranked, both studies were under
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¼ lower cost/poorer health outcome.
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Table 4: Dominance ranking framework (acute/sub-acute patients)
+ – Reject intervention  None 
0 – Reject intervention  None 
+ 0 Reject intervention  None 
Cost Health 
benefit 
Implication for decision makers  No. of studies 
– – Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay  
None 
0 0 Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay  
None 
+ + Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay  
None 
– 0 Favor intervention  118 
0 + Favor intervention  None 
– + Favor intervention  133 
(þ) ¼ higher cost/better health outcome; 0 ¼ equal cost/equal health outcome; (–) ¼ lower cost/poorer health outcome.
SYSTEMATIC REVIEW K. Lo et al.which might indicate that robotic therapy was pref-
erable for acute and sub-acute patients (Table 4).
Studies with chronic patients
There were three studies that included chronic
patients. When ranked, two studies came under
the band that favored the robotic intervention,
and one was under the band that rejected the inter-
vention (Table 5). Based on the higher number of
studies in the ‘‘favor intervention’’ band, it seemed
to indicate that robotic therapy was preferable for
chronic patients.
Studies with mild/moderate patients
There were two studies that included mild/mod-
erate patients. When ranked, one study was under
the band that favored the robotic intervention,
and one study was under the band that rejected
the intervention (Table 6). This seemed to indi-
cate no preference for either robotic therapy
or conventional therapy for mild/moderate
patients.JBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. UnauthorizedStudies with severe patients
There were three studies that included severe
patients. When ranked, all studies were under the
band that favored the robotic intervention, which
might indicate that robotic therapy was preferable
for severe patients (Table 7).
Dominance ranking score
The following dominance ranking scores were com-
puted by taking into account the sample sizes of the
studies, as illustrated in the methods section.
All included studies
In terms of the weighted cost benefit, the included
studies had a score of0.78, which showed a strong
dominance of the robotic intervention. However, in
terms of the weighted health benefit, the studies had
a score of 0.13, which showed a moderate domi-
nance of the intervention. Combined together, the
overall dominance ranking score was 0.46, which
indicated a moderate dominance of the robotic
intervention. 2019 THE JOANNA BRIGGS INSTITUTE 530
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Table 5: Dominance ranking framework (chronic patients)
Cost Health 
benefit
Implication for decision makers No. of studies
+ – Reject intervention None
0 – Reject intervention None
+ 0 Reject intervention 132
– – Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
0 0 Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
+ + Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
– 0 Favor intervention 216,30
0 + Favor intervention None
– + Favor intervention None
(þ) ¼ higher cost/better health outcome; 0 ¼ equal cost/equal health outcome; (–) ¼ lower cost/poorer health outcome.
Table 6: Dominance ranking framework (mild/moderate patients)
Cost Health 
benefit
Implication for decision makers No. of studies
+ – Reject intervention None
0 – Reject intervention None
+ 0 Reject intervention 132
– – Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
0 0 Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
+ + Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
– 0 Favor intervention 130
0 + Favor intervention None
– + Favor intervention None
(þ) ¼ higher cost/better health outcome; 0 ¼ equal cost/equal health outcome; (–) ¼ lower cost/poorer health outcome.
SYSTEMATIC REVIEW K. Lo et al.
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Table 7: Dominance ranking framework (severe patients)
Cost Health 
benefit
Implication for decision makers No. of studies
+ – Reject intervention None
0 – Reject intervention None
+ 0 Reject intervention None
– – Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
0 0 Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
+ + Unclear: judgment required on whether intervention is 
preferable considering incremental cost effectiveness 
measures and priorities/willingness to pay 
None
– 0 Favor intervention 216,18
0 + Favor intervention None
– + Favor intervention 133
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Figure 4: Dominance ranking score (acute/sub-acute patients)
SYSTEMATIC REVIEW K. Lo et al.Studies with acute/sub-acute patients
In terms of the weighted cost benefit, the included
studies had a score of1.00, which showed a strong
dominance of the robotic intervention. However, inJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedterms of the weighted health benefit, the studies had
a score of 0.35, which showed a moderate domi-
nance of the intervention. Combined together, the
overall dominance ranking score was 0.68, which 2019 THE JOANNA BRIGGS INSTITUTE 532


















 23 +1 +0.17 0 0.00 
Bustamante Valles et al.
30
 20 -1 -0.15 0 0.00 
Wagner et al.
16
 93 -1 -0.68 0 0.00 
00.066.0-631latoT -0.33 
Figure 5: Dominance ranking score (chronic patients)
SYSTEMATIC REVIEW K. Lo et al.indicated a strong dominance of the robotic inter-
vention.
Studies with chronic patients
In terms of the weighted cost benefit, the included
studies had a score of0.66, which showed a strong
dominance of the robotic intervention. However, in
terms of the weighted health benefit, the studies had
a score of 0.00, which showed that the robotic
intervention was equivalent to the conventional con-
trol. Combined together, the overall dominance
ranking score was 0.33, which indicated a moder-
ate dominance of the robotic intervention.
Studies with mild/moderate patients
In terms of the weighted cost benefit, the included
studies had a score of þ0.07, which showed a
moderate dominance of the conventional control.
In terms of the weighted health benefit, the studies
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Figure 7: Dominance ranking score (severe patients
JBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedintervention was equivalent to the conventional
control. Combined together, the overall domi-
nance ranking score was þ0.03, which indicated
a moderate dominance of the conventional con-
trol.
Studies with severe patients
In terms of the weighted cost benefit, the included
studies had a score of1.00, which showed a strong
dominance of the robotic intervention. However, in
terms of the weighted health benefit, the studies had
a score of 0.16, which showed a moderate domi-
nance of the intervention. Combined together, the
overall dominance ranking score was 0.58, which
indicated a strong dominance of the robotic inter-
vention.
In summary, the results according to the different
sub-groups are shown in Table 8 (based on domi-
nance ranking framework) and Table 9 (based on the
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Table 8: Summary of dominance levels (based on dominance ranking framework)
Sub-group Overall dominance level 
of the intervention
Number of studies
(number of studies by 
implication)
All studies Favor intervention 5 studies 
(1 reject; 4 favor)
Acute/sub-acute patients Favor intervention 2 studies
(2 favor)
Chronic patients Favor intervention 3 studies 
(1 reject; 2 favor)
Mild/moderate patients No preference 2 studies 
(1 reject; 1 favor)
Severe patients Favor intervention 3 studies 
(3 favor)
Table 9: Summary heatmap of dominance levels (based on dominance ranking score)
Sub-group Overall dominance level Dominance level of cost 
benefit
Dominance level of health 
benefit
All studies Moderate robotic Strong robotic Moderate robotic
Acute/sub-acute patients Strong robotic Strong robotic Moderate robotic
Chronic patients Moderate robotic Strong robotic Equivalent
Mild/moderate patients Moderate control Moderate control Equivalent
Severe patients Strong robotic Strong robotic Moderate robotic
SYSTEMATIC REVIEW K. Lo et al.Sensitivity analysis
In the study by Bustamante Valles et al.,30 the
authors found that there was no statistically signifi-
cant difference in health benefit between robotic and
conventional groups for upper limb motor move-
ment; however, for lower limb motor movement,
the authors found that there was a statisticallyTable 10: Summary heatmap of dominance levels (a
Sub-group Overall dominance level
All studies Moderate robotic 
Acute/sub-acute patients Strong robotic
Chronic patients Moderate robotic
Mild/moderate patients Moderate robotic
Severe patients Strong robotic
JBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedsignificant difference in health benefit in favor of
the robotic group. The prior dominance ranking
score analysis had used an equivalent health benefit
for this study but to account for the better health
outcome of the lower limb, a sensitivity analysis was
conducted to assess the effect of changing the health
outcome from equal (0) to better (1). Table 10 andfter sensitivity analysis)
Dominance level of cost 
benefit
Dominance level of health 
benefit
Strong robotic Moderate robotic
Strong robotic Moderate robotic
Strong robotic Moderate robotic
Moderate control Moderate robotic
Strong robotic Moderate robotic
 2019 THE JOANNA BRIGGS INSTITUTE 534
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Figure 8: Sub-groups affected by sensitivity analysis
SYSTEMATIC REVIEW K. Lo et al.Figure 8 showed the summary heatmap and sub-
groups that were affected by the sensitivity analysis.
Discussion
We conducted a cost comparison of the included
studies and reviewed the data based on two
approaches: the dominance ranking framework
and the dominance ranking score. By simply com-
paring the cost outcome of each study, four of the
five studies showed lower cost data for the robotic
intervention group. Under the dominance ranking
framework, as most sub-groups favored robotic
intervention, it also seemed to indicate that robotic
therapy had better cost and health benefits. Under
the dominance ranking score, the overall dominance
levels for most sub-groups favored robotic interven-
tion and seemed to indicate that robotic therapy had
better cost and health benefits. Overall, the results
appeared to be promising that robotic therapy could
potentially have better economic cost benefits thanJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedconventional therapy. However, the limited number
of studies in this review required us to view the
results with caution.
Despite the limited number of studies, we did see
some corresponding similarities between our domi-
nance ranking scores and previous systematic
reviews. Under the dominance ranking score, an
equivalent health benefit was shown between
robotic intervention and conventional therapy for
mild/moderate patients. However, for severe
patients, a moderate dominance in health benefit
favoring robotic intervention was found. Robotic
intervention was also found to be more beneficial
for severely affected patients in the systematic
reviews of Lo et al.5 and Mehrholz et al.2 The
authors found that robotic training was more effec-
tive for patients with severe impairment, although
their review finding was for training lower limbs. For
mild/moderate patients, the weighted dominance
ranking score for health benefit was 0, which was 2019 THE JOANNA BRIGGS INSTITUTE 535
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therapy was equivalent to conventional therapy for
the sub-group of mild/moderate patients.
Comparing the cost benefit under the dominance
ranking score between the sub-groups of mild/mod-
erate and severe patients, there was a moderate
dominance for conventional control for mild/mod-
erate patients and a strong dominance for robotic
intervention for severe patients. The better cost
benefit of robotic intervention for severely impaired
patients might be due to the need for more one-to-
one therapist time during conventional therapy to
gain the same health benefits as robotic therapy. In
conventional therapy, therapists manually support
and exercise the impaired limbs of patients, which is
physically demanding for therapists to sustain at
high intensity, especially for severely impaired
patients with minimal volitional movements.11 Fur-
thermore, during conventional therapy for lower
limbs of severe patients, because of the weight and
muscle spasticity (i.e. stiffness) of the legs, the num-
ber of walking steps that can be facilitated by ther-
apists is also limited. Because severely affected
patients had less motor movement ability, therapists
would need to spend more time exercising the limbs
of patients to achieve the same number of repetitions
during conventional therapy as robotic devices,
which would increase the cost of therapy.
In the review, the cost comparison was based on
the cost measure: cost per patient and cost per
patient session. For both measures, the result was
dependent on the number of patients who can be
treated in a given time period. If a robotic therapy
session was able to treat more patients in a given time
period, then the cost would be further reduced. For
example, in the trials by Bustamante Valles et al.30
and Hesse et al.,18 the number of patients who could
be treated under robotic training was, respectively,
six times and two times more than that under con-
ventional training. The higher number of patients
who can be treated within a given time period helped
to spread the cost of the robotic therapy across more
patients and this, in turn, resulted in a lower cost
outcome for robotic intervention. This relation to
the number of patients treated in a given time period
was also mentioned by Wagner et al. during his
sensitivity analysis.16 From the sensitivity analysis,
the authors found that their results were most sensi-
tive to how efficiently (in terms of the number of
patients per robotic session) the robotic device wasJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedused and the time therapists spent with patients
during a robotic session. If more patients could be
treated per robotic session, then cost would decrease.
Similarly, if less therapist involvement was needed
during robotic training, then cost would decrease.
Our review was in line with the sensitivity factors
identified by Wagner et al.16 that i) robotic sessions
that could treat more patients than conventional
sessions in a given time period would have lower
costs and ii) patients with severe impairment would
require less therapist time to achieve a high number
of training repetitions during robotic therapy and
therefore incur a lower cost.
Limitations of the review
Heterogeneity of studies
A potential limitation of our analysis was the hetero-
geneity of studies. The main sources of heterogeneity
were study design, types of robotic devices, cost of
therapist and cost computation methods for robotic
intervention and conventional control groups.
Study design
Two of the included studies (Bustamante Valles
et al.30 and Hesse et al.18) utilized a robotic circuit
training program, whereby a mix of robotic and non-
robotic devices were used for the robotic interven-
tion group. The studies provided no breakdown on
the cost of each individual device used, and as a
result, the robotic cost computed included the cost of
the non-robotic devices. As such, the overall cost of
the intervention would have been inflated by the
non-robotic devices. Despite the mixed robotic cir-
cuit training increasing the cost of therapy, the cost
of robotic intervention was still lower than conven-
tional therapy. Although the magnitude of the cost
was affected by the non-robotic components, the
direction of the comparison would have remained
the same, even if we were able to remove the cost of
the non-robotic devices. However, the health benefit
might not be attributable to just robotic training, as
some of these non-robotic devices were FES equip-
ment or pure mechanical arm trainers. In terms of
the health benefits, the use of both robotic and non-
robotic devices in the intervention group was a
source of uncertainty.
Types of robotic devices
Various types of robotic devices were used in the
studies, with different levels of complexity and costs. 2019 THE JOANNA BRIGGS INSTITUTE 536
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group) in Table 2, we could see the annualized device
cost ranged from s6000 (approximately USD
$7000) for a hand robotic device to USD $46,150
for an upper limb robotic device. This wide range of
costs depends on the nature of the robotic devices,
with more complex devices costing more. If studies
used more complex robotic devices, it could increase
the intervention cost and alter the economic out-
come. The various types and complexities of robotic
devices and their associated variable costs might lead
to imprecise economic outcomes.37
Cost of therapist
Under annual cost of therapist in Table 2, the cost of
therapist ranged from USD $19,612 to USD
$98,000, which is a wide variance. In the study by
Wagner et al.,16 only the hourly cost of a therapist
was provided. If we were to work out the annual cost
based on this hourly rate, we would have an annual
cost of USD $408,096 (based on annual work days
of 234 days and eight work hours per day). It is likely
that the cost of therapist in the study by Wagner
et al.16 included other cost factors such as overhead
and administrative charges. Nevertheless, the wide
variability of therapist cost would have an impact on
the economic outcome, especially since the resource
use of therapist had been identified as a main cost
sensitivity factor.
Cost computation methods for robotic
intervention and conventional control groups
In calculating the cost of the robotic intervention
group, different cost components were considered.
The studies by Bustamante Valles et al.30 and Hesse
et al.18 considered robotic device cost (depreciated to
an annual amount), an overhead that covered annual
device maintenance and consumables cost and
annual cost of therapist. It should be noted that
Hesse et al.18 considered the cost of electrical con-
sumption of the robotic device under the overhead,
but it was not mentioned if cost of power was
included in the Bustamante Valles et al. study.30
For the trial by McCabe et al.,32 robotic device
cost (depreciated to an annual amount), annual
device maintenance cost and annual cost of therapist
were considered. In the study by Vanoglio et al.,33
robotic device cost (depreciated to an annual
amount) and annual cost of therapist were consid-
ered, but there was no mention of annual deviceJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizedmaintenance cost or cost of consumables or electrical
power. In the study by Wagner et al.,16 robotic
device cost (depreciated to an annual amount),
annual device maintenance cost and annual cost of
therapist (which includes an overhead and fixed
expenses) were considered, but the authors also
considered additional cost components such as
financing and facility overhead expenses.
Furthermore, the cost of robotic devices was
depreciated to calculate the annual device cost,
and this depended on the depreciation period used.
Most studies used five years as the depreciation
period, but Hesse et al.18 used four years while
Bustamante Valles et al.30 used two years. In the
study by Bustamante Valles et al.,30 the two years
was actually based on their commercial payment
period, while the device depreciation period was
not reported.
Similarly, for the cost computation of conven-
tional control group, different cost components were
utilized. In the study by Bustamante Valles et al.,30
cost of therapist, cost of maintenance and consum-
ables for conventional therapy equipment were
included. However, cost of the conventional therapy
equipment was excluded. For Hesse at al.,18 only the
cost of therapist with an overhead was included. For
McCabe et al.,32 annual salary of therapist was
included. In the study by Vanoglio et al.,33 cost of
therapist was used, and for the study by Wagner
et al.,16 annual cost of therapist (which included an
overhead and fixed expenses) was considered.
The inconsistency of cost components used to
compute the cost of robotic and conventional thera-
pies and the device depreciation period that the
authors used to compute the annual cost of robotic
device were sources of heterogeneity.
Limited number of studies and small sample
sizes
The limited number of included studies and the
relatively small sample sizes (except in the trial by
Wagner et al.16) do not lend confidence to our
results. Because there will be variability among the
salary levels of therapists, types and prices of robotic
devices, and device depreciation periods, economic
studies should have large sample sizes to be suffi-
ciently powered for both cost and clinical outcomes,
especially when resource use variables have a skewed
statistical distribution pattern, while clinical varia-
bles are usually normally disrtibuted.38 One such 2019 THE JOANNA BRIGGS INSTITUTE 537
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requires a maximum acceptable incremental cost-
effectiveness ratio35,40 to be pre-determined. Typi-
cally, sample sizes required for economic variables
will be overpowered for clinical outcomes, which
raises the ethical question on whether it would be
inappropriate to carry out a trial beyond the sample
size at which clinical effectiveness has been demon-
strated.38 With inclusion of studies with larger sam-
ple sizes, there would be sufficient sampling data to
ensure that resource variations can be adequately
powered to detect cost differences and give a more
definitive result.38 This is an important consider-
ation, given that the distribution of cost data for
resource use can be skewed, which would mean that
sampling sizes for cost outcomes need to be much
larger than that for clinical outcomes.38
Better comparison of cost and clinical
effectiveness measures
The included studies were conducted in various
countries using different motor impairment scales,
different currencies and over different time points. If
the motor impairment scale and currency value
could be standardized, it would allow for a better
comparison across studies in terms of the cost and
health benefits using a cost-effective (CE) plane. The
CE plane is a two-dimensional space with the x-axis
being the average difference (treatment minus con-
trol) in effectiveness (DE) per patient and the y-axis
being the average difference in cost (DC) per
patient.34,35 If each economic trial is able to compute
DE and DC, it would be possible to plot these point
estimates on the CE plane for several trials. With a
scatter plot on the CE plane, depending on which
quadrant the scatter is most prominent, it would give
us a simple but clear view of the direction of the
economic outcome.34
Data extraction issues
We faced some challenges when extracting data. The
study by Bustamante Valles et al.30 included both
upper and lower limb training in the robotic inter-
vention group. Based on the Fugl-Meyer Assessment,
the authors reached different clinical effectiveness
conclusions for upper and lower limbs. For upper
limb, the authors found that there was no statisti-
cally significant difference between robotic and con-
ventional groups, but for the lower limb, the authors
found that there was a statistically significantJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizeddifference in favor of the robotic group. However,
this finding was complicated by the fact that the
average age of the intervention group was much
younger. This might have contributed to the interven-
tion group gaining more improvements during their
lower limb training due to the younger ages of
patients. Under the dominance ranking framework,
we can only have one grading for health benefit, so we
have taken the more conservative value of no statisti-
cally significant difference, i.e. health benefit is graded
as 0. Nevertheless, even if we had graded the health
benefit as ’’better’’ (þ), the study would still be within
the band favoring the robotic intervention. In terms of
the dominance ranking framework, we would still
have had the study placed in the same band, regardless
of the grading for the health benefit.
In terms of the dominance ranking score, a sensitiv-
ity analysis was performed and there were changes not
only in terms of the values of dominance scores but also
in terms of the bands of the dominance levels. For sub-
groups of chronic and mild/moderate patients, a mod-
erate dominance in health benefit for robotic interven-
tion was shown, which was previously equivalent. For
the overall dominance level of sub-group mild/moder-
ate patients, instead of the previous moderate domi-
nance of control, a moderate dominance for robotic
intervention was shown. Overall, the sensitivity analy-
sis generated a more pronounced shift towards favor-
ing the robotic intervention.
Another point to note was that in the study by
Wagner et al.,16 using a societal perspective, the
authors had an uncertain conclusion when compar-
ing the costs between robotic therapy and conven-
tional therapy. However, when using a healthcare
organization perspective in our review, the cost
conclusion favored robotic therapy.
Another restriction is the lack of reporting on the
quantities of resources used. Some studies included
cost of consumables, electrical power and overheads
in their cost computations, but there were no details
of the quantities and unit prices for these resources.
If these had been stated, it would allow for reviewers
to extract resource use data of interest to the review
and thereby enable cost computations that could be
more comparable across studies.
Generalizability to healthcare settings and
external validity of review findings
Various factors limit the findings of this review to be
generalizable to healthcare providers in a developed 2019 THE JOANNA BRIGGS INSTITUTE 538
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Valles et al.,30 which was conducted in a developing
economy, affects the cost applicability of our find-
ings to a developed economy. There could also be
differing clinical practice patterns among the studies,
as each country might use different levels of clinical
resources to treat their patients.41 The difference in
study designs (i.e. some studies used robotic circuit
training with non-robotic devices) adds uncertainty
to the cost and health benefits, thus limiting external
validity of the review results. Most of the studies
examined upper limb outcomes, and only one study
(Bustamante Valles et al.30) examined upper and
lower limbs. The predominance of studies for upper
limb might limit the economic outcome only to this
limb extremity.
Conclusion
Our review indicated that robotic therapy had a better
economic outcome than conventional therapy. For
patients with severe effects from stroke, a moderate
dominance favoring robotic therapy was found for
health benefit, and a strong dominance for robotic
therapy was found for cost benefit. However, the
limited number of studies in the review required us
to view the results with caution. Key sensitivity factors
affecting robotic therapy were the number of patients
who could be treated per robotic session and the time
therapists spent with patients during a robotic session.
If more patients could be treated per robotic session,
then the cost would decrease. Similarly, if less thera-
pist involvement was needed during robotic training,
then the cost would decrease.
The main sources of heterogeneity were study
design, types of robotic devices, cost of therapist
and cost computation methods for robotic interven-
tion and conventional control groups. Key among
these factors was the cost computation method.
There were many inconsistencies in the resources
used, which could affect the cost computations and
economic outcomes.
Recommendations for practice
Robotic therapy seemed to have a better economic
outcome, especially for patients with severe effects
from stroke, where a dominance for robotic therapy
was found. In view of this, robotic therapy could be
prescribed more for adult patients with severe
impairments after stroke. However, this needed to
be considered with caution, as there was a limitedJBI Database of Systematic Reviews and Implementation Reports
©2019 Joanna Briggs Institute. Unauthorizednumber of studies in our review. (Grade B; JBI
Grades of Recommendation42)
As robotic therapy was associated with the sensi-
tivity factors of number of patients per robotic
session and the time of therapists, hospital providers
might wish to organize their robotic therapy pro-
gram accordingly to maximize the cost economics of
robotics. Hospital providers could increase the num-
ber of patients treated during a robotic therapy
session and minimize the involvement of therapists
as far as possible, while still maintaining patient
safety. (Grade B; JBI Grades of Recommendation42)
Recommendations for research
More comparable cost computations
To achieve more comparable cost computations
among studies, researchers ought to report both
the quantities of resource use and their unit prices,
especially for device consumables and electrical
power consumption, if included in their trials. As
a minimum, researchers should include the following
resources and their associated cost per unit prices:
i) reResources for robotic intervention group
For annual cost of robotic device:
 Purchase price of robotic device
 Depreciation period of the robotic device
 Annual cost of device maintenance/warrantyproe of therapist based on annual gross salary
mputation for conventional control groupTim
ii) Co
For annual cost of conventional therapy equip-
ment:
 Purchase price of therapy equipment
 Depreciation period of the therapy equip-
ment
 Annual cost of equipment maintenance/war-ranty
of therapist based on annual gross salaryTime
Researchers should also report their computation
steps so that readers are able to calculate how values of
the cost per patient or cost per patient session measures
are derived. It would also allow for reviewers to extract
resource use data that were of interest to the review and
thereby enable cost computations that could be more
comparable across studies.
Larger trial sample sizes
As there will be variability among resource use,
economic studies should have large sample sizes to
be sufficiently powered for both cost and clinical
outcomes. As sample sizes required for economic 2019 THE JOANNA BRIGGS INSTITUTE 539
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this brings up the ethical question of whether it
would be inappropriate to carry out a trial beyond
the sample size at which clinical effectiveness has
been demonstrated.38 If ethical barriers limit patient
sample size, then this will affect the reliability of cost
outcomes, and we may have to accept higher error
rates for economic trials.39 While research into
power and sample size calculations that are suitable
for trials with economic and clinical outcomes is
suggested, the ethical perspectives of acquiring
greater patient sample sizes for cost outcomes also
needs to be addressed.
Cost effectiveness plane
If each economic study is able to compute the mea-
sures DE and DC, it would be possible to plot these
point estimates on the CE plane for several trials.
Depending on which quadrant the scatter is most
prominent, it would give us a simple but clear view of
the direction of the cost economic outcome.34 Thus,
it may be advisable for researchers to compute DE
and DC for their trials. In terms of DE, researchers
should preferably use a common motor impairment
scale such as Fugl-Meyer Assessment (upper limb or
lower limb) to have DE comparable across various
studies. While systematic reviewers would need to
set costs to a common currency and price year,
researchers ought to use a standardized cost outcome
measure such as cost per patient session hour (i.e. the
cost to treat a patient for one hour of therapy).
Standardizing the therapy duration to one hour
will allow reviewers to compare DC across studies.
Currently, we have the measure cost per patient
session, but the duration of therapy session varies
among studies. The trial therapy dosage also has
to be dose-matched for both intervention and con-
trol groups.
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OR Habilitation:ti,ab AND Stroke/exp OR Stroke/syn OR Stro-
ke:ti,ab OR ‘Cerebrovascular Accident’/exp OR ‘Cerebrovascular
Accident’/syn OR ‘Cerebrovascular Accident’:ti,ab OR Cerebral:ti,ab
OR ‘Cerebral Stroke’:ti,ab OR ‘Cerebrovascular Stroke’:ti,ab OR
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Technology Devicesþ OR TI ‘‘Assistive Technology Devices’’ OR AB
‘‘Assistive Technology Devices’’ OR TI Exoskeleton OR AB
Exoskeleton OR TI ‘Gait Trainer’ OR AB ‘Gait Trainer’ OR TI
Lokomat OR AB Lokomat AND MH Rehabilitationþ OR TI
Rehabilitation OR AB Rehabilitation OR TI Habilitation OR AB
Habilitation AND MH Strokeþ OR TI Stroke OR AB Stroke OR
TI ‘‘Cerebrovascular Accident’’ OR AB ‘‘Cerebrovascular Accident’’
OR TI Cerebral OR AB Cerebral OR TI ‘‘Cerebral Stroke’’ OR AB
‘‘Cerebral Stroke’’ OR TI ‘‘Cerebrovascular Stroke’’ OR AB ‘‘Cere-
brovascular Stroke’’ OR TI ‘‘Acute Stroke’’ OR AB ‘‘Acute Stroke’’
OR TI ‘‘Sub-acute Stroke’’ OR AB ‘‘Sub-acute Stroke’’ OR TI
‘‘Subacute Stroke’’ OR AB ‘‘Subacute Stroke’’ AND MH Economics
in Healthcareþ OR TI ‘‘Economics in Healthcare’’ OR AB ‘‘Eco-
nomics in Healthcare’’ OR MH Cost Benefit Analysis or Cost
Effectivenessþ OR TI ‘‘Cost Benefit Analysis or Cost Effectiveness’’
OR AB ‘‘Cost Benefit Analysis or Cost Effectiveness’’ OR MH Costs
and Cost Analysisþ OR TI ‘‘Costs and Cost Analysis’’ OR AB
‘‘Costs and Cost Analysis’’ OR MH Health Care Costsþ OR TI
‘‘Health Care Costs’’ OR AB ‘‘Health Care Costs’’ OR MH
Technology Assessment, Biomedicalþ OR TI ‘‘Technology Assess-
ment, Biomedical’’ OR AB ‘‘Technology Assessment, Biomedical’’
OR MH Cost Effectivenessþ OR TI ‘‘Cost Effectiveness’’ OR AB
‘‘Cost Effectiveness’’ OR MH Cost Effectiveþ OR TI ‘‘Cost
Effective’’ OR AB ‘‘Cost Effective’’ OR MH Cost Benefit Analysisþ
OR TI ‘‘Cost Benefit Analysis’’ OR AB ‘‘Cost Benefit Analysis’’ OR
MH Costþ OR TI Cost OR AB Cost38S INSTITUTE 542
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hibiteQ11Bustamante Valles et al.30 Y Y Y Y Y Y N N N N NHesse et al.18 Y Y Y Y Y Y N N N N NMcCabe et al.32 N Y Y Y Y Y N N N N YVanoglio et al.33 Y Y Y Y Y Y N N N N YWagner et al.16 Y Y Y Y Y Y Y Y Y Y YTotal % 80% 100% 100% 100% 100% 100% 20% 20% 20% 20% 60%Y ¼ yes; N ¼ no.
JBI critical appraisal checklist for economic evaluations:
Q1. Is there a well-defined question?
Q2. Is there comprehensive description of alternatives?
Q3. Are all important and relevant costs and outcomes for each alternative identified?
Q4. Has clinical effectiveness been established?
Q5. Are costs and outcomes measured accurately?
Q6. Are costs and outcomes valued credibly?
Q7. Are costs and outcomes adjusted for differential timing?
Q8. Is there an incremental analysis of costs and consequences?
Q9. Were sensitivity analyses conducted to investigate uncertainty in estimates of cost or consequences?
Q10. Do study results include all issues of concern to users?
Q11. Are the results generalizable to the setting of interest in the review?545
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IG (n) CG (n) Outcome measure of interest
Bustamante  
Valles et al.30
Mexico IG: 44.1 ± 12.55
CG: 64.1 ± 8.38
7 NR NR x x x x 48 10 10 Cost per patient per session
Fugl-Meyer (upper limb)
Fugl-Meyer (lower limb)
Hesse et al.18 Germany IG: 71.4 ± 15.5
CG: 69.7 ± 16.6
28 41 9 x x x 20 25 25 Cost per patient per session
Fugl-Meyer (upper limb)
McCabe et al.32 USA IG: 21-49 (n = 2); 50-81 (n = 10)
CG: 21-49 (n = 2); 50-81 (n = 9)
16 NR NR x x x 300 12 11 Cost per patient (over intervention 
period) Fugl-Meyer (upper limb)
Vanoglio et al.33 Italy IG: 72 ± 11
CG: 73 ± 14
14 17 10 x x x 20 14 13 Cost per patient (over intervention 
period) Motricity Index (upper limb)
Wagner et al.16 USA IG: 66 ± 11
CG: 64 ± 11
89 80 13 x x x 36 47 46 Cost per patient per session
Fugl-Meyer (upper limb)
IG: intervention group; CG: control group; n: sample size; SD: standard deviation; NR: not recorded.JBI Database of Systematic Reviews and Implementation Reports  2019 THE JOANNA BRIGGS INSTITUTE 546
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equivalent
to con-
ventionalIG: intervention group; CG: control group; NR: not recorded; FES: functional electrical stimulation; TPR: therapist-to-patient ratio; USD: U.S. dollar; MXN: Mexican peso.547
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The economic cost of robotic rehabilitation for adult
stroke patients: a systematic review protocol
Kenneth Lo  Matthew Stephenson  Craig Lockwood
Joanna Briggs Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia
Review question/objective: The objective of this review is to identify the best available evidence on the economic
cost of robotic rehabilitation for adult stroke patients to improve their motor movement abilities. More specifically,
the objective is to identify the evidence on the economic cost of robotic training compared to conventional
physiotherapy for adult stroke patients, from the perspective of hospitals.
Keywords Stroke; Robotics; rehabilitation; Economic; Systematic Review Protocol
JBI Database System Rev Implement Rep 2018; 16(8):1593–1598.
Introduction
S troke is a leading cause of disability with 15million people suffering a stroke yearly.1 In the
United States, the annual healthcare spending for
stroke patients is USD80 billion.2 Given the large
social and economic burden of stroke, it is important
to identify appropriate treatment methods that can
not only reduce the disability of stroke survivors, but
also do so cost effectively. Traditionally, stroke
patients would undergo rehabilitation post stroke
and, depending on the nature of the disability, reha-
bilitation would be administered by a multi-disci-
plinary team of physiotherapists, occupational
therapists, speech therapists and neuropsychologists,
who work together to offer integrated, holistic reha-
bilitation therapy.3 For physical impairments, stroke
patients will usually undergo conventional physio-
therapy, which involves patients undergoing repeti-
tive, high intensity, task-specific exercises that
enable them to regain their motor and functional
abilities.4,5 In animal studies, it has been shown that
test subjects regain motor abilities after intensive
and repetitive task training.6 This was associated
with a reorganization of the undamaged motor
cortex to enable recovery of motor abilities of
the affected limbs.7 This ‘‘neuroplasticity’’ is the
underlying principle of motor learning involving
repetitive, high intensity, task-specific exercises.8
However, conventional physiotherapy trainings
are labor intensive and places physical strain on
physiotherapists.9
To facilitate the high repetitions required, robotic
devices have been used to assist therapists to reha-
bilitate patients based on high repetitions of task
specific exercises.10 These robotic devices provide
intensive, consistent and repetitive cycles over long
periods to train the impaired limbs of patients.
There are two main types of robotic devices: exo-
skeletons or end-effectors. Exoskeletons are devices
that wrap around limbs and are able to assist each
limb joint to move. End-effectors are devices that
assist only the extremities of a limb (either hands or
feet).9 Regardless of the design mechanism, one key
feature of robotic devices is the ability to automati-
cally assist patients to move their limbs when
they are unable to do so by themselves. This auto-
mated assistive feature enables high repetitions to be
achieved.
Systematic reviews conducted on these robotic
devices showed varying degrees of effectiveness.
One systematic review that assessed lower limb out-
comes found that robotic-assisted gait training
increased the odds of participants being able to walk
independently.11 For the sub-group of severely
impaired patients, findings indicated that robotic
treatment was more effective.11 In terms of upper
limb outcomes, systematic reviews have found that
robot-assisted arm training improved arm motor
movement12,13 and activities of daily living scores.12
A recent systematic review found that robotic
training was just as effective as conventional
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physiotherapy for upper limb motor movement,
lower limb walking and activities of daily living,
but for severely impaired lower limb patients,
robotic training was found to be more effective than
conventional training.14 Overall, these reviews
showed that robotic devices, at a minimum, offered
equivalent treatment outcomes as conventional
physiotherapy.
While robotic devices enable a high intensity
training regime that can be just as effective as con-
ventional therapy, the robotic training equipment
can cost up to several hundred thousand dollars15
per device, which is a significant capital outlay for
hospitals. Hence, the decision to introduce robotic
devices into clinical settings and offer robotic stroke
rehabilitation to patients has an important cost
consideration for healthcare providers. Despite its
cost, robotic devices may increase the work effi-
ciency of therapists, hence more patients can be
treated and this could lead to an overall reduction
in cost of treatment per patient.16 There have been
clinical studies to determine the economic cost of
robotic devices in the rehabilitation of stroke
patients.17 However, these studies presented a mixed
picture of the cost impact of robotic devices. One
study18 that compared the cost-effectiveness of
robotic rehabilitation with conventional rehabilita-
tion had an uncertain finding, while another study19
found that robotic devices were economically sus-
tainable. A third study20 compared the treatment
costs and found that robotic training was less expen-
sive than conventional training. A preliminary
search of PubMed, Embase, JBI Database of Sys-
tematic Reviews and Implementation Reports,
Cochrane Library and PROSPERO was carried
out to identify systematic reviews that had been
conducted on this topic area and no reviews were
found.
The current literature does not provide a clear
determination of the cost impact of using robotic
devices for stroke rehabilitation and it is the aim of
this review to provide clarity to the discussion and
assist healthcare providers to understand the eco-
nomic cost of robotic rehabilitation.
Inclusion criteria
Participants
This review will consider studies that include adult
stroke patients (18 years and over) of all genders,
regardless if stroke is due to ischemic or hemorrhagic
causes. Patients with pre-existing impairments that
are not caused by stroke, such as disabilities due to
spinal cord injuries, Parkinson’s disease, multiple
sclerosis and traumatic brain injuries, will be
excluded. Study participants may be new stroke
patients or repeat stroke patients at acute, sub-acute
or chronic stages of their stroke, as long as they
have been accepted into a rehabilitation program.
Intervention and comparator
The review will consider studies that evaluate reha-
bilitation of stroke patients using robotic devices and
compare the outcomes to control groups which use
conventional physiotherapy. The types of robotic
devices can be varied (e.g. either robotic exoskele-
tons or end-effectors for gait training), as long as
interventions involve electro-mechanical devices
with automated assistive feature to help patients
regain their motor abilities.
Interventions involving the devices below are not
considered as robotic rehabilitation devices as they
do not exhibit assistive automation that robotic
devices have:
 Non-interactive devices that deliver passive
motion such as treadmills, static body-weight
assisted treadmills, bicycles, static walking aids,
static orthoses (such as ankle-foot orthoses
addressing foot drop) or pure mechanical trainers
(e.g. Reha-Slide, Reha-Slide duo).
 Standalone video games controlled solely by
patient without automated assistive feature, such
as Nintendo Wii.
 Rehabilitation programs using non-conventional
therapies such as acupuncture, functional electri-
cal stimulation (FES), transcranial direct current
stimulation, motor imagery, biofeedback and
constrain induced therapy (CIT).
The intervention group can have an added con-
ventional physiotherapy component or not. If the
intervention group has an added conventional phys-
iotherapy component, this can involve non-interac-
tive static devices. The intervention should not
contain other types of non-conventional therapy
(e.g. FES, transcranial direct current stimulation,
motor imagery or CIT). For multiple-arm studies,
only results of the intervention arm with robotic
rehabilitation will be compared to the conventional
therapy control arm. The intervention arm with a
combination of robotic devices and non-conven-
tional therapy will be excluded from analysis.
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As control groups, patients do not receive robotic
rehabilitation but receive only conventional physio-
therapy. The conventional physiotherapy treatment
may include non-interactive static devices (e.g.
bicycles, treadmills, acupuncture). The amount of
therapy treatment in both intervention and control
groups should be the same in terms of duration, i.e.
dose-matched. For example, if patients in the inter-
vention group undergo 60 minutes of therapy using a
robotic device on top of a conventional physiother-
apy component, then in the control group the
patients should also undergo an additional 60
minutes of conventional physiotherapy. Therefore,
the total amount of therapy time planned for patients
(over the intervention period) should be the same for
both groups.
Context
Studies where the rehabilitation setting is either
inpatient or outpatient will be included. Home reha-
bilitation patients will be excluded due to potential
confounding of treatment adherence. The rehabili-
tation program can be conducted in hospitals, nurs-
ing facilities or across multi-centers, and only
physical impairments related to upper and lower
limbs will be considered.
Outcomes
This review will consider studies that include the
following outcomes:
 Cost minimization:
Studies that aim to compare the cost of providing
robotic rehabilitation against the cost of provid-
ing conventional physiotherapy will be included.
 Cost-effectiveness:
Studies that aim to compare the cost of providing
robotic rehabilitation against the cost of provid-
ing conventional physiotherapy will be included,
whereby the outcome is presented as relative
costs to achieve a unit of effect. The unit of effect
should reflect the motor movement ability of
patients and should involve the following mea-
surement scales:
 For measurement scale of upper limbs, the
Fugl-Meyer Assessment21 (upper extremity
score) is the preferred scale. If a study does
not use this scale, then an alternative mea-
surement scale that quantifies upper limb
motor movement (e.g. upper limb Motricity
Index22) will be considered.
 For measurement scale of lower limbs, the
Functional Ambulation Category23 is the pre-
ferred scale. If a study does not use this scale,
then an alternative measurement scale that
quantifies walking will be considered, e.g.
Barthel Index24 (ambulation item) or Func-
tional Independence Measure25 (walking
item).
 Cost utility:
Studies that aim to compare the cost of providing
robotic rehabilitation against the cost of provid-
ing conventional physiotherapy will be included,
whereby the outcome is presented as relative
costs to achieve a unit of utility, which is mea-
sured in quality adjusted life years (QALY).
 Cost benefit:
Studies that aim to compare the cost of providing
robotic rehabilitation against the cost of provid-
ing conventional physiotherapy will be included,
whereby the outcome is presented as relative
costs to achieve a unit of benefit, which is also
measured in monetary units.
The cost perspective adopted is from the view-
point of hospitals, as hospitals are the main decision
makers for introducing robotic rehabilitation to
stroke patients in a clinical setting. As such, only
direct medical costs (e.g. therapist time, medical
devices) will be considered. Indirect costs, such as
cost of patients’ caregivers or patients’ travel
expenses, will be excluded. Direct non-medical costs
(e.g. hospital administrative cost) will also be
excluded as this type of cost is common to all
patients, regardless of robotic or conventional train-
ing. Cost components during the follow-up period
will be excluded, as it is the intent of the review to
examine the costs associated with providing the
intervention during the treatment period.
Types of studies
Economic studies of robotic training involving upper
and lower limbs will be included. The economic
component of the review will consider cost minimi-
zation, cost-effectiveness, cost utility and cost benefit
studies, which compare robotic rehabilitation to
conventional physiotherapy in dose-matched ther-
apy sessions. Partial economic evaluations (i.e. cost
analysis, cost-description studies and cost-outcome
descriptions) of robotic rehabilitation versus dose-
matched conventional physiotherapy will also be
considered for inclusion. Modeling studies will not
SYSTEMATIC REVIEW PROTOCOL K. Lo et al.
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be considered, as the review aims to collect empirical
data from prospective clinical trials.
Studies published in English will be considered for
inclusion in this review and a date limit starting from
2000 will be set, as automated robotic devices have
increasingly been used since 2000, together with




The search strategy will aim to find both published
and unpublished studies. An initial limited search of
PubMed will be undertaken followed by analysis of
the text words contained in the title and abstract,
and of the index terms used to describe the articles.
This will inform the development of a search strategy
which will be tailored for each information source.
A full search strategy for PubMed is detailed in
Appendix I. The reference list of studies selected
for critical appraisal will also be screened for
additional studies.
Information sources
The databases to be searched include: PubMed,
Embase, CINAHL, Cochrane (CENTRAL), PEDro
(Physiotherapy Evidence Database), NHS Economic
Evaluation Database (NHS EED), Cost Effectiveness
Analysis (CEA) registry, and Health Technology
Assessment (HTA) database.
The search for unpublished studies will include:
MedNar, ProQuest Dissertations and Theses and
ClinicalTrials.gov
Study selection
Following the search, all identified citations will be
collated and uploaded into bibliographic software
or citation management system and duplicates
removed. Titles and abstracts will then be screened
for assessment against the inclusion criteria for
the review. Studies that meet the inclusion criteria
will be retrieved in full and assessed in detail against
the inclusion criteria. Full text studies that do not
meet the inclusion criteria will be excluded and
reasons for exclusion will be provided in an appen-
dix in the final systematic review report. Included
studies will undergo a process of critical appraisal.
The results of the search will be reported in full in
the final report and presented in a PRISMA flow
diagram.
Assessment of methodological quality
Selected studies will be critically appraised by
two independent reviewers at the study level for
methodological quality using the standardized crit-
ical appraisal instruments from the Joanna Briggs
Institute for Economic Evaluation.26 Any disagree-
ments that arise between the reviewers will be
resolved through discussion or with a third
reviewer.
As economic analysis of robotic devices is an
emerging research area, all studies regardless of
their methodological quality will undergo data
extraction and synthesis (where possible) to
maximize data collection. However, study quality
will be considered in the interpretation of review
findings.
Data extraction
Data will be extracted by two independent reviewers
from papers included in the review using the stan-
dardized data extraction tool from Joanna Briggs
Institute System for the Unified Management,
Assessment and Review of Information (JBI
SUMARI). The data extracted will include: firstly,
descriptive data about the intervention/s and com-
parator/s examined, study population/participants
and context, study methods; and secondly, results
for the resource use, cost and cost-effectiveness
measures; thirdly, where possible, author conclu-
sions about factors that promote (impede) cost-
effectiveness of the intervention. In the event
of specific key data of interest being absent from
published articles, corresponding authors will
be contacted.
Data synthesis
Economic findings will, where possible, be synthe-
sized and presented in a tabular summary. Where
this is not possible, findings will be presented in
narrative form. In general, depending on quantity,
quality and nature of the economic papers identified,
economic results will be subjected to:
 Narrative summary, or
 Sorting in tables by comparisons/outcomes, or
 Tabulated in a permutation matrix.27,28
Data permitting, sub-group analysis may be con-
ducted to shed light on whether there are differences
in costs due to: i) upper limb; ii) lower limb; iii)
impairment levels; and iv) stages of stroke recovery
(acute/sub-acute/chronic).
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PubMed search terms:
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As the base of clinical evidence grows, it is increasingly common to conduct economic evaluations in 
addition to clinical evaluations of effectiveness in order to inform health policies. For economic 
systematic reviews there is currently no agreed-upon quantitative method to obtain a pooled economic 
effect size. With no suitable quantitative method available, the hierarchical decision matrix stands out 
as a tool that enables a visual summary of different types of economic studies, but there are limitations 
with the hierarchical decision matrix. We extended the hierarchical decision matrix with a weighted 
scoring system (termed dominance ranking score) to allow for useful information of a study design to 
be incorporated.  
 The scoring system of the dominance ranking score incorporates weighting factors that are based 
on sample size, effect size and methodological quality of a study. 
 The dominance ranking score enables a more differentiating analysis of dominance levels. 
 For systematic reviews that include partial economic studies, both the hierarchical decision matrix 
and the dominance ranking score assist to indicate the level of economic potential for a particular 
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Systematic review of clinical effectiveness has become the gold standard for evidence-based medical 
research. As the base of clinical evidence grows, it is increasingly common to conduct economic 
evaluations in addition to clinical evaluations of effectiveness in order to inform health policies.1,2 
Economic evaluations can be classified into two main types: empirical economic evaluations which 
collect patient-level data on costs and outcomes, and decision model (simulation) based economic 
analyses.2 Empirical economic evaluations involve data collection and synthesis of existing evidence 
using the framework of a systematic review, while economic decision modeling involves the data 
collection and synthesis of existing evidence in order to generate a new economic evaluation using the 
framework of a decision model.3 For either type of economic evaluation, the economic outcomes are 
expressed using a variety of measures, such as cost effectiveness, cost utility, cost benefit and 
incremental cost effectiveness ratios (which measure relative efficiency and are expressed as 
incremental gains in clinical effectiveness, health utility values or monetary valuations).3-5 
 
Systematic reviews of empirical economic studies involve several stages of research which are similar 
to systematic reviews of clinical effectiveness: defining the review question and inclusion criteria for 
study eligibility; identifying and collecting data; appraising methodological quality; analyzing collected 
data and undertaking meta-analysis (where appropriate); and summarizing and presenting results.4,5 
On the other hand, economic decision modelling involves computing the expected costs and outcomes 
of alternative interventions, based on a synthesis of evidence for the probabilities, costs and outcomes 




However, in the systematic review of empirical economic studies, there are currently no agreed-upon 
methods to obtain a pooled economic effect size from included empirical trials using meta-analysis or 
other quantitative synthesis methods.4,6 The main reasons are the generalizability and transferability of 
the empirical economic studies. Economic trials are context and time sensitive,3 as resource use and 
unit costs are dependent on local settings, clinical practices and currency values at a particular time. 
This generates high heterogeneity if the economic studies in a systematic review come from different 
clinical contexts in different countries. Only if the studies have similar resource use and unit costs, with 
economic outcomes expressed in a common metric, then meta-analysis could be appropriate.4 
 
Given the current lack of quantitative synthesis methods, systematic reviews of economic studies have 
been restricted to methods of using descriptive narratives (via summaries or tables)4 or plotting the 
magnitude and direction of cost and effectiveness using the CE-plane,7 or applying visual summaries 
in a hierarchical decision matrix.1,5 Here, we propose methods to extend the hierarchical decision matrix 
in order to enhance its use and address some of its limitations. 
 
Hierarchical decision matrix 
The hierarchical decision matrix (also known as dominance ranking framework)1,5 enables a visual 
summary of various economic studies that have different economic outcome measures (e.g. cost-
effectiveness, cost-utility, cost-benefit), which would otherwise not be possible in a quantitative meta-
analysis approach.8 Although the hierarchical decision matrix is not a quantitative synthesis method, its 
hierarchical structure enables an interpretation of the dominance levels of an intervention based on 
assessment of benefits for both cost and health outcomes within a trial. If there are more studies in a 
certain color band, it would indicate a dominance level which is associated with that band.  
 
Another advantage of the hierarchical decision matrix is that it allows for economic synthesis even when 
only partial economic data (e.g. cost minimization data) is available. For emerging research areas, basic 
economic cost data is usually collected in parallel to a trial on clinical effectiveness. These trials do not 
usually incorporate extensive economic analysis, such as calculations of incremental cost effectiveness 
ratio or acceptability curves. In such a scenario, the hierarchical decision matrix allows for rudimentary 




Limitations of Hierarchical decision matrix/Dominance ranking framework 
The hierarchical decision matrix shows the distribution of studies in the three different bands, where a 
predominance of the number of studies in a certain band will indicate the likely implication of the 
intervention. However, if there are equal numbers of studies across two or three bands, no clear 
conclusion can be drawn.  
 
As the basis of the distribution is based on the number of studies, this approach also does not take into 
account sample sizes of the clinical trials, which affect the statistical power of a trial to detect an effect. 
To illustrate, in an example where there are three studies and one of them is within the band that favors 
the intervention, while the other two studies are within the band that rejects the intervention. Under the 
current hierarchical decision matrix, it will imply that the intervention is to be rejected. However, the two 
studies that reject the intervention could be smaller trials while the study that favors the intervention 
may have a larger sample size and greater precision. Rejecting the intervention in such a scenario may 
lead to an inaccurate conclusion. 
 
The current hierarchical decision matrix does not give a clear interpretation in certain scenarios and 
also does not incorporate considerations of other aspects of a study design, such as sample sizes of 
the studies. If we can extend the hierarchical decision matrix to incorporate additional study aspects, it 
may provide more informative analysis of dominance levels. 
 
Methods 
We extend the hierarchical decision matrix using a weighted scoring system which is described here. 
We term this method the dominance ranking score.  
 
The data transformation of the benefit value to make it suitable for use in the dominance ranking score 
is shown in Table 1. To calculate the traditional dominance ranking we transform the qualitative 
expression of the benefits in terms of ‘+’ and ‘-‘ into quantitative data that can be calculated. This 
process of converting qualitative data into quantitative data is called quantitizing9 and this approach of 
data transformation is commonly used in mixed method analysis and synthesis.10-12 For the dominance 
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ranking score, in order to align the direction of the scoring for health outcome to be the same as the 
direction for cost outcome, a better health outcome for the intervention of interest is given a negative 
sign. Note that this is in opposite contrast to the hierarchical decision matrix, where a better health 
outcome is given a positive sign.1 
 
Table 1: Benefit values for dominance ranking score 
Benefit Value Cost Outcome Health outcome 
-1 Lower Better 
0 Same Same 
+1 Higher Poorer 
 
We know the sample size of a trial improves the precision of the trial and the larger the sample size, 
the smaller the confidence interval.13 We also know that under the fixed effects model for meta-analysis, 
studies are weighted by their variance, with larger studies having more weight.14 To give a similar 
weighting to larger studies, which should have more precision in their effects, we can modify the existing 
hierarchical decision matrix by adding a weighting to the cost and health benefits that is based on their 
sample sizes. 
 
The weighting calculation schema are as follows: 
 
Weighted Benefit =  𝑛𝑛
𝑁𝑁
 x Benefit Value 
Where: 𝑛𝑛 = sample size of a study; 𝑁𝑁 = total sample size of studies in a sub-group analysis; Benefit Value = -1, 0 or +1 
 
Overall Dominance Ranking Score = (  ∑ 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡𝑊𝑊𝑡𝑡 𝐶𝐶𝐶𝐶𝐶𝐶𝑡𝑡 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡𝑘𝑘𝑖𝑖=1   +  ∑ 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡𝑊𝑊𝑡𝑡 𝐻𝐻𝑊𝑊𝐻𝐻𝐻𝐻𝑡𝑡ℎ 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡𝑘𝑘𝑖𝑖=1  ) / 2 
Where: 𝑘𝑘 = number of studies included in a sub-group analysis 
 
By adding a weighting based on sample size to the cost benefit, the cumulative dominance ranking 
score will range from -1 to +1. Similarly, by weighting the health benefit, the cumulative ranking score 
will range from -1 to +1. Assuming that both cost and health benefits play an equal role in determining 
the overall ranking result, the weighed cost and health benefits can be averaged to obtain the overall 
dominance ranking score. Based on this approach, we can color-code the dominance ranking scores 




Table 2: Dominance ranking score scale 
-1               -0.5        0  0 0.5              1 
     
 












Dominance of  
Control 
Strong 
Dominance of  
Control  
 
If the overall score is in the green zone (-1 ≤ score < 0), then the result favors the intervention, with a 
score in the lighter green zone (-0.5 ≤ score < 0) showing a moderate dominance of the intervention 
and a score in the deeper green zone (-1 ≤ score < -0.5) showing a strong dominance of the intervention. 
If the overall score is in the red zone (0 < score ≤1), then the result favors the control, with a score in 
the lighter red zone (0 < score ≤ 0.5) showing a moderate dominance of the control and a score in the 
deeper red zone (0.5 < score ≤1) showing a strong dominance of the control. In the case that the overall 
score is equal to 0, then it would mean that the intervention is equivalent to the control. 
 
Results 
Using an example from a published economic review,15 we illustrate calculations of the dominance 
ranking score and presentation of its color-coded scale. In the example, five studies were included for 
economic review and Tables 3 and 4 show the results of the original review. From Table 3, there are 
more studies under the green band, which indicates that the intervention is favored. For the sub-groups 
analysis (Table 4), all sub-groups except for the sub-group “mild/moderate”, indicate that the 
intervention is favored. Under the “mild/moderate” sub-group, there is one study favoring the 
intervention and one study rejecting the intervention, which leads to an inconclusive result. 
 
Table 3: Hierarchical decision matrix/Dominance ranking framework (all studies) 




Implication for decision makers  
+ 0 - Reject intervention  
0 0 - Reject intervention  
+ 116 0 Reject intervention  
- 0 - Unclear – Judgment required on whether intervention 
preferable considering incremental cost 




0 0 0 Unclear - Judgment required on whether intervention 
preferable considering incremental cost 
effectiveness measures and priorities/willingness to 
pay  
+ 0 + Unclear - Judgment required on whether intervention 
preferable considering incremental cost 
effectiveness measures and priorities/willingness to 
pay  
- 317-19 0 Favor intervention  
0 0 + Favor intervention  
- 120 + Favor intervention  
 
Table 4: Summary of dominance levels (based on hierarchical decision matrix) 
Sub-groups Overall Dominance Level 
of the Intervention 
Number of Studies 
(number of studies by 
implication) 
All Studies Favor intervention 5 studies  
(1: Reject Intervention 
4: Favor Intervention) 
Acute/sub-acute Patients Favor intervention 2 studies 
(2: Favor Intervention) 
Chronic Patients Favor intervention 3 studies  
(1: Reject Intervention 
2: Favor Intervention) 
Mild/moderate Patients No preference 2 studies  
(1: Reject Intervention 
1: Favor Intervention) 
Severe Patients Favor intervention 3 studies  
(3: Favor Intervention) 
 
Using the data transformation key in Table 1, these studies were assigned values of either -1, 0, +1 for 
their cost and health benefits. Thereafter the cost and health benefits were weighted based on sample 
sizes of the studies (Table 5). 
 

















Bustamante Valles et al.18 20 -1 -0.09 0 0.00  
Hesse et al.17 50 -1 -0.23 0 0.00  
McCabe et al.16 23 1 +0.11 0 0.00  
Vanoglio et al.20 27 -1 -0.13 -1 -0.13  
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Wagner et al.19 93 -1 -0.44 0 0.00  
Total 213  -0.78  -0.13 -0.46 
 
 
The calculations are then repeated for every subgroup and a summary can be tabulated as shown in 
Table 6. As a comparison, the results using the hierarchical decision matrix and its summary tabulation 
are shown in Tables 3 and 4 respectively. 
 
Table 6: Summary heatmap of dominance levels (based on dominance ranking score) 
Sub-groups Overall Dominance Level Dominance Level of  
Cost Benefit 
Dominance Level of 
Health Benefit 
All Studies Moderate Robotic  Strong Robotic Moderate Robotic 
Acute/sub-acute Patients Strong Robotic Strong Robotic Moderate Robotic 
Chronic Patients Moderate Robotic Strong Robotic Equivalent 
Mild/moderate Patients Moderate Control Moderate Control Equivalent 
Severe Patients Strong Robotic Strong Robotic Moderate Robotic 
 
In Table 4, for “mild/moderate” subgroup, as there was one study in each band, no clear interpretation 
can be drawn; whereas under the dominance ranking score (Table 6), we can glean further analysis. In 
this case, that overall, for the “mild/moderate” subgroup, there is a moderate dominance for control. For 
the cost benefit, moderate dominance for control is shown and for the health benefit, equivalent 
dominance is shown. Under a dominance ranking score which incorporates sample sizes, we can have 
not only a more differentiated analysis for overall dominance level, but also analysis which can be 




Weighting the effects of cost and health outcomes 
In the example illustrated above, we had assumed that cost and health outcomes had an equal role in 
determining the overall dominance ranking score. For certain trials this may not be so, for example in 
certain infectious diseases with high mortality rates, the health outcome might have a larger emphasis. 
With sufficient evidence and justification provided, reviewers can alter the weights of the cost and health 
outcomes for the dominance ranking score, thus enabling researchers the flexibility to determine the 
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ranking score that is applicable to their research context. The revised calculation schema incorporating 
weights to cost and health outcomes is: 
 
Overall Dominance Ranking Score = ( Wcost × ∑ 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡𝑊𝑊𝑡𝑡 𝐶𝐶𝐶𝐶𝐶𝐶𝑡𝑡 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡 𝑘𝑘𝑖𝑖=1 ) + ( Whealth ×
 � 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡𝑊𝑊𝑡𝑡 𝐻𝐻𝑊𝑊𝐻𝐻𝐻𝐻𝑡𝑡ℎ 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡 𝑘𝑘𝑊𝑊=1 ) 
 
Wcost + Whealth = 1 
 
Where: Wcost = weight applied to cost outcome; Whealth = weight applied to health outcome; 𝑘𝑘 = number of studies included in a 
sub-group analysis 
 
Incorporating multiple weighting factors 
With a weighting scheme, various aspects of a study design can be incorporated as multiple weighting 
factors. In our method, besides the sample sizes, we could incorporate two other weighting factors that 
mirror key considerations when conducting a systematic review: effect sizes of trials and methodological 
quality of studies. 
 
Effect Size Weighting 
If effect size data is available, it could be an additional weighting factor. Studies that show greater effect 
sizes will have more weight and the effect size weighting will shift the dominance ranking score towards 
such studies. Effect sizes are proposed as a weighting factor, as a greater effect size indicates a larger 
difference between the mean effects of experimental and control groups,4 which would imply that there 
is likely a clinical difference between the two groups. The use of effect size weighting is also contingent 
upon studies having sufficient power and are methodologically well conducted.   
 
The calculation schema to incorporate effect size weighting is: 
 
Weighted Benefit (Effect Size) =  |𝑒𝑒|
𝐸𝐸
 x Benefit Value 
 




Overall Dominance Ranking Score = ( Wcost × 
� �  𝑛𝑛𝑁𝑁 × 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 𝐵𝐵𝑒𝑒𝑛𝑛𝑒𝑒𝐵𝐵𝑖𝑖𝐶𝐶
𝑘𝑘
𝑖𝑖=1






 )  + ( Whealth 
×   
� �  𝑛𝑛
𝑁𝑁
 × 𝐻𝐻𝑊𝑊𝐻𝐻𝐻𝐻𝑡𝑡ℎ 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡
𝑘𝑘
𝑊𝑊=1











Where: |𝑊𝑊| = modulus of effect size of a study; 𝐸𝐸 = sum of effect sizes of studies in a sub-group analysis; [|𝑒𝑒|
𝐸𝐸
]𝑐𝑐𝐶𝐶𝐶𝐶𝐶𝐶 is the effect 
size weight for cost data; [|𝑒𝑒|
𝐸𝐸
]ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝐶𝐶ℎ is the effect size weight for health data; F = number of weighting factors applied (here F = 2); 
n = sample size of a study; N = total sample size of studies in a sub-group analysis; Wcost = weight applied to cost outcome; 
Whealth = weight applied to health outcome; k = number of studies included in a sub-group analysis; Benefit Value = -1, 0 or +1 
 
Note: Effect sizes can have positive or negative values, depending on whether intervention is favored, 
or control is favored. As the direction of effect size is already indicated by the sign of the benefit value, 
only the modulus (i.e. absolute value) of the effect size is needed for calculation of effect size weighting. 
As there are both cost and health (i.e. clinical effectiveness) outcomes, there will also be two effect size 
data: one for cost outcome and one for health outcome. It is also to note that the presented weighting 
scheme applies to effect sizes of continuous data (i.e. weighted mean difference, standardized mean 
difference), as the meta-analysis of such data is centered on a neutral value of “0”, with either side 
representing effects favoring intervention or control on symmetrical scales. 
 
Methodological Quality Weighting 
Another weighting factor that can be incorporated is the methodological quality of studies. During critical 
appraisal, systematic reviewers can assign a score to rate the quality of a study. With this appraisal 
score, we can incorporate quality aspects of study design into the dominance ranking score. Studies 
that have better methodological quality will have more weight and the quality weighting will shift the 
dominance ranking score towards such studies. The calculation schema to incorporate quality weighting 
is: 
 
Weighted Benefit (Quality) =  𝑞𝑞
𝑄𝑄
 x Benefit Value 
 




Overall Dominance Ranking Score = ( Wcost ×  
� �  𝑛𝑛
𝑁𝑁
 × 𝐶𝐶𝐶𝐶𝐶𝐶𝑡𝑡 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡
𝑘𝑘
𝑊𝑊=1












  ) + ( Whealth 
×  
� �  𝑛𝑛
𝑁𝑁
 × 𝐻𝐻𝑊𝑊𝐻𝐻𝐻𝐻𝑡𝑡ℎ 𝐵𝐵𝑊𝑊𝑛𝑛𝑊𝑊𝐵𝐵𝑊𝑊𝑡𝑡
𝑘𝑘
𝑊𝑊=1












  ) 
 
Where: 𝑞𝑞 is the methodological quality score of a study; 𝑄𝑄 is the total methodological quality score in a sub-group analysis; |𝑊𝑊| 
= modulus of effect size of a study; 𝐸𝐸 = total effect size of studies in a sub-group analysis; [|𝑒𝑒|
𝐸𝐸
]𝑐𝑐𝐶𝐶𝐶𝐶𝐶𝐶 is the effect size weight for 
cost data; [|𝑒𝑒|
𝐸𝐸
]ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝐶𝐶ℎ is the effect size weight for health data; F = number of weighting factors applied (here F = 3); n = sample 
size of a study; N = total sample size of studies in a sub-group analysis; Wcost = weight applied to cost outcome; Whealth = weight 





We have shown how weights based on factors relevant and important to most reviews, namely: sample 
size, effect size and methodological quality of studies can be considered in the analysis. The weighting 
factors serve to incorporate useful aspects of a study design into the hierarchical decision 
matrix/dominance ranking framework and helps to provide more information for analysis and 
understanding of dominance levels. In our example, we have demonstrated a technique to increase 
precision in the analysis, through incorporating a weighting scheme that is based on sample sizes of 
the included studies. 
 
Effect size weighting factor 
With additional weighting factors that incorporate effect size and methodological quality, the dominance 
ranking score can be further enhanced for a better analysis of dominance levels. However, effect size 
data for economic cost measures is often not available, as meta-analysis for economic cost data is not 
encouraged due to resource use and cost data that are sensitive to variability across settings and 
between countries.8 Even if economic effect size data is available, the different economic outcome 
measures used in economic trials (e.g. cost-effectiveness, cost-utility, cost-benefit, cost minimization) 
also make the comparison of effect sizes currently not possible, so we urge caution when incorporating 
effect size weighting. For economic studies where the cost setting is similar, with low variability across 
resource use or clinical practice, and the economic outcome measure is the same, effect size weighting 
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may be appropriate. If only effect size data for clinical effectiveness is available, it is not suggested to 
conduct effect size weighting for the health benefit without a similar effect size weighting for the cost 
benefit. Such an approach, while incorporating more information for health benefit analysis, will render 
an unbalanced weighting approach towards the overall interpretation of dominance levels. 
 
Another consideration to incorporating effect size weighting factor is that outlying studies in a meta-
analysis would skew the dominance ranking score towards such studies. Unless the causes for the 
outlying effect can be explained, such outliers should be viewed with caution and be justified if included.  
 
Methodological quality weighting factor 
For methodological quality weighting, the quality score assigned to a study after critical appraisal would 
depend on the appraisal tool used. There are various appraisal tools available and some of these tools 
are scales or checklists. For checklists, there is usually no scoring mechanism reported for these tools 
and to obtain a summary quality score, review authors would need to apply their own scoring 
mechanism. Even for tools that are scales, there is also debate on the validity of the summary quality 
score.8 Although incorporation of the quality weighting in the dominance ranking score is independent 
of the tools, because of the subjective nature of quality scores, review authors ought to exercise caution 
when applying the quality weighting. To add credibility and reliability, it is suggested that the scoring 
matrix be made clear in the systematic review and, preferably, be pre-specified in a review protocol. 
There should also be two appraisers to rate a study and the quality score be averaged for use in the 
dominance ranking score.  
 
Sample size weighting factor 
The dominance ranking score is flexible to allow multiple weighting factors to be incorporated. However, 
reviewers might wish to limit their weighting factors and only incorporate those factors that are most 
relevant to their review. Given that effect size and methodological quality weightings have their 
limitations and are to be used with caution, we would recommend that sample size weighting be the 
preferred weighting factor. Sample sizes are usually reported (unlike economic effect sizes) and can be 
easily extracted from studies. It is also a form of objective data, in that it is not subject to interpretation 





It is important to note that the weightings are associated with a benefit value (-1, 0, +1) which is, itself, 
a categorical expression of the direction of dominance. As such, it may not be appropriate to have too 
many weighting factors, as the starting point (i.e. the benefit value) is not a precise measure of 
dominance level. For example, in the scenario that all studies in a review have lower intervention cost 
outcome than control, this will mean that the cost benefit values assigned would all be -1. In such a 
case, regardless of the weightings, the calculated cost dominance level would always be -1. Hence the 
dominance ranking score is useful when studies have heterogeneous benefit values and can help to 
better differentiate the dominance level. The dominance ranking score is also useful when the 
hierarchical decision matrix shows an unclear interpretation (such as equal number of studies in each 
band).  
 
Extending the hierarchical decision matrix 
In no sense do we claim that the dominance ranking score is able to perform a quantitative meta-
analysis of economic data or that the hierarchical decision matrix is irrelevant. We merely extend the 
hierarchical decision matrix tool to have more differentiating information incorporated into it and thereby 
enable a more informed analysis of dominance levels to be performed. In fact, we suggest reviewers 
conduct a review tabulation using the hierarchical decision matrix and then supplement their analysis 
with the dominance ranking score. 
 
We also recognize that for decision making, good quality economic trials or models that represent the 
specific context of the healthcare system is necessary. However, the proposed dominance ranking 
score and the associated hierarchical decision matrix are still useful when evaluating partial economic 
studies, such as studies with only cost minimization data. Such cost minimization studies are usually 
conducted for emergent research areas where basic economic data is collected, in parallel to a trial on 
clinical effectiveness. On this spectrum of rudimentary economic studies, we see a role for the 
hierarchical decision matrix and the dominance ranking score to provide some degree of dominance 
analysis. Through such a ‘pilot’ analysis, it could indicate the level of economic potential and pave the 




Sub-weighting of weighting factors 
If the use of multiple weighting factors is appropriate, it is possible to further weight each individual 
weighting factor, such that one can assign more priority to a certain factor. For example, if 
methodological quality is more relevant to a review, the methodological quality weighting can be given 
a higher weight. This will shift the direction of the dominance ranking score towards studies that have 
better methodological quality. If such further sub-weights are adopted, it is suggested that justifications 
for the levels of sub-weightings be reported and that these sub-weights be consistently applied for both 
cost and health benefit calculations. The sum of the sub-weights should always add up to 1. 
 
Conclusion 
For economic systematic reviews there is currently no agreed-upon quantitative method to obtain a 
pooled economic effect size. With no suitable quantitative method available, the hierarchical decision 
matrix stands out as a tool that enables a visual summary of different types of economic studies. 
Extending the hierarchical decision matrix with a weighted scoring system (termed dominance ranking 
score) allows for useful information of a study design to be incorporated and enables a more 
differentiating analysis of dominance levels.  
 
Various study characteristics can be incorporated via weighting factors in the dominance ranking score, 
although the appropriate use of each weighting factor needs to be considered. In this paper, we have 
incorporated weights based on factors that we deem are relevant to most reviews, namely: sample size, 
effect size and methodological quality of studies. Given that effect size and methodological quality 
weightings have their limitations, we would recommend that sample size weighting be the preferred 
weighting factor, as sample sizes are usually reported and are a more objective form of data. 
 
For systematic reviews that include partial economic studies, we see a role for the hierarchical decision 
matrix and the dominance ranking score to provide some degree of dominance analysis, which would 
otherwise not be possible. This analysis could improve the utility of such reviews by indicating the level 
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A qualitative descriptive study was conducted to interview stroke therapists about their 
experiences and interactions with robotic rehabilitation.  Perspectives pertaining to the clinical, 
human behavioural and organizational factors of adopting robotic stroke rehabilitation into 
clinical settings were examined in order to inform rehabilitation clinicians about the various 
aspects of adopting and integrating robotic stroke therapy into clinical settings. Overall, we 
found that a structured plan addressing various factors was necessary, and that both therapist 
attitude and device benefit worked together to shape the motivations of therapists to adopt 
robotics. It would be worthwhile to have an adoption plan that actively generated positive 
attitudes and expounded the benefits of robotic training, and that the plan be well thought-
through and be all-encompassing. We hope that findings of this study would assist to inform 





One of the main goals in stroke rehabilitation is the restoration of motor skills and this involves 
the patient undergoing repetitive, high intensity, task-specific exercises that enables them to 
regain their motor movements and functional abilities.1,2 Over the years, a number of robotic 
devices have been developed to assist therapists to rehabilitate patients, and these devices are 
complex in nature involving interactive automation, sensors and dynamic control logic to 
enable patients to keep repeating their exercises over long periods, without much intervention 
from therapists. There are two main types of robotic devices: exoskeletons and end-effectors. 
Exoskeletons are devices that wrap around limbs and are able to assist each limb joint to move, 
while end-effectors are devices that assist only the extremities of a limb (either hands or feet).3 
Regardless of design mechanism, one key feature of robotic devices is the ability to 
automatically assist patients to move their limbs when they are unable to do so by themselves. 
Conventional therapy, on the other hand, is labour-intensive in nature and places physical strain 
on therapists,3 and it is hoped that with robotic devices improved rehabilitation progress can be 
achieved for patients, such that therapists could offer appropriate levels of personalized 
treatment for patients and increase their efficiency.3 
 
The end goal of rehabilitation is to improve the functional ability of patients.4 For physical 
disability, this requires gradual training of minimal movements then progressing to more 
complex functional actions. Depending on patient needs, rehabilitation can be a multi-
disciplinary approach, involving not just physical/occupational therapists but also speech and 
cognitive therapists.5 There are also various types of robotic devices with different 
functionalities, adding to the complexity of adopting robotic rehabilitation.6 The complexity of 
interaction between these multiple rehabilitation disciplines and types of devices raises 
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questions on implementation, such as how therapists can work with robotics to improve 
rehabilitation outcomes of patients. 
 
Robotic devices also do not work alone but are part of a wider spectrum of clinical care that 
involves clinicians, patients and hospital administrators. This interconnection to other parties 
could affect adoption into a clinical setting in various ways. For example, what would be the 
work scope of therapists when robotic devices are doing the rehabilitation? How would patients 
respond to robotic treatment that has less human contact? What are the optimal treatment 
protocols for a rehabilitation unit that has both therapists and robotic devices? The presence of 
robotic devices could change the way clinicians work and how patients are handled in a 
rehabilitation unit. However, the clinical, human behavioural and organisational dimensions 
can present challenges to the adoption of robotic devices. 
 
A recent paper discussed the limits of robotic stroke rehabilitation and identified barriers such 
as technological, behavioural, organizational, and economic factors.7 While the paper 
identified the broad ranging considerations that goes into adoption, no interviews were 
conducted to obtain direct perspectives from stroke therapists who work with robotic 
rehabilitation devices. Another paper8 approached the topic of technology adoption with the 
aim of identifying priorities for the development of assistive stroke rehabilitation technologies 
and generating ideas to improve its adoption. However, the focus of this paper was broad and 
did not specifically consider adoption of robotic stroke rehabilitation devices in the context of 
a clinical setting.3 With a need for more primary research into the adoption of robotic 
rehabilitation for stroke patients, the aim of this study was to interview clinical therapists 
involved with robotic rehabilitation in order to understand how clinicians experienced robotic 
training and its relationship to conventional therapy, what factors to consider when introducing 
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robotic devices into clinical settings, and how best to conduct robotic training. Through the 
data gathered, we seek to inform rehabilitation clinicians and clinical managers about the 
various aspects of adopting and integrating robotic stroke rehabilitation into clinical settings. 
Methods 
Design of study 
The study applied a qualitative description design,9 which involved the identification of 
findings that was close to the data, with minimal transformation (i.e. with little imputation of 
meaning by researchers).9 This descriptive analysis approach enabled us to identify and extract 
data that described specific adoption considerations, such as what worked/did not work as 
expressed by participants, i.e. manifest context is described with low interpretation of data.9 
We used qualitative description as it allowed us to understand the actual nature of the situations 
faced by those involved, thereby giving us a sharper resolution of the events that were being 
encountered on the ground, without any loss of details or contextual meaning.9 Data collection 
involved interviewing therapists who worked with robotic devices in clinical settings that 
provided rehabilitation services to adult patients. The semi-structured interview format offered 
not only allowed us tap into their knowledge, past experiences and learning points, but also 
enabled the collection of further information to uncover and probe deeper into specific points 
during the interviews. From the data collected, qualitative descriptive analysis was used to 
inductively identify codes, categories and central themes.  
 
Participants 
Purposive sampling10 was used to recruit interview participants. In terms of sample size, as 
qualitative studies were exploratory in nature and not hypothesis testing, the participants were 
selected based on criteria that could best contribute to the research aim, and not based on certain 
participant sizes which were statistically representative.11 In addition, the therapists 
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interviewed were all very experienced in robotic rehabilitation and thus had higher information 
power, which states that a study can have less extensive sample participants when these 
participants have characteristics that are highly relevant and specific for the study aim.12 
Inclusion criteria were physiotherapists, and occupational therapists involved in adult 
rehabilitation units with robotic training devices. As we sought a broader perspective on robotic 
rehabilitation, the participants were geographically distributed across Asia, Australia, Europe, 
and the United States. Altogether we interviewed eight therapists from five hospitals across the 
above regions.  
 
Data collection 
The interviews lasted from 45 to 100 minutes and were conducted from October 2017 to 
February 2018. Data collection was primarily directed toward discovering the who, what and 
why of events and experiences, and involved one-to-one interviews with participants. For 
participants based in Australia, interviews were conducted either face-to-face at the 
rehabilitation hospital or over phone, and for participants based internationally, online 
communication media [such as Skype® (Skype Communications SARL)] was used. All 
interviews were audio recorded and transcribed verbatim. At the beginning of the interview, 
warm up questions related to demographics and establishing an understanding of the specific 
clinical settings were used. This was followed by questions on their robotic rehabilitation 
programs and therapy experiences. The list of interview questions was piloted by co-authors 
and is included under Appendix 1. 
 
Data analysis 
The method guiding the data analysis was qualitative descriptive analysis, which involved the 
identification of findings that were close to the data.9  Following the interviews, the recorded 
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data was transcribed then reviewed and coded using QDA Miner Lite® (Provalis Research). 
From the transcripts, the authors identified various concepts and arranged similar concepts into 
codes. The codes were then sorted based on their relationships and linkages into higher level 
categories. From these categories, central themes were inductively derived. Numerous readings 
of the transcripts and discussions among the authors were necessary to reach consensus on the 
coding and category structure.  
 
Researcher influence 
A reflexivity approach was taken during data collection and analysis stages in order to ensure 
an adequate balance between objective and purposeful analysis, as opposed to self-indulgent, 
personal analysis.13-15 Findings were reported as they were presented by the participants, and 
discussed observations flowed directly from the findings. In addition, all findings and 
observations were jointly reviewed among the primary and co-authors who have clinical 
backgrounds and are experienced in conducting qualitative research. In this study, all 
participants were not known to any of the authors until the day of interview. This provided a 
measure of independent feedback to our interview questions, as there were no relational 
elements which could influence the findings. During the interviews, the primary author asked 
the same questions in the same sequence to each participant, although in some cases where 
interesting aspects were raised, the primary author would ask additional questions in order to 
better understand and interpret the context of a particular feedback. Although the intention was 
to gain a deeper and clearer understanding, this could potentially lead to some influence on the 
responses provided by participants. 
 
Ethical considerations 
This research was approved by the University of Adelaide Human Research Ethics Committees 
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and all participants provided informed written consent to be interviewed (approval number H-
2017-151). Anonymity and confidentiality of findings were maintained by assigning codes to 
the participants, and participants also received their own individual transcripts to verify the 
authenticity of the raw data. 
Results 
Demographics 
The eight interview participants from five hospitals were all rehabilitation therapists who had 
worked with adult patients using robotic devices. Seven of the participants were based at public 
hospitals (funded via national budgets, private insurances, or a mix of both), and one was based 
at a private hospital (receives both in-country and international patients). Except for the private 
hospital which specialized in rehabilitation, the other four hospitals were large general 
hospitals. Four of the eight participants were recruited from a single hospital, as the hospital 
was undergoing transition during the interview period, and there was a need to interview further 
participants to understand the rehabilitation practices before and after the transition. 
 
The average rehabilitation experience of the participants was around 12 years, of which an 
average of 5 years was with robotic rehabilitation. In terms of the number of rehabilitation in-
patients treated per month, the private hospital treated around 15 patients, while three other 
hospitals treated on average 45 patients per month. One public hospital treated around 2500 
rehabilitation patients per month (both in- and out-patients). Except for the private hospital 
which had 20 beds, three public hospitals had on average 50 beds for inpatient rehabilitation 
(the public hospital that treated 2500 patients did not indicate its number of beds). Two 
hospitals had mainly stroke patients, while the other three hospitals treated patients with 
various neurological conditions such as stroke, spinal cord injury, multiple sclerosis, brain 
tumours and traumatic brain injuries. The average age of in-patients at four hospitals was 
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around 60 years old, while at the private hospital it ranged from 40 to 60 years. In terms of 
robotic equipment, three hospitals had robotic devices for upper and lower limb training, while 
two hospitals had upper limb robotic devices only. 
 
Study findings 
Three main themes emerged from the study findings: clinical considerations, benefits of robotic 
training, and robotic improvements. Figure 1 provides an overview of the themes and their 
associated categories. In the following sections, we describe and illustrate the main findings 
under these themes and categories with relevant participant quotes. For a detailed listing of all 
the codes and their associated participant quotes, the authors are able to provide a 
supplementary data sheet upon request. 
 
Figure 1: Organization of themes and categories 
 
To maintain anonymity, the eight participants were assigned codes from A to H, and to reflect 
their clinical backgrounds, we have used the abbreviations: “OT” (denoting occupational 
therapist) and “PT” (denoting physiotherapist). However, it is to be noted that some participants 
have clinical managerial responsibilities and provided more organizationally focused 
responses. 
 
Theme: Clinical Considerations 
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This theme covered aspects regarding the interactions, opinions and experiences of therapists 
and patients, in the context of the rehabilitation service program. The theme was informed by 
three categories: robotic rehabilitation program, robotic treatment protocol, and frontline views 
of robotic rehabilitation. The category “robotic rehabilitation program” encompassed codes 
pertaining to the organizational aspects of robotic rehabilitation program (i.e. how to adopt 
robotic rehabilitation? What were the various factors to consider?). The category “robotic 
treatment protocol” described the treatment protocol for robotic training (i.e. how was robotic 
training conducted? What was the patient inclusion criteria?), and the category “frontline views 
of robotic rehabilitation” detailed the attitudes and opinions of therapists towards robotic 
rehabilitation, and the training experiences of patients (as narrated by therapists). Figure 2 
illustrates the organization of the theme “clinical considerations”, and its associated categories 
and codes. 
 
Figure 2: Organization of theme “clinical considerations”, its categories and codes 
 
Category: Robotic rehabilitation program 
Under this category, there were nine codes pertaining to organizational considerations when 
introducing robotic rehabilitation into clinical settings (see Figure 2). These codes were 
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associated with different aspects of rehabilitation program planning, delivery and financing. 
Some experiences included therapists being given a robotic device with no organizational 
support for integration into existing rehabilitation services, with one interviewee noting:   
 
“The medical team, actually, acquired it for us, … and told us that we've got 
it. And then it was our responsibility to get trained in it, train everyone else 
up in using it and to make sure that it is used as much as possible.” [D/OT] 
 
The lack of adequate pre-implementation planning to ensure staff and systems were in place 
also led to increased stress levels and decreased motivation to enable robotic training. 
Participants indicated that the ad-hoc implementation of robotics was leading to sub-optimal 
rehabilitation. There were also practical barriers when robotics was introduced without 
consideration for patient transfers within the organization, distances from ward to the robotic 
devices, and sufficient physical space. In one hospital, the robotic device was initially placed 
near the inpatient ward, but after some time, it was relocated away from the ward, which led to 
a decline in usage. Location and space considerations were often overlooked in the 
implementation but yet had an impact on the organization and delivery (scheduling) of care. 
 
“I've faced a lot of the challenges for…making sure patients are ready, on 
time, toileted, dressed and getting here. Essentially, I have done the running 
around to do that and driven myself crazy doing that. Because those systems 
aren't in place and it's very intensive.” [F/PT] 
 
The funding arrangements for robotic training also played a part in determining the patient 
inclusion criteria for robotic rehabilitation. In one of the hospitals, conventional therapy was 
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subsidized by a national health insurance plan, but robotic therapy was not. This affected which 
patients had access to the robotic training. Instead of a needs-based approach, patients who 
could afford the more expensive robotic therapy had access to it.  
 
“… the services of robotic devices are not covered by the national health 
insurance and that makes the price of robotic gait training services much 
higher than conventional.” [H/PT] 
 
Category: Robotic treatment protocol 
This second category for the theme of Clinical Considerations included six codes that 
illustrated how robotic training was conducted in terms of patient inclusion criteria, duration 
(dosage) of robotic therapy, and setup and supervision of robotic training. From the interviews, 
we found that robotics seemed to be the preferred treatment option for patients with severe 
impairments. 
 
“If they can't move, then they shouldn't be on the ‘arm-weight supported 
device’. They should be on the ‘powered robotic device’.” [D/OT] 
 
In terms of the dose of a robotic therapy session, we found that an upper limb training session 
lasted either 30 or 60 minutes, while for lower limb training it was either 45 or 60 minutes. 
Within each session, the amount of exercise time was inversely proportional to the impairment 
levels of patients. There was also variation in terms of the number of robotic therapy sessions 
per week for a patient. Some hospitals scheduled two robotic sessions per patient over a week 




The staffing, resources and time needed to set-up a patient also varied between robotic lower 
and upper limb training. The set-up took longer for lower limb devices, as the patient had to be 
transferred from a wheelchair onto the device and be secured into a body-weight support 
harness. Generally, the participants mentioned that the time for the initial set-up and down a 
patient in an upper limb device was around 10 to 15 minutes; while for lower limb devices, it 
was around 15 to 20 minutes. There was also a difference in the number of staff needed for 
robotic setup between upper and lower limb devices. For upper limb robotics, one staff was 
required as such devices did not require physical patient transfer to a body-weight support 
harness; while for lower limb two were needed. Some hospitals had assistants that worked 
alongside therapists but the training parameters during setup were still determined by the 
therapists, due to the need for clinical reasoning in evaluating the progress of a patient. 
 
“All therapy exercises and the degree of difficulty is set by the therapist. 
That's why, the therapist has to review it every week.” [C/OT] 
 
After setup, some participants mentioned that there was no need for a qualified therapist to 
monitor the patient performing the exercise; that such a task could be assigned to a therapist 
aid who need not have a clinical degree. However, not all participants shared this view. Some 
thought that it was necessary for a therapist to be around to monitor the patient performing the 
exercises and provide training guidance. 
 
“But then after the initial setup, the COTA (Certified Occupational 
Therapist Assistants) can end up helping to carry out the program.” [B/PT] 
 
“We thought about a rehab aid being able to do that after I set it up but, I'm 
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not speaking for all robotics, I'm just speaking specifically for the (upper 
limb device). I think you need someone knowledgeable there to observe the 
session.” [G/OT] 
 
On maximizing patients’ training during the robotic exercise, participants shared on several 
training tips, ranging from encouraging patients to participate actively in the training, 
discouraging compensatory movements of patients, and to challenging the limits of patients.  
 
“Obviously, we hope patients improve, maybe every session, maybe every 
week, you're always trying to bring those parameters down to make it harder 
as they improve, if you can.” [F/PT] 
 
Category: Frontline views of robotic rehabilitation 
The third category, consisting of two key codes, described how therapists perceived robotic 
rehabilitation in relation to existing conventional training, their own abilities and work 
attitudes, and narrated the robotic training experiences of patients as a core aspect of the clinical 
considerations in adoption of robotic rehabilitation. 
 
Viewpoints of therapists 
The participants perceived robotic training as one of many treatment options, that robotic 
training was supplemental to existing conventional training as a way to increase training 
repetitions. Participants also viewed robotic training as a lead-in for patients to ultimately 
achieve functional outcomes. 
 
“They complement. I would never use it as the sole means of treatment. I 
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think it helps to increase the repetitions and therefore maybe the intensity 
and overall really the dose. We're looking at dose.” [D/OT] 
 
The way robotic training was organized affected how some of therapists at this hospital saw 
themselves professionally. Some therapists did not have a sense of patient ownership and felt 
that they were no longer clinicians. 
 
“You become a technician and we're not technicians, we're clinicians who 
use our clinical reasoning.” [E/PT] 
 
In relation to their own abilities, therapists felt that it required skill to use robotic devices well, 
but on the other hand, that they could also lose their conventional therapy skills depending on 
the amount of time they spent with robotics. The respondents also shared a mix of positive and 
negative attitudes towards robotic training. The positive attitudes stemmed from the fact that 
therapists did not view robotics as a threat to their job; instead participants recognized the need 
for a therapist to be involved during robotics training. Some participants even commented that 
robotics helped fill gaps in conventional training. 
 
“Because you will lose your physio skill as well, if you're just on the robot 
the whole time. You still need to be able to do some sort of clinical work, 
so that you're not losing skill and you want to continue to upskill as well.” 
[E/PT] 
 
Training experiences of patients 
Participants shared a spectrum of positive and negative experiences that had been related by 
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their patients. On the positive side, the patients enjoyed the training, felt that it was beneficial, 
and were motivated by the animated training games. This beneficial view of robotics, in turn, 
motivated patients to want more robotic training. Interestingly, seeing the motivated patient 
exercising also created a positive work experience for therapists. 
 
“Patients would definitely comment to us that: “Oh, it's just so nice to be up 
and walking.” And even though they are not doing it themselves, completely 
obviously, it's just so nice for them to be out of bed, out of the chair and 
upright and doing something, you know, walk and walking.” [F/PT] 
 
Another aspect of robotic devices that helped to motivate patients was the ability to keep score 
and display analytic data on exercise movements. Some patients were motivated by having a 
deeper understanding of how they performed during the robotic exercise. 
 
However, a number of patients experienced discomfort when using robotic devices. For lower 
limb robotic training, this mainly involved the body-weight support harness, as it exerts 
pressure in the groin region. For both upper and lower limb devices, the cuffs that secured the 
frame of robotic devices onto limbs were also a source of discomfort. Such discomfort could 
be amplified for patients, due to hypersensitivity after a stroke incident. Overall, despite these 
discomforts, there were no safety concerns for patients. Other negative experiences were that 
patients felt exhausted after a robotic training session, they found the number of games limited, 
and for a small number that they were unable to move in tune with the robotics. Due to such 





“It's becomes not that effective because what we call 'fighting with it'. As I 
said, the machine moves in this pattern, in this time, and there's no change 
to that. If they don't join in with that, it's not helping their therapies…We 
had a few that we actually had to say: "You know what, this isn't the right 
therapy for them" because of that reason.” [F/PT] 
 
Theme: Benefits of robotic training 
The second theme identified through this study described the returns that patients gain from 
receiving robotic training, and the benefits to therapists from using robotics to conduct 
rehabilitation training. The theme was developed from two categories: ‘for patients’ and ‘for 
therapists’, in order to illustrate the specific benefits experienced by each of the two main user 
groups. Figure 3 illustrates the organization of the theme and its associated categories and 
codes. 
 
Figure 3: Organization of theme “benefits of robotic training”, its categories and codes 
 
Category: For patients 
With robotic rehabilitation, patients were able to have a higher intensity of training with more 
repetitions, which provided a cardio-vascular work out that was safe and engaging (through 
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interactive games). All this helped patients to have a better recovery. 
 
“People would perform far greater number of steps on the robotic than they 
would in conventional physiotherapy.” [F/PT] 
 
The robotic devices also enabled a better quality of motor movement for patients. The upper 
limb devices enabled patients to focus on improving their motor movements, without being 
impeded by the weight of their weakened arms. For lower limb devices, patients had a more 
physiologically correct walking pattern. 
 
“In terms of the quality of the gait, after stroke patients often have very 
asymmetrical type gait patterns. The ‘lower limb device’ takes them through 
a somewhat normal walking pattern, you've got that symmetry between step 
length, between cadence, timings and things like that.” [E/PT] 
 
Interestingly, as patients did not need to rely on cues from therapists during robotic training, 
they had more confidence and actively exerted their limbs, without expecting the therapists to 
help them. 
 
“And because it (i.e. conventional therapy) was hands-on, therapists; 
patients really were not confident in what part of it they were doing and 
what part of it the therapist was doing. And they were relying on the 
therapists to give them that feedback.” [D/OT] 
 
Category: For therapists 
18 
 
One of the main benefits for therapists was that they experienced less physical strain when 
using robotic devices to perform rehabilitation training, as the devices took over the task of 
supporting the limbs of patients. 
 
“Manual handling, sort of that active assisted ranging, functional tasks were 
very burdensome for the therapist. The load of holding the arms and doing 
all of that sort of stuff.” [D/OT] 
 
Robotics also offered a range of other benefits, such as enabling therapists to start rehabilitation 
early, and helping to progress their patients towards functional training. The ease of adjusting 
the training parameters also permitted therapists to adapt robotic training to suit the abilities of 
patients, where therapists could safely challenge patients to their limits. As the robotic devices 
could record various training parameters, therapists had accurate, up-to-date data to assess the 
progress of patients.  
 
Therapists also had more confidence to treat severely impaired patients, which needed a fair 
amount of clinical experience in order to recognize deficits and prescribe the right type of 
training. Because the robotic devices could finely calibrate a patient’s range of motion during 
the initial setup, this assisted therapists to determine the training needed. 
 
“And they're like: well, actually they (i.e. patients) have got this, that and 
they (i.e. therapists) just haven't been able to know how to look for, how to 
set a patient up to get an analysis of that movement. Whereas the robotic is 




Theme: Robotic improvements 
From the interviews, we received a number of suggestions for device manufacturers to improve 
the robotic devices. These suggestions pertained to various aspects of the devices: interactive 
games, design of the devices, user training and technical support. Figure 4 shows the categories 
and codes under this theme. 
 
Figure 4: Organization of theme “robotic improvements”, its categories and codes 
 
Category: Interactive games 
Therapists commented that they needed to adjust the game training parameters in order to 
customize the exercises for individual patients. Other improvements were related to the 
functionalities of the games, that games should reflect the real-world use of limbs. There was 
also a need to have more sophisticated game graphics that matched existing computer games. 
 
“They (i.e. manufacturers) try and make them (i.e. games) functional, to be 
honest, I don't think they're as functional as they can be.” [D/OT] 
 
Category: Robotic device design 
Some patients found the upper limb devices hard to move, even though active assistance was 





Targeting both distal and proximal parts of the upper limb was necessary to provide a holistic 
training. However the upper limb robotic devices used by the therapists did not include training 
appendages for the hand.  
 
“You don't use the hand for any (robotic exercise) activities. At the end you 
have one of the most important or the most important part of the arm 
neglected. It is the part that you need for all functional activities, you need 
to use the hand for grasping, opening, everything.” [A/OT] 
 
Category: User training 
To help therapists understand how to best use the device for patients with different levels and 
types of impairments, user training should identify which training exercises/games would 
facilitate what types of rehabilitation goals.  
 
“…when the people from the different companies they come, they tell you 
how to use the devices but very general way. They mainly tell you the safety 
information but they are not really clinicians. Normally they don't know too 
much about therapy. At the end you have to find yourself the way to use the 
devices with different patients.” [A/OT] 
 
The model of user training also affected the adoption and usage of robotic devices, for example 
a train-the-trainers model would facilitate the usage of the devices, as trainers could 




Category: Technical support 
Without accessible technical support, the onus was on therapist to trouble-shoot issues that 
came up. This could hinder the adoption of robotics and would be a relevant aspect for suppliers 
to consider. 
 
“We're having to spend time out of our clinical day trying to fix the 
problems. That is a negative in that it is sometimes quite burdensome to try 
and overcome some of the problems that come up with it and it's just the 
general wear and tear that comes with the use of them day to day.” [D/OT] 
 
Discussion 
We conducted a qualitative descriptive study to understand the clinical, human behavioural and 
organizational factors of adopting robotic rehabilitation in clinical settings. Our findings 
indicated that a structured plan was needed to adopt robotic training into an existing 
rehabilitation program, and such a plan would need to consider the factors of staff (capacity, 
capability and motivation), patient flow and transport, location and physical space of the 
robotic devices, financial funding model of robotic therapy, and availability of technical 
support. Not only does intra-coordination within the physical rehabilitation unit need to be 
considered, but also inter-disciplinary coordination between the rehabilitation unit and other 
hospital disciplines was needed. 
 
Robotics more suitable for severely impaired patients 
From the study, we found that powered robotic devices were the preferred treatment option for 
severely impaired patients. This could imply that such devices could be more for inpatient use, 
as inpatients usually have more severe impairments than outpatients.16 This findings is also 
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similar to the results from two quantitative systematic reviews conducted on robotic stroke 
rehabilitation, which found that robotic therapy produced better outcomes for more severely 
impaired patients.6,17,18 This could then imply that such powered robotic devices should ideally 
be located near to inpatient wards in order to facilitate patient preparations and transport. This 
may also make sense, as from our interviews we found that most of the patients for robotic 
devices came from acute inpatient care. Nevertheless, we are also mindful that this could be 
due to the funding arrangement, which provided inpatients with more access to robotic devices 
than outpatients. 
 
Although powered robotic devices could be more suitable for inpatients with severe 
impairments, this does not mean that non-powered robotic devices were not useful.19,20 From 
our interviews with therapists who work with upper limb impairments, we found that the 
powered upper limb devices were sometimes found by patients to be ‘heavy’, and that non-
powered devices with arm weight support was more suitable instead. Hence it could be ideal 
to co-locate all types of robotic devices (whether powered or non-powered, upper or lower 
limb) together, into a kind of robotic gym.21 This can also provide therapists and patients with 
more robotic training options. 
 
Robotic training protocol 
Setting up 
During the setting up of robotic devices, it is necessary that the therapist determines the training 
parameters, as this required clinical reasoning in evaluating the progress of a patient.22,23 
Regular reviews of patients’ progress are also necessary5 and, as the devices are able to record 
the training performance of patients, therapists should tap into such data to assist in evaluating 




In determining the durations of robotic training, therapists should take into account the time 
differences for setting up patients, which has also been alluded to in trials on robotic 
rehabilitation.24,25 From our study, due to the need for bodily transfer, we found that the amount 
of time for setting-up/down lower limb patients is longer than for upper limb patients, and the 
set-up time for the first therapy session is longer than subsequent sessions. Again, because of 
the body transfer, the setup for lower limb robotics requires two staff, whereas upper limb 
robotics require only one staff. 
 
Supervision of patients 
After patients have been setup, there were differing views on who should supervise patients 
while they trained. Some therapists mentioned that it was not necessary for a fully qualified 
therapist to be monitoring the patient throughout the training session, and that an assistant 
without a clinical degree would suffice. The clinical therapist would only need to be in close 
proximity to the patient. However some other therapists were of the view that it was necessary 
for a therapist to be present in order to observe the movements of patients and provide real-
time guidance to help patients perform better. Nevertheless, some participants also provided 
the feedback that it could be a more effective use of therapist resources if therapists could treat 
another patient whilst one patient was on robotic training. Such a “multi-patient tasking” 
concept has been tested in clinical trials, and these trials have demonstrated equivalent or better 
clinical and cost outcomes as compared to one-on-one conventional therapy.21,26 Hence it could 
be feasible for one therapist to simultaneously treat more than one patient.  
 
Robotic training dosage 
From the participants, we found that, in terms of the duration per training session, an upper 
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limb session lasted either 30 or 60 minutes, while a lower limb session was 45 or 60 minutes. 
There is still debate regarding the optimal duration of a robotic training session,27,28 but from 
studies included in systematic reviews conducted, most of the therapy durations were between 
20 to 90 minutes for upper limb training28 and 20 to 50 minutes for lower limb training.27 It is 
also recommended in a stroke clinical guideline to offer at least 45 minutes of rehabilitation 
training per therapy session.29 We believe our findings are within the ranges of these studies 
and the clinical guideline. 
 
It is also to note that the actual time that a patient spends on robotic training would be dependent 
on the patient’s impairment level.29 For more severe patients, they would tire faster due to 
general cardiovascular deconditioning post stroke and would need more rest breaks, which 
would reduce the amount of time they spend training. Hence, due to the time for setup and rest 
breaks, the effective training duration would be less than the allocated schedule. Taken 
together, in determining the duration of a robotic therapy session, therapists would need to 
consider the minimum amount of exercise time that a patient is required to have, while taking 
into account the time needed for setting patients up/down and rest breaks of patients.30 
Therapists should also note that, within the daily working hours, a shorter therapy duration 
would provide more training slots per day and hence more patients can train on the devices, 
which would improve the utility of the robotic devices. 
 
Another consideration to note is to align the duration of a therapy session between in- and out-
patients, which would facilitate the flexible booking of therapy sessions between both patient 
groups. As robotic devices are costly investments, it would make sense to offer such devices 
to both in- and out-patients in order to maximize the device usage. This would be in line with 
an economic systematic review, where the authors had found that the number of patients treated 
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during a single robotic session should be maximised in order to optimise the cost economics of 
robotic devices.31 
 
Therapists and robotics 
The way robotic therapy was structured affected the attitudes and motivations of therapists 
towards the robotic devices. In one hospital where robotic training was structured as a 
standalone service, into which in- and out-patents were referred, the therapist felt that the work 
was not rewarding. This could be caused by a number of factors. In such a standalone setup, 
the robotic therapist did not have an assigned patient load. They only provided robotic training 
but did not see how patients progressed overall. This lack of patient ownership and follow 
through from robotic training to other rehabilitation goals did not fulfil the provision of care to 
patients and the exercise of clinical judgment that therapists were trained to provide. This then 
subsequently led to a perception that they were not clinicians but were more like robotic 
technicians. That the therapist worked at a separate location from other therapists who were 
based at the inpatient wards, could also have contributed to this ‘non-clinician’ perception. 
Another associated finding was that such a standalone robotic model could affect the skills of 
therapists. While working full-time with the robotic devices enhanced their skills to use the 
robotic devices well and provide better robotic benefits to patients, it also reduced their 
conventional therapy skillsets over time. Conversely, if someone is not working regularly with 
the robotic devices, they would enhance their conventional skills but reduce their robotic skills. 
These findings regarding satisfaction and acceptability by clinicians have also been recognised 
as an important factor to consider in studies on adoption of robotic rehabilitaion.7,32 Therefore 
clinical managers should note the implications that a therapy model would have on staff 




The benefits that robotic devices offer should be explained to therapists not just by using 
evidence examples but also ‘lived’ experiences of patients who had progressed after robotic 
training. Therapists, upon directly seeing the patient benefits themselves, would be more 
motivated to adopt robotic rehabilitation. The use of ‘lived’ experience as a training approach 
has been shown to be useful and effective,33,34 and could enhance the acceptability of robotic 
rehabilitation by therapists. For hospitals where robotics was offered as part of a standard 
rehabilitation program, therapists should also take note not to neglect the human relational 
aspect of rehabilitation but remember to engage patients in a meaningful way, even though 
most of the therapy is performed by the devices. 
 
One barrier to the uptake of robotic devices was the capacity of therapists to learn new 
technologies, with a participant commenting that it was easier for newly recruited staff to adopt 
robotic devices when such use was already included into their job descriptions, i.e. that the use 
of robotic devices was facilitated when it was expected and determined upfront. It has been 
found that undergraduate education and a structured training curriculum are useful in learning 
new skills35,36 and by extending this principle further, it could be worthwhile to include robotic 
devices as a standard module in the undergraduate educational curriculum of therapists. This 
would enable future therapists to be familiar with robotic rehabilitation and facilitate the 
adoption of robotic therapy as a routine clinical practice. 
 
Patients and robotics 
To encourage usage by patients, it is necessary to understand how robotics motivate them. 
From our study, we found that when patients saw their impaired limbs moving (although they 
knew this was robotic assisted), they experienced a positive sense of recovery, which motivated 
them psychologically. Patients’ motivation was also augmented by the interactive games they 
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played as part of their training regimes. It was not just the animations but also that the games 
were scored. This score-keeping presented itself as a goal, and it was likely that patients 
associated higher scores with better limb movements. This then motivated patients to train 
more in order to improve their scores. Our finding is generally in line with the positive patient 
engagement effects of virtual interactive games that have been described in other studies, where 
virtual reality games have been shown to be particularly motivating, especially interactive 
games with functionally meaningful reactions to motor performance.37-39 However our finding 
on the positive effect of competitive score-keeping of games is in contrast to a study which 
found that competitive games did not increase patient engagement.37 
 
Patients should also be made aware that robotic training is an exhausting experience. This is 
due to therapists actively seeking patients to participate in each movement by constantly 
challenging them to their limits.25 If patients progress in their training, the level of robotic 
support would actually reduce in order to keep challenging them. 
 
Despite patients finding robotic devices beneficial, care should be taken that patients do not 
over emphasize the use of robotics and neglect other rehabilitation goals. Patients should be 
made aware that robotic training is one component of the overall rehabilitation treatment plan 
that includes conventional, speech, cognitive and other group/pool therapies, and that all 
components are equally important for their rehabilitation.4,29 It is also to note that a small 
number of patients would not be able to move in sync with the robotic assistive movements 
and would actually resist it. Such patients would not be suitable for robotic training and 
therapists would have to excuse them from robotic training. 
 
Manufacturers and robotics 
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The study uncovered suggested improvements for manufacturers of robotic devices. Several 
participants asked for the ability to customize game parameters, that they could adjust the game 
complexity as their patients improved. It is likely that therapists, given their clinical training, 
would like to able to exercise their clinical judgment in progressing a patient. This should be 
encouraged as it could lead to customized training exercises for each individual patient, which 
could potentially maximize the benefits that robotic devices could offer.39 
 
Additional feedback was to have more games that were functional in nature, and which 
mimicked real-life activities of patients. Currently some games were seen as being ‘gamey’, 
even though they served to illicit the desired locomotor movement. This observation is in line 
with a similar finding that games with functionally meaningful activities increased patient 
engagement.37 Another aspect related to the games is the sophistication of the game graphics. 
Computer games are nowadays very detailed with life-like graphics but in comparison the 
robotic game graphics are rudimentary, although the robotic devices themselves are complex 
machines.  
 
Motivation of therapists 
The adoption of robotic rehabilitation ultimately depends on the motivation of therapists to use 
the robotic devices, which in turn flows from their attitudes towards robotic devices and the 
benefits that robotics can offer. Hence, it would be worthwhile to have an adoption plan that 
actively generated positive attitudes and expounded the benefits of robotic training. A well 
thought-through adoption plan with seamless integration into existing settings would then 
sustain the motivations of therapists on a daily work basis. Therapists also need to be convinced 
of the benefits that robotics bring, not just the direct benefits to themselves (e.g. less physical 
strain) but also witnessing the benefits that their patients can gain. Manufacturers, through the 
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device functionalities and after-sales policies, also play a part in shaping the attitudes of 
therapists and the benefits that they experience. These organizational, user, vendor, and benefit-
related factors have been identified in studies on the adoption of generic healthcare 
technologies,40-42 and our study on robotic stroke rehabilitation have also uncovered these 
similar considerations. 
Study limitations 
Type of robotic devices 
Although most of the robotic rehabilitation devices that the hospitals had were of the 
exoskeleton type, we believed most of our findings still applied to robotic devices in general. 
However our findings on the amount of time and staff resources needed for setting up/down a 
patient, and certain aspects of patient training experiences (such as the discomfort of cuffs to 
secure the exoskeleton frame to patients, and the inability of patients to move in sync with the 
exoskeleton frame) would be more applicable to exoskeleton devices. 
 
Mainly acute inpatients 
The clinical therapists we interviewed worked mainly with acute inpatients, and this might 
have limited the scope of their answers to our questions, although we did not limit the therapist 
interviewees to any patient group. 
 
Only clinical participants 
Our interviews involved only clinical therapists and no patients were included, due to resource 
and time limitations on recruiting patients from different countries. While we did ask clinicians 
about patient experiences, the lack of direct data from patients might have reduced the validity 
of patients’ perspectives reported here and the level of insights that could have been gained. 
Despite this, we believe that therapists, as part of their professional therapeutic relations with 
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patients, would have provided bona fide and patient-centred insights. 
 
Generalizability to other healthcare settings 
Our findings would be more relevant for multi-discipline hospitals in an urban setting of higher 
socio-economic countries, given the profiles of the hospitals where the interviewed therapists 
worked. Having said this, we had interviewed only eight therapists from five hospitals, and this 
small number of participants and hospitals might not be representative of the hospital setting 
that we had postulated. Nevertheless, to maximize the generalizability of our findings, we have 
attempted to incorporate a global perspective on robotic rehabilitation via recruiting study 
participants in Asia, Australia, Europe, and the United States. This provided us with a broader 
perspective across various countries in different continents. Another point to note was that none 
of the hospital rehabilitation units treated solely stroke patients. Although two hospitals had 
mainly stroke patients, all hospitals had a mix of stroke and other neurological conditions such 
as spinal cord injury, multiple sclerosis, and traumatic brain injury. While the findings were 
not only related to stroke patients, the findings did reflect the real-world patient mix of 
rehabilitation units, which would enhance the external validity of the findings. 
Conclusion 
We had conducted a study to understand the various aspects of adopting robotic stroke 
rehabilitation in clinical settings. The study found that a structured plan addressing various 
factors (such as staff capacity, patient flow and transport, location and physical space of the 
robotic devices, financial funding model of robotic therapy, and availability of technical 
support from suppliers) needed to be in place in order to ensure the successful adoption of 
robotic rehabilitation in a multi-discipline hospital located in an urban setting. The study also 
examined the attitudes and views of therapists and patients (as expressed via their treating 
therapists) towards robotic rehabilitation, and discussed the benefits that robotic training 
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brought to these two user groups. Both therapist attitude and device benefit work together to 
shape the motivation of therapists to adopt robotics, and it would be worthwhile to have an 
adoption plan that actively generated positive attitudes and expounded the benefits of robotic 
training. Overall, an adoption plan needs to be well thought through and be all-encompassing, 
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Appendix 1 – Interview Questions 
1. Demographics & Clinical Setting 
 What is your occupation title? 
 How many years have you worked in stroke rehabilitation? 
 How many years have you worked with robotic rehabilitation devices? 
 Where is your hospital located (country, state, city)? 
 How many patients does the stroke rehabilitation unit handle per month? 
 How many clinicians are working at the stroke rehabilitation unit? 
 What types of robotic training (upper limb, lower limb) are offered at your unit? 
 What are the makes and models of the robotic devices? 
 
2. How is robotic therapy conducted? What are the differences when providing robotic 
training compared with providing conventional rehabilitation? 
 
3. To what extent do you think robotics could enhance or complement the work of therapists?  
o What are the major areas of potential for robotic rehabilitation training? 
 
4. What effects do robotic devices have on rehabilitation outcomes for patients? Why do you 
think it has that effect? 
 
5. Could you tell me about your stroke unit’s experience during the transition from 
conventional training to the current therapy program utilizing robotic devices? 
o What were the impacts on clinical care? Were there changes to the way clinicians 
worked and how patients are managed? 
 
6. What barriers were experienced when implementing robotics therapy? 
o What organisational, work, cultural, belief or behaviour-based barriers were 
encountered? 
o Has the introduction of robotics influenced staffing profiles within your unit? 
o Are staff generally open to or resistant to robotic therapy? 
 
7. Could you tell me about your perceptions of robotic therapy? 
o Can you expand on what attitudes and values influenced your perceptions? 
 
8. What feedback have you had from patients about their views or feelings when offered 
robotic therapy? Would you classify their experiences as generally positive, or generally 




Chapter Seven: Conclusion – Discussion of thesis 
findings and Conceptual Framework for 
implementation of Robotic Rehabilitation 
 
Aim of thesis 
Robotic rehabilitation in various formats and levels of technology has been offered to 
stroke patients since early 2000,37,38 in order to assist therapists to provide high intensity 
training which is required for recovery of stroke impairments. However, it is uncertain if 
robotic rehabilitation is effective, for which patient groups,39 or whether it is economically 
feasible.40 Methods for operationalisation and integration of robotic rehabilitation with 
other clinical services are also unclear.41 In view of these uncertainties, this thesis sought 
to answer the following research questions: 
1. Can robotic devices help adult stroke patients to regain motor movement of their 
upper and lower limbs?  
2. Can robotic devices rehabilitate adult stroke patients cost economically?  
3. What are the clinical views and experiences of utilizing robotic rehabilitation? 
What are the factors to consider when introducing robotic devices into the clinical 
care environment? 
4. How can findings from the effectiveness, economic cost and adoption studies be 
aggregated to create a conceptual framework for providing robotic rehabilitation? 
 
In the prior chapters, the first three questions have been examined, namely regarding 
the clinical effectiveness, economic cost effectiveness, and considerations involved with 
clinical adoption of robotic rehabilitation. In this concluding chapter, we seek to answer 
the final research question of the thesis, i.e. how to amalgamate the findings from the 
prior studies and to generate a conceptual framework that models integration of robotic 
rehabilitation services. However, before we delve into the conceptual framework, the 
implications and significance of the prior thesis findings are first discussed. This 
discussion would also provide the foreground information which is incorporated into the 
framework, and illustrate the reasoning for doing so. 
 





To investigate the clinical effectiveness of robotic rehabilitation among adult stroke 
patients, a systematic review which included 51 studies and 1,798 patients was 
conducted.42 The Joanna Briggs Institute (JBI) systematic review methodology has been 
applied in our research as it offers a robust method for finding and reviewing the available 
evidence, and to undertake meta-analyses of individual study results.32,43 Rehabilitation 
outcomes for both upper and lower limbs were examined, with 30 studies evaluating 
upper limb interventions and 21 studies evaluating lower limb gait training. Overall, the 
systematic review found that robotic training was just as effective as conventional 
physiotherapy for outcomes of upper limb motor movement, lower limb walking and 
activities of daily living. However, for severely impaired lower limb patients, robotic 
training was found to be more effective than conventional training.42 Previous systematic 
reviews on the clinical effectiveness of robotic rehabilitation devices for lower limb 
patients,44-46 found that robotic-assisted gait training increased the odds of participants 
becoming independent in walking, and for the sub-group of severely impaired patients 
the findings indicated that robotic treatment was more effective. In terms of upper limb 
outcomes, two systematic reviews found that robot-assisted arm training improved arm 
motor movement39,47 and activities of daily living scores.39 In our effectiveness 
systematic review, we found that robotic therapy was as effective as conventional 
therapy for both upper and lower limb patients, and we identified severely impaired lower 
limb patients as a key patient subgroup that would benefit from robotic rehabilitation. Our 
finding that robotic rehabilitation was more beneficial for patients with severe lower limb 
impairments is in concordance with previous systematic reviews, and in terms of the 
clinical significance, this could imply that lower limb patients should be treated using 
robotic gait training devices. However for patients with upper limb impairments, our 
finding is in contrast to the two other systematic reviews.39,47 These reviews had shown 
improvements in outcomes, but in our review both robotic and conventional therapies 
had equivalent outcomes. As explained in our published manuscript, this could be due 
to the method of data analysis. In the other systematic reviews, the authors had pooled 
together data from different intervention arms (containing robotic training, and robotic 
training that is combined with other interventions such as electroencephalography-based 
brain computer interface48 or functional electrical stimulation26) and compared it with the 
conventional training control arm. In our review, we only compared robotic interventions 
(without any concurrent therapy methods) with conventional therapy.  
 
Overall, the effectiveness systematic review of this thesis has contributed additional 
knowledge to the body of evidence regarding the clinical effectiveness of robotic 
rehabilitation for stroke patients, but for the sub-group of severely impaired lower limb 
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patients, our evidence assists to corroborate the findings of previously conducted 
systematic reviews. 
 
Economic cost effectiveness 
A systematic review of cost-related data was undertaken to examine the economic 
implications, which included a total of five studies with 213 patients.49 As with the 
effectiveness systematic review, the economic review methodology of JBI50,51 has been 
adopted for this project. The included studies compared the cost of providing robotic 
intervention against the cost of providing conventional therapy in dose-matched therapy 
sessions, and computed the cost measures in terms of cost/patient session or 
cost/patient. The review found that robotic therapy had better economic outcomes than 
conventional therapy. For patients with severe disability from significant stroke, in terms 
of the health benefit, a moderate preference favoring robotic therapy was found. 
However, in terms of the cost benefit, a strong preference for robotic intervention was 
found. Practice-wise, this may imply that robotic therapy could be prescribed for severely 
impaired adult stroke patients. That robotic intervention had better cost benefit for 
severely impaired patients might be due to the need for more one-to-one therapist time 
during conventional therapy in order to gain the same health benefits as robotic therapy. 
In conventional therapy, therapists manually support and exercise the impaired limbs of 
patients, which is physically demanding for therapists to sustain at high intensity, 
especially for severely impaired patients with minimal volitional movements.23 Robotic 
devices, on the other hand, were designed to specifically support the limbs and provide 
higher training repetitions.52 
 
Two factors which highly influence the economic cost benefits of robotic therapy (i.e. 
sensitivity factors) were also identified from our review: the number of patients that could 
be treated per robotic session and the time therapists spent with patients during a robotic 
session. If more patients could be treated per robotic session, then cost would decrease. 
Similarly, if less therapist involvement was needed during robotic training, then cost 
would decrease. Hence, to maximize the cost benefits of robotics in view of these 
sensitivity factors, healthcare providers might wish to increase the number of patients 
treated during a robotic therapy session, and minimize the involvement of therapists as 
far as possible, without compromising patient safety. 
 
While there have been individual economic studies on robotic rehabilitation,26,40,53-55 no 
economic systematic reviews were found during our literature review. This leads us to 
believe that the economic systematic review that has been conducted as part of the 
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thesis is the first such economic review on robotic rehabilitation. Since publishing our 
review report, there has been a number of requests from researchers based in Germany, 
Switzerland and France for our report. In this respect, we believe that our economic 
systematic review has generated new knowledge in terms of which patient sub-group 
would benefit from robotic training and the key sensitivity factors that impact the 
economic cost of robotics. 
 
Adoption of robotic rehabilitation 
Although robotic rehabilitation devices for adult stroke patients have been in use since 
year 2000,37,38 there is a lack of deeper research into the adoption and integration of 
robotic stroke rehabilitation in clinical settings. During our literature search, an article 
discussing factors that influence adoption was found, which identified that the successful 
usage of these robotic rehabilitation devices depends on several factors, such as clinical 
effectiveness, economic viability, human behavioral and organizational variables.41 
However no detailed information was provided in the article about these aspects, and 
there was no direct research conducted with users of robotic devices to gain their insights 
into these aspects. Hence, we believe that our qualitative adoption study assists to 
address this information gap. The adoption study uncovered original insights from 
therapists who work directly with robotics in clinical settings, detailing their motivations, 
benefits and attitudes towards robotic training, and understanding the barriers to 
adoption.  
 
The qualitative adoption study included semi-structured interviews with eight therapists 
from various countries (Australia, Taiwan, Switzerland and the United States).56 The 
methodology of qualitative descriptive analysis was applied for this study as it allowed 
us to understand the actual nature of the situations faced by those involved, thereby 
giving us a sharper resolution of the events that were being encountered on the ground, 
without any loss of details or contextual meaning,36 which then enabled the identification 
of specific adoption findings. Through our study, it was found that a structured plan 
addressing various aspects (such as staff capacity, patient flow and transport, funding 
mechanism, location and physical space of the robotic devices) was important to the 
successful adoption of robotic rehabilitation in a multi-discipline hospital setting. It was 
also found that therapists and patients generally had positive attitudes towards robotic 
training, and coupled with the benefits offered by the robotic devices, motivated them to 
use the devices. Ultimately, the adoption of robotic rehabilitation depends on the 
motivation of therapists to use the robotic devices, which in turn flows from their attitudes 
towards robotic devices and the benefits that robotics can offer. Therefore, it would be 
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worthwhile for healthcare providers who plan to introduce robotic rehabilitation to have 
an adoption plan that actively generated positive attitudes and expounded the benefits 
of robotic training. Such an adoption plan would also need to seamlessly integrate into 
existing settings in order to sustain the motivations of therapists on a daily work basis.  
 
Therapists also need to be convinced of the benefits that robotics bring, not just the 
direct benefits to themselves (e.g. less physical strain) but also witnessing the benefits 
that their patients can gain. The use of ‘lived’ experience as a training approach has 
been shown to be useful and effective.57,58 That this consideration has also been similarly 
uncovered by our study helps to validate our findings. 
 
These organizational, user, and benefit-related factors that have been identified in our 
study are similarly discussed and considered in studies on the adoption of generic 
healthcare technologies.59-61 In one of these studies,60 the authors presented a 
technology implementation model, which mapped out components influencing adoption, 
such as users (individuals who are impacted by the technology use: patients, clinicians, 
administrators), workflow (the steps of accomplishing a patient care task), interfacing 
systems (supplementary systems that interfaces or communicates with the new 
technology to be adopted), communication (strategies that influence adoption: education 
programs, change champions, audits), leadership (the roles of executives and managers 
to promote technology adoption), and economic environment (determinants such as 
government funding, political environment, business competition). Our study has also 
uncovered similar considerations, with many of our findings mirroring the components of 
users, workflow, interfacing systems, and communication. In the area of users, we 
uncovered the relationships and interconnections between the two main user groups of 
robotic devices: therapists and patients. That there is an interplay between them and the 
robotic devices which is influenced by their attitudes towards robotic devices and the 
benefits that they gain from using robotics. Eventually, this culminates in their 
motivations to use the devices, which would then reinforce their attitudes and benefits, 
thus creating a positive strengthening cycle. The findings on organisational aspects such 
as staff capacity, patient flow and transport, location and physical space of the robotic 
devices, and the need to integrate into existing settings reflect the components of 
workflow and interfacing systems. The need to convince therapists of the benefits of 
robotic rehabilitation in order to facilitate adoption mirrors principles of the 
communication component.  
 
Overall, that our study findings corroborate with these published studies on generic 
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technology adoption provides a measure of confidence to our analysis. Furthermore, our 
findings contribute to a deeper understanding regarding the specific technology adoption 
of robotic rehabilitation for stroke patients. 
 
Summary 
The over-arching aim of this thesis was to investigate the usefulness of robotic 
rehabilitation for adult stroke patients. Based on the findings of our research, we are 
judiciously confident to say that robotic rehabilitation is useful, that it is not only clinically 
effective but also economically cost effective, and especially for severely impaired lower 
limb patients robotic therapy provides better outcomes. While the clinical effect and 
economic cost aspects were reported in the systematic reviews (i.e. Chapters 2 and 4), 
the adoption study represents the more context-based dimensions, in that it sought to 
understand the usage of these robotic devices in daily clinical settings. The findings of 
this adoption study complement the effect and economic review studies, in the sense 
that it bridges the gap between evidence and translation into clinical practice. Such a 
bridge is important in order to fully realise, in a tangible and meaningful way at the 
coalface, the benefits that robotic rehabilitation can offer to users. Without this 
perspective, it will result in a gap between research evidence and the delivery of 
evidence-based care in routine practice.62,63 The adoption study uncovered a multitude 
of factors that need to be taken into consideration when introducing robotic rehabilitation 
into practice. These factors involve not just simply user training for these devices, but 
also aspects such as workflow processes, interfacing systems, communication 
strategies to influence adoption, perceived benefits, and attitudes and motivations of 
users. These host of considerations would need to be addressed when translating 
evidence into practice. 
 
Conceptual framework 
We have discussed the findings and implications of our studies on effectiveness, 
economic cost and adoption of robotic rehabilitation, which distilled the essence of the 
knowledge and understanding that have been gained through the thesis research. The 
three studies have each shed some light on the topic of robotic stroke rehabilitation. In 
an attempt to combine the knowledge from each of these studies into a coherent 
spectrum that is both practical and useful for evidence translation, a conceptual 
framework of implementing robotic rehabilitation was developed. Figure 1 illustrates the 





Figure 1: Conceptual framework to aid in the planning for robotic 
rehabilitation 
* Economic cost-sensitivity factors: number of patients treated per robotic session, and time 
involvement of therapist per robotic session 
ǂ The adoption of robotic rehabilitation depends on the motivations of therapists and patients to 
use the robotic devices, which flows from their attitudes towards robotic devices and the benefits 
that these devices offer. An adoption plan that actively generates positive attitudes and benefits 




The framework may assist administrators, managers and clinicians who are planning or 
managing the implementation of robotic rehabilitation into clinical services. It shows the 
various actors and concepts to consider; and illustrates the inter-connections and 
dependencies among these actor and concept elements.  
 
The framework is informed by the Joanna Briggs Institute conceptual model of Evidence-
Based Healthcare, which states that best practice occurs where current evidence is 
considered in conjunction with patient perspectives and local context.64,65 The integration 
of the three studies reported in this thesis, represents the bringing together of current 
evidence and stakeholder perspectives and thus demonstrates congruity with the JBI 
Model of Evidence-Based Healthcare. 
 
The “Evidence” block (Figure 1) informs the rest of the framework, particularly the actors 
who are critical for the planning and implementation of robotic rehabilitation, namely 
“Patients”, “Therapists” and “Organisation”. Encompassed within the “Evidence” block 
are the systematic review findings from the effectiveness and economic cost reviews, 
and the experiential findings from the qualitative adoption study with therapists who work 
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with robotic devices. From these findings, the evidence generated informs the context 
for the middle blocks of “Organisation” and “Outcomes”.  
 
In line with the JBI Model of Evidence-Based Healthcare (which states that healthcare 
practices is to be informed by the best available evidence, the context in which the care 
is delivered, the individual patient, and the professional judgment and expertise of the 
health professional), we grouped our findings into similar co-related blocks. To facilitate 
an easier-to-understand representation of the conceptual framework, we had chosen to 
group the findings into the two blocks of “Organisation” and “Outcomes”. “Organisation” 
encapsulates our findings that mirror the JBI Model of expertise and perspectives of 
stakeholders (i.e. patient and professional staff), and the local context of care delivery. 
The stakeholder and local context are closely intertwined to the healthcare organisation, 
in the sense that it is the organisation which employs the professional therapist staff and 
is also the physical location where patients receive treatments. The organisation is also 
the location where both therapists and patients interact with the robotic devices, and 
through these interactions a cascade of events follow based upon the nature and quality 
of the experience. Thus, organisation defines the context where rehabilitation care is 
delivered. Given the close links that these various factors had in connection with 
organisational attributes, these findings were grouped together under “Organisation”. 
“Outcomes” mirrors the best available evidence of the JBI Model. In our conceptual 
framework, “Outcomes” conveys the practice implications of the effectiveness and 
economic systematic reviews that had been conducted in this thesis. It presents the 
evidence base that seeks to inform healthcare professionals about the clinical practices 
of conducting robotic rehabilitation. In the following sections, further context about the 
two middle blocks are elaborated. 
 
In terms of “Organisation”, implementation considerations from this thesis pertaining to 
the organisational aspects of robotic rehabilitation indicate that robotic devices do not 
work alone but are part of a wider eco-system that involves linkages between various 
clinical departments (e.g. inpatient wards, outpatients, and other rehabilitation units such 
as pool therapy, group therapy), and also to other organisational domains such as 
patient transport, staff capacity and treatment protocols. This thesis found that both intra-
coordination within the rehabilitation unit and inter-coordination with other clinical 
disciplines are needed in order to have a smooth integration into practice. For example, 
patient scheduling, patient transport and location of the robotic devices would need to 
be addressed in order to bring patients to their treatment session on time, which would, 
in turn, affect the utilisation rate of the robotic devices. These findings are similar to the 
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concepts of workflow and interfacing systems that have been discussed earlier. 
Likewise, as one therapist commented in the adoption study, many organisational 
aspects need to be considered when adopting robotic rehabilitation. 
 
“All of them (i.e. adoption models) probably need to take into account 
the space and design of the layout, of where you position your device 
and the flow of getting patients on and off and how do you, depending 
on which model you choose, how do you best utilize that design, so 
that you're maximizing the efficiency of time. Whichever model you 
choose, basically, maintaining patient safety. If you want to take into 
account staff satisfaction, and obviously cost efficiency and things like 
that.” [Physiotherapist F] 
 
“But because of the historical way of working on the wards, this has 
not fitted in very well to those models. I think whilst the model for 
robotics can get looked at, I think, the model for inpatient therapy 
could get looked at, to better utilize the two things together and work 
out the best way to maximize both.” [Physiotherapist F] 
 
Other organisational aspects relating to staff capacity, staff training, robotic treatment 
protocols and funding mechanism (as elaborated in the adoption study) are also equally 
important. Clinical managers need to adequately educate their clinical staff about the 
evidence base of robotic training in order to gain their acceptance of robotic training. 
This approach is important as studies have shown that the use of evidence in training 
enables changes in knowledge, skills, attitudes, and behaviour, which leads to the 
uptake of new practices that benefit patients.66,67 Managers also need to recognise the 
differing capacities of staff to adopt new technologies, that some therapists would find it 
easier to pick up new technologies than others.  
 
“It would be very different if we were trying to ask our therapists, all of 
our therapists, to be efficient with it; especially it's like having 
somebody learn a new computer program if they already have 
difficulty with technology. Certain therapists aren't necessary going to 
pick up on some of the…are going to feel comfortable with learning 
and using some of the new technology. Change can be difficult 




How a robotic therapy session is structured is also an important consideration. The 
therapy training model affects the attitudes of therapists in terms of patient responsibility 
and ownership, therapists’ ability to exercise clinical judgement, and personal fulfilment 
when patient recovers. It also affects the clinical skills of therapists, that while therapists 
appreciate learning new robotic skills, they do not wish to lose their conventional therapy 
skills. For example, it was found from the adoption study that a stand-alone training 
model where in- and out-patients were referred to for robotic training resulted in the 
robotic therapist feeling like a technician, isolated from other therapists, and without 
clinical responsibility or job fulfilment. 
 
“You become a technician and we're not technicians, we're 
clinicians who use our clinical reasoning. We assess, we set goals 
and we come up with intervention.” [Physiotherapist E] 
 
“From a goal’s perspective and from a fulfillment perspective, you 
feel very much like a robotic technician. I'm just putting them on and 
setting their parameters, I'm just putting them on and setting their 
parameters.” [Physiotherapist F] 
 
Under “Outcomes” are the findings from the systematic reviews on clinical effectiveness 
and economic cost effectiveness, which seeks to inform therapists about the clinical 
aspects of implementing robotic rehabilitation. Based on our review findings, although 
robotic therapy is as effective as conventional stroke therapy, it particularly benefits 
patients with severe lower limb impairments. Economically, robotic therapy has better 
cost outcomes than conventional therapy and most benefits severely impaired patients. 
The identified economic sensitivity factors (i.e. number of patients per robotic therapy 
session, and the time spent by therapists for a robotic session) also serve to inform 
clinicians to structure their robotic therapy sessions while maximising the economic 
benefits of robotic rehabilitation. The review findings imply that robotic training would be 
more beneficial for inpatients who are usually more severely impaired having survived a 
recent stroke incident.68 As such, severe inpatients could be prioritised for robotic 
training. At the same time, clinical managers could also consider how robotic training is 
to be optimally conducted, in view of the economic sensitivity factors. 
 
On the same plane as “Organisation” and “Outcomes”, two other important actors 
include: “Therapists” and “Patients”. These were identified as critical to the model by 
virtue of their centrality to both implementation of robotics, and the direct relationship 
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between care delivery and patient outcomes. Associated with these two actors are the 
domains of “Attitudes/Benefits” and “Motivation”. From our adoption study, we found that 
the interactions of therapists and patients with the robotic devices shaped their attitudes 
and the benefits that they experienced from using the devices. The “Attitudes/Benefits” 
and “Motivation” icons were also influenced in part by “Organisation” and “Outcomes”. 
The organisation context (in terms of workflow, interfacing systems, and communication) 
would determine the work environment, which would then influence how attitudes are 
formulated, and how benefits are perceived and interpreted. As an example of the role 
that organisation context plays, from the adoption study, it was found that certain 
organisational problems (e.g. lack of internal coordination) led to frontline therapists 
feeling overwhelmed as they had to sort out by themselves the daily operational 
challenges of transporting patients on time to and from robotic rehabilitation sessions. 
This then negatively influenced their attitudes towards robotic therapy and the level of 
perceived benefits that these devices offer.  
 
“I've faced a lot of the challenges for, against the ward not, systems, 
not against people but systems of making sure patients are ready, on 
time, toileted, dressed and getting here. Essentially, I have done the 
running around to do that and driven myself crazy doing that. 
Because those systems aren't in place and it's very intensive.” 
[Physiotherapist F] 
 
The appropriate use of the evidence under “Outcomes” to guide robotic rehabilitation 
practices determines the effectiveness and utility of robotic training, which also 
subsequently influences the attitudes of users and the nature of benefits they receive.  
 
“They showed the clinicians the medical evidence to talk about how 
the robotic works and what kind of effects, benefits that both patients 
and therapists will get.” [Physiotherapist H] 
 
“If you don't see the benefit of using the device, you're not necessarily 
gonna make the effort to put your patients on there either. If you used 
the device enough, you can kind of see that patients can gain a lot 
from it and therefore you feel more motivated to put your patients, 




Hence to show the inter-dependencies among all these elements, the icons of 
“Attitudes/Benefits” and “Motivation” are overlaid across the plane of “Organisation” and 
“Outcomes”. 
 
The inter-connection between “Attitudes/Benefits” and “Motivation” of therapists and 
patients is best illustrated by the interplay that is found between attitudes, benefits and 
motivation from the findings of our adoption study. One of the main benefits experienced 
by patients was the ability to do more training repetitions in a stimulating environment, 
which was facilitated by the interactive games and score keeping integrated with certain 
robotic devices. That the robotic devices are able to keep score of each individual patient 
generates a positive attitude, which drives patients to beat their previous scores and 
thereby motivating them to exercise more. This, in turn, helps them to recover their motor 
movements and reduce their impairment levels. For therapists, one of the benefits is that 
the devices enable higher training repetitions while reducing the physical load on 
therapist. This is especially so for rehabilitation of lower limb patients where the robotic 
devices would take over the task of moving and supporting the lower limbs and cycle 
patients through the stepping motions. Another benefit was that the ease of adjusting 
the training parameters (e.g. limb guidance force, body weight support, speed, etc) 
allowed therapists to adapt robotic training to suit the individual abilities of patients at 
different stages of recovery. This enabled therapists to safely and continuously challenge 
patients to their training limits, which leads to better recovery of their motor movements. 
Seeing these benefits, therapists are predisposed to use the devices more. Overall, the 
attitudes/benefits of therapists and patients determine their motivation level to use the 
robotic devices. When there are positive attitudes and benefits, this leads to higher 
motivation. And when motivation is high, it creates a positive feedback loop, in which 
therapists and patients experience further benefits from using the robotic devices and 
have better attitudes towards robotic rehabilitation, which then reinforces their motivation 
to use robotic devices. Hence it is important for an implementation plan to actively 
generate positive attitudes and benefits in order to motivate users. 
 
Taken altogether, the inter-play between the various domains of “Evidence”, 
“Organisation”, “Outcomes”, “Therapists”, “Patients”, “Attitudes/Benefits” and 
“Motivation” represent the key planning blocks that should be taken into account when 
planning to implement robotic rehabilitation. The evidence from this thesis suggests that 
integration of these domains would generate a positive momentum that funnels upwards 





Limitations of framework 
 
Small number of studies in economic systematic review 
While the effectiveness review included 51 studies and provided robust evidence, the 
economic review only included five studies. The limited number of economic studies and 
that most of these studies had a relatively small sample sizes does not lend confidence 
to our economic findings. With inclusion of economic studies with larger sample sizes, 
there would be sufficient sampling data to ensure that resource variations can be 
adequately powered to detect cost differences and give a more definitive result.69  
 
Clinical setting 
In the qualitative adoption study, the interviewed therapists were from five hospitals and, 
except for one hospital, all four hospitals were relatively large hospitals with 
multidisciplinary rehabilitation departments, and all hospitals were located in 
metropolitan areas of higher socio-economic countries. This has an effect on the way 
hospitals are organized and funded, which in turn, may influence how robotic 
rehabilitation is adopted, such as the quantity and range of robotic devices, therapy 
access for which patient group, and the availability and competency of staff resources. 
Hence, our organisational findings are most relevant for larger hospitals in urban settings 
with established rehabilitation units. Having acknowledged the limitations of the settings 
in terms of wider applicability, the number of participants sampled in qualitative research 
is not considered a key characteristic for credibility or dependability of the data 
obtained.70 In addition, the therapists interviewed were all very experienced in robotic 
rehabilitation and thus had higher information power, which states that a study can have 
less extensive sample participants when these participants have characteristics that are 
highly relevant and specific for the study aim.71 While acknowledging the limitations of 
the clinical settings, we believe the findings of this study still have applicability in similar 
contexts.  
 
Lack of direct insights from patients 
The adoption study involved only therapists and no patients were interviewed. While 
patient experiences were referred to by therapists, there was no direct data from 
patients. Hence the framework might not be reflective of the viewpoints of patients. 
Nevertheless, given the professional therapeutic relationships that the interviewed 
therapists had with their patients, we believe that the therapists provided relevant 
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feedback about the experiences of their patients.  
 
Significance of thesis 
The thesis has reported on important and critical facets of robotic rehabilitation for stroke 
patients, such as clinical effectiveness, economic feasibility, and adoption into practice. 
In an attempt to integrate all these various facets during the research, a conceptual 
framework illustrating the various actors, concepts and interdependencies that need to 
be considered and addressed when implementing robotic rehabilitation was created. We 
believe that the combination of research methods applied to the questions in this thesis 
research offers a novel approach to robotic stroke rehabilitation and facilitate a holistic 
understanding of the topic.  
 
The various studies conducted under the thesis have also made a meaningful 
contribution to knowledge on robotic stroke rehabilitation, including identifying future 
directions and practice recommendations for robotic stroke rehabilitation. The 
effectiveness systematic review has corroborated published findings that robotic training 
produced better outcomes for severely impaired lower limb patients, while the economic 
systematic review and the qualitative adoption study have generated new knowledge 
and assisted to address the evidence gap. As mentioned in prior sections, the economic 
review, since its publication, has garnered considerable interest from other researchers. 
 
In terms of future areas of research, both the previously identified economic sensitivity 
factors, and insights obtained from the adoption study could potentially serve as starting 
points for further investigation. In view of the economic finding that patient numbers 
should be maximised per robotic training session, and that some therapists commented 
that there was no need for continuous patient monitoring by a therapist during robotic 
training, trials could be conducted to investigate if treatment protocols, especially during 
the patient supervision phase, could be modified for robotic rehabilitation. Some of the 
research questions could be to explore the actual need for continuous monitoring of 
patients by therapists while patients are training on robotic devices, the possibility of 
partial monitoring in view that the robotic devices are largely automated and have safety 
controls built in, and the option of leveraging on robotic automation for therapists to 
conduct both robotic and conventional training at the same time. These questions could 
be the starting points to investigate the optimisation of treatment protocols for robotic 
rehabilitation in order to determine its economic feasibility while taking into account 




Finally, as discussed in this chapter, the amalgamated conceptual framework of robotic 
rehabilitation is (as far as we know) the first such structured, evidence-informed 
framework proposed for implementing robotic stroke rehabilitation. This conceptual 
framework would facilitate planning by administrators, managers and clinicians when 
preparing to introduce robotic rehabilitation into their clinical practices. The framework 
covers aspects of clinical effectiveness, economic cost and adoption considerations, 
which we believe would offer clinicians a holistic and comprehensive planning aid.  
 
Concluding remarks 
The research conducted to address the questions in this thesis required the author to 
adopt a breadth of methodologies and analysis approaches that are both quantitative 
and qualitative in nature. Besides the need to examine the clinical effects of robotic 
stroke rehabilitation via meta-analysis (which involved a sizeable 51 studies), the author 
also has to understand economic cost aspects, which entails branching into 
understanding the limitations of meta-analysis for economic reviews,50,72 and the 
alternate use of hierarchical decision matrix,51,73 cost effectiveness plane,74 and 
incremental cost effectiveness ratio.75,76 The diverse study designs of the included 
economic studies also presented difficulties in extracting and analysing comparable 
data. In addition, to gain further insights into the economic benefits, the author extended 
the hierarchical decision matrix to incorporate a ranking score in order to have a deeper 
analysis of the economic benefits.77 For the qualitative adoption study, to gain a broad 
and more comprehensive perspective, the author interviewed therapists who worked not 
only in Australia but also in various countries across Asia, Western Europe and Northern 
America. This was a challenging exercise in terms of participant recruitment and the 
logistics to conduct interviews with participants from different time zones. Analysis of the 
large amount of data from the interviews also required significant time and discussions 
with supervisors to identify and organise the codes and themes. Despite these 
challenges, the author hopes that the thesis research would contribute to the base of 
knowledge and evidence regarding robotic stroke rehabilitation, and be able to benefit 
users of robotic devices. Ultimately, it is hoped that stroke patients can gain better 
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